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Competition between the red and grey squirrels and an epidemic disease caused by a
Squirrel parapoxvirus (SPPV) both play a crucial role in the replacement of red squirrels by
the grey species. Serological evidence suggests that the grey squirrel may act as a reservoir
host for SPPV, however no route of transmission between the two species has been
identified. The aims of this study were to characterise the SPPV genome and to identify
other potential host species. Knowledge gained from this will be invaluable for the future
development of a vaccine against SPPV, which could be used in conjunction with red
squirrel conservation programmes.
A preliminary investigation to identify rodent species that may act as a reservoir for SPPV
was carried out. Sera collected from wood mice and bank voles were screened for antibodies
to SPPV using an enzyme-linked immunosorbent assay. No alternative hosts were identified
using this approach.
Viral DNA was purified from scab material collected from a red squirrel found dead in the
wild during an epidemic of SPPV in Northumbria. The composition of the SPPV genome is
G+C-rich at approximately 66%, and the genome is estimated to be 158kb in size. The G+C
content is comparable with parapox and molluscipox viruses, but the genome does not
correspond in size to viruses belonging to either of these genera. DNA hybridisation studies
indicate that the central regions of the SPPV and Orf virus (ORFV) genomes are highly
related; however the two viruses are divergent towards the genome ends. Twenty-eight
previously identified poxvirus genes were identified and mapped on to the SPPV genome,
including two genes previously believed to be unique to the molluscipox virus Molluscum
contagiosum (MOCV). Comparison of the organisation of genes in SPPV with Vaccinia
(VACV), MOCV and ORFV revealed an overall conservation in the order of genes, but
differences in the spatial distribution.
Further characterisation revealed that three known parapoxvirus-specific genes that are
associated with virus virulence and immuno-modulation (homologues of interleukin-10 and
vascular endothelial growth factor and the granulocyte macrophage colony stimulating factor
inhibitory protein) appear to be absent in SPPV. In addition, sequence analysis of a putative
SPPV homologue of the conserved poxvirus interferon (IFN) inhibitory gene suggests that
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this gene is disrupted in SPPV and not involved in the inhibition of IFN-induced anti-viral
pathways.
The genomic inconsistencies between SPPV and the other parapoxviruses suggest that the
initial classification of SPPV as a parapoxvirus may be incorrect. Preliminary phylogenetic
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PVNZ Parapoxvirus of red deer in New Zealand
ReindeerPPV Reindeer parapox virus
RPXV Rabbitpox virus
SealPPV Seal parapox virus
SFV Shope fibroma virus
SPPV Squirrel parapox virus
SPV Sheeppox virus
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EEV Extracellular enveloped virus
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dsRNA Double stranded RNA
dNTP Deoxynucleotide triphosphate
FBS Foetal bovine serum
FLMC Foetal lamb muscle cells
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VEGF Vascular endothelial growth factor
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In 1981 a virus morphologically similar to the parapox viruses when visualised by electron
microscopy was identified in scab material collected from a British red squirrel (Scott et al.,
1981). It was proposed that this virus contributed to the rapid decline in red squirrel population
numbers in the UK (section 1.8). The squirrel virus was shown to be antigenically distinct from
the parapoxvirus species Orf virus (ORFV), Pseudocowpox virus (PCPV) and Bovine papular
stomatitis virus (BPSV) by immunodiffusion agar gel tests using polyclonal sera (Sands et al.,
1984). Based on this and its morphological similarities to other parapoxvirus species, the squirrel
virus was formally classified as a separate species of the parapoxvirus genus and named Squirrel
parapoxvirus (SPPV) (van Regenmortel et al., 2000).
The Poxviridae family contains viruses that are capable of infecting both vertebrate (subfamily
Chordopoxviridae) and invertebrate (subfamily Entomopoxviridae) hosts. The Chordopoxviruses
are epitheliotropic and produce a broad spectrum of disease severity, ranging from localised self
limiting infection (for example ORFV) to systemic disease with high mortality [for example the
smallpox virus Variola (VARV)] and a number of poxviruses [for example Molluscum
contagiosum virus (MOCV)] induce tumour formation (Driven, 2001). Disparity in host range is
common in the poxviruses; for example MOCV is restricted to a human host, whereas Vaccinia
virus (VACV) has a wider host range affecting humans and experimental animals.
Successful vaccination against one species of poxvirus can be obtained using another related
species, as illustrated by the protection against VARV provided by vaccination with VACV.
This strategy proved so successful that the World Health Organisation (WHO) embarked on a
global smallpox eradication programme in 1967. The WHO achieved its goal in 1977, and the
world was certified free of smallpox in 1979 (WHO, 1980).
Routine smallpox vaccination has been halted since VARV eradication, but vaccine research has
continued because of the risk of VARV re-emergence due to bioterrorism and the degree of
protection it provides against emerging poxvirus diseases like that caused by Monkeypox virus
(MPV) (Heymann et al., 1998; Smith and McFadden, 2002). In addition, there has been a
resurgence of interest in VACV due to the ease of creating recombinant virus. Recombinant
VACVs are utilised for expression of foreign proteins enabling characterisation of protein
structure and function, and as experimental vaccines (Moss, 1996a).
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Many poxviruses, like ORFV, Fowlpoxvirus (FPV) and the capripoxviruses result in significant
economic losses for commercial farmers (Robinson and Balassu, 1981; Fenner, 1996; Afonso et
al., 2000). The need for effective vaccines and control methods has resulted in considerable
research of these poxviruses. Although not commercially important; SPPV is significant from a
welfare and conservation perspective and the development of an effective vaccine may prove to
be pivotal for the survival of the red squirrel in the UK (Sainsbury et al., 1997; Gurnell et al.,
1999).
As a result of its use as the vaccine against smallpox, VACV is the most characterised member
of the poxvirus family and is used as a model for other poxviruses. Much of the literature
reviewed here (chapter 1.0) is based on VACV, however differences between VACV and the
parapoxviruses undoubtedly exist, and these will be discussed where relevant.
1.2 GENERAL MORPHOLOGY AND CLASSIFICATION OF THE
POXVIRIDAE
Poxviruses are the largest of all animal viruses and posses a single, covalently closed, double
stranded DNA (dsDNA) genome ranging from 130kb to 375kb in length (van Regenmortel et
al., 2000). Poxviruses contain RNA-polymerase activity and transcriptional systems that are pre¬
packaged into the viral core (Kates and McAuslan, 1967b; Munyon et al., 1967) and viral
replication and assembly occurs within the host cell cytoplasm.
Sufficient variation exists within the Chordopoxviridae to warrant subdivision into eight genera,
summarised in table 1.1. Generally genus members share a similar morphology and are
genetically and antigenically related (Moss, 1996b). As the names suggest the virus species
belonging to the leporipox, avipox and capripox genera also infect similar host species.
Viruses belonging to the parapoxvirus genus were generally considered to affect ruminants, until
the inclusion of Parapoxvirus of red deer in New Zealand (PVNZ). In addition, phylogenetic
evidence suggests that a seal poxvirus (sealPPV) also belongs in the parapox genus (Becher et
al., 2002). Other tentative parapoxvirus species have been reported such as auzduk disease virus,
reindeer parapoxvirus and chamois contagious disease virus (Mercer et al., 1997a; Tryland et al.,
2001).
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Brick-shaped virion, DNA-200 Kb, G+C
content~36%, variable host range.
Orf Ovoid-shaped virion, DNA-140 Kb,






Brick-shaped virion, DNA-150 Kb, G+C
-35%, bird hosts, insect vector.
Capripoxvirus Sheeppox3
Lumpy skin disease





Brick-shaped virion, DNA-160 Kb, G+C
-40%, fibroma, insect vector.
Suipoxvirus Swinepox3 Brick-shaped virion, DNA-170 Kb, narrow
host range
Molluscipoxvirus Molluscum contagiosum3 Brick-shaped virion, DNA-190 Kb, G+C
-60%, tumours, human host.
Yatapoxvirus Yaba monkey tumour3
Yaba like disease
Tanapox
Brick-shaped virion, DNA-145 Kb, G+C
-33%, host range limited.
Table 1.1 Classification of the subfamily Chordopoxviridae summarising the characteristic of
each genus and examples of species classified with in each genus (adapted from van
Regenmortel et al., 2000). The prototypal species of each genus is indicated by the suffix (a).
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Poxviruses are generally brick-shaped and range in size from 220 to 450nm in length by 140 to
260nm in width, except for the parapoxviruses which are ovoid in shape and vary between 220
to 300nm in length by 140 to 170nm in width (van Regenmortel et al., 2000). A basket weave
surface morphology is a characteristic of all parapoxviruses when visualised using negative
contrast electron microscopy (Nagington and Home, 1962; Nagington et al., 1962; Wilson and
Sweeney, 1970; Falk, 1978; Scott et al., 1981; Homer et al., 1987). The regular criss-cross
surface details of the parapoxviruses was determined to consist of a single tubular thread that
winds around the virus core in a left-hand spiral coil, which crosses at regular intervals
(Nagington et al., 1964). Other members of the poxvirus family display short tubular or globular
filaments on the surface of the virion and are therefore morphological distinguishable from
parapoxviruses (van Regenmortel et al., 2000).
Sectioned negative contrast images have shown that the internal organisation of VACV consists
of a nucleoprotein biconcave core and two adjacent structures known as lateral bodies bound by
a membrane(s) (Medzon and Bauer, 1970). The surface morphology, the biconcave shape of the
core and the lateral bodies may be artefacts produced as a result of the virion collapsing inward
due to dehydration in sample preparation (Dubochet et al., 1994). However due to the
reproducibility, these artefacts must result from some underlying structure.
1.3 POXVIRUS GENOMES
Vertebrate poxviruses possess large double-stranded DNA genomes. The complete genome
sequence for at least one species of each genus, except for the parapoxvirus genus, have been
published (Goebel et al., 1990; Johnson et al., 1993; Massung et al., 1994; Senkevich et al.,
1997; Cameron et al., 1999; Wilier et al., 1999; Afonso et al., 2000; Tulman et al., 2001; Lee et
al., 2001; Afonso et al., 2002; Shchelkunov et al., 2002; Gubser and Smith, 2002). The length
and the guanine and cytosine (G+C) content of poxvirus genomes varies dramatically between
the genera. Chordopoxvirus genomes vary between 131 kb and 288kb (van Regenmortel et al.,
2000) and G+C content is generally less than 50%, except for the parapox and mollusci
poxviruses, which have G+C contents greater than 60% (Wittek et al., 1979; Senkevich et al.,
1997). The general structure and organisation of poxvirus genomes are reviewed in the following
sections. However, as SPPV has been classified as a parapoxvirus, particular emphasis is given
to parapoxvirus genomes.
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1.3.1 General Properties of Parapoxvirus Genomes
Parapoxviruses are the smallest poxviruses in terms of genome size. Their genomes range from
13lkb to 158kb in length (Gassmann et al., 1985; Robinson et al., 1987; Mercer et al., 1987;
Cottone et al., 1998; Mazur et al., 2000; Mclnnes et al., 2001). Parapox and molluscipox
genomes are comparable in terms of G+C content at 64.5% for ORFV, 61.5% for BPSV and
66% for MOCV (Wittek et al., 1979; Senkevich et al., 1997). The high G+C content of the
MOCV and the parapoxvirus genomes implies that translation stop codons (TAA, TAG, TGA)
will be rare. The paucity of stop codons means that identifying true open reading frames (ORFs)
is relatively difficult, as many potential overlapping ORFs exist within the genome (Fraser et al.,
1990; Fleming et al., 1993; Senkevich et al., 1997). However, since the high G+C content results
in the use of codons which contain a G or a C residue at the third position (Fleming et al., 1993),
codon usage provides an excellent tool for predicting ORFs. This was found to be true for
MOCV (Senkevich et al., 1997).
1.3.2 Hairpin Loops
Rapid renaturation of FPV and VACV DNA following heat and chemical denaturation indicated
the presence of cross-linkage within poxvirus genomes (Szybalski et al., 1963; Berns and
Silverman, 1970). The terminal location of the cross-link was first described in VACV virus
(Geshelin and Berns, 1974) and further work demonstrated that cross-linked ends are a general
feature of the Poxviridae (Wittek et al., 1977; Menna et al., 1979; Thomas et al., 1980;
Gassmann et al., 1985; Mercer et al., 1987).
DNA sequencing of the terminal fragments in VACV revealed that each terminus consists of a
hairpin loop structure, which are complementary and inverted with respect to each other. The
VACV terminal loop structure is A+T rich, 104bp in length, and consists of many mismatched
bases (Baroudy et al., 1982). Although terminal DNA sequence is not available for ORFV, the
terminal loop is estimated to be approximately lOObp and is therefore consistent with VACV in
terms of length (Mercer et al., 1987).
During the replication of poxvirus genomes, concatamers are formed of progeny genomes
(Wilier et al., 2000). Several models of genome replication have been proposed (Baroudy et al.,
1982). The terminal hairpin loops are a structural necessity for genomic replication in all
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proposed models and concatamer junctions require processing to separate the progeny strands.
VACV proteins encoded by the genes H6R and A22L are able to cleave synthetic concatamers
(Holliday junctions) in vitro (Sekiguchi et al., 2000; Garcia el al., 2000). In addition, in vivo
characterisation of a VACV A22L deletion mutant demonstrated that A22L is essential for the
cleavage of the concatameric forms into genome length units and successful virus replication
(Garcia and Moss, 2001).
1.3.3 Inverted Terminal Repetitions
The presence of identical terminal sequences, which are inverted with respect to each other
[inverted terminal repeats (ITRs)] were first suspected when restriction endonuclease fragments
of equal length were cleaved from both ends of the VACV and Rabbit poxvirus (RPXV)
genomes (Wittek et al., 1978a). Single stranded VACV DNA was also observed by electron
microscopy to circularise presumably by the hybridisation of terminal regions (Garon et al.,
1978). Hybridisation of DNA fragments derived from one end of the genome with fragments
from the other end also demonstrated the presence of ITRs in parapoxvirus genomes (Menna et
al., 1979; Gassmann et al., 1985; Mercer et al., 1987).
The DNA sequence of the ITR regions are not conserved amongst the parapoxvirus genus, as
demonstrated by the absence of terminal fragment hybridisation between the different parapox
species (Gassmann et al., 1985; Robinson and Mercer, 1995). In addition, cross-hybridisation of
the ITR fragments derived from different ORFV isolates produced varying hybridisation
intensities suggesting that there is some degree of ITR sequence divergence between isolates of
the same species (Robinson et al., 1987).
Sequencing of the terminal regions of VACV revealed that the ITRs consist of blocks of
sequence ranging in size from 54 to 125bp which are tandemly repeated up to 18 times (Baroudy
et al., 1982). Repetitions of short sequences located within the ITRs appear to be a general
feature of poxvirus genomes, with the exception of Shope fibroma virus (SFV) (Wilier et al.,
1999). Sequencing of the left end+ of ORFV strain NZ2 revealed a 15bp sequence repeated
+
Fleming et al., (1993) reversed the orientation of the ORFV genome to allow alignment with VACV. All
references prior to this paper incorrectly orientate the ORFV genome. This review corrects for this
discrepancy when referring to the left or right of the genome.
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fourteen times, and sequences of 16 to 36bp repeated two to four times; these repeats were inter¬
spaced with unique regions (Fraser et al., 1990). The size variation of terminal fragments in the
VACV genome was shown to be the result of differences in the number of repeated elements.
Variation in ITR size is postulated to arise from unequal recombination events during DNA
replication or incorrect processing of the concatamers (Baroudy et al., 1982). It is unknown if
blocks of repeated sequence provide a selective advantage in replication or whether they are
non-functional. The lack of repeats in SFV supports the latter view (Fraser et al., 1990; Wilier et
al., 1999).
Fraser et al., (1990) described the ORFV ITRs as being organised into three distinct regions
comprising of the hairpin loop structure, a non-coding region consisting of tandem repeats
(adjacent to the hairpin) and coding regions (near to or overlapping the ITR/unique sequence
junction). DNA sequencing recognised a number of potential ORFs in the ORFV ITR. Whether
all of these are transcribed is uncertain, although conserved poxvirus transcription promoter
sequences were identified preceding two of the potential ORFs: one overlapping the ITR
junction (ORF2) and one present within the ITR (ORF3) (Fraser et al., 1990). To date only
ORF3 has been confirmed as being transcriptionally active, encoding for an early protein of
unknown function (Fleming et al., 1991; Fleming et al., 1992; Vos et al., 1992).
1.3.4 Conservation and variation of poxvirus genomes
Poxvirus genomes are organised into distinctly conserved and variable regions. Restriction
endonuclease mapping of several orthopoxvirus species has revealed a high degree of
conservation within the central regions of the genomes (Wittek et al., 1977; Mackett and
Archard, 1979; Esposito and Knight, 1985). However, the restriction maps of the terminal
regions are only identical or similar between isolates of the same species (Mackett and Archard,
1979; Esposito and Knight, 1985). In contrast, the central regions of the different parapoxvirus
species do not exhibit the same level of cross-species restriction site conservation as seen in the
orthopoxviruses (Wittek et al., 1980; Robinson et al., 1982; Rafii and Burger, 1985), nor the
same level of conservation between isolates of the same species (Wittek et al., 1980; Robinson
et al., 1982; Rafii and Burger, 1985; Gassmann et al., 1985; Robinson et al., 1987; Gilray et al.,
1998; Mazur et al., 2000). Wittek et al., (1980) proposed that lack of restriction site conservation
between the different parapoxvirus species and isolates must result from a greater divergence at
the nucleotide level when compared to the situation in orthopoxviruses. Despite restriction site
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heterogeneity, central fragments from different parapoxviruses hybridise strongly with each
other (Gassmann et al., 1985; Robinson and Mercer, 1995). These fragments mapped to similar
genomic locations, revealing the true conserved nature of the central regions of the different
parapoxvirus genomes.
DNA hybridisation has been used to investigate the degree of conservation between poxviruses
belonging to the different genera. For example, the central region of the capripoxvirus genome
was shown to be essentially collinear to VACV (Gershon et al., 1989). The use of DNA
hybridisation as a method of investigating the genomic relationship between the parapoxviruses
and other genera is however redundant due to the dissimilarity in the G+C content. This situation
has been largely resolved with DNA sequencing. Although the complete genome sequence of a
parapoxvirus has yet to be determined, non-contiguous sequences amounting to approximately
20% of the total genome of ORFV has been published (Mercer et al., 1997a). Predicted amino
acid sequences of putative ORFV genes exhibit a high degree of identity to many essential
VACV proteins (Fleming et al., 1993; Mercer et al., 1995). The orientation and location of these
conserved genes were similar for ORFV and VACV (Mercer et al., 1989; Naase et al., 1991;
Fleming et al., 1993). A genetic map of ORFV demonstrated that of the thirty-seven putative
genes identified, thirty-two share homology and are relative in position, orientation and spatial
arrangement with VACV genes (Mercer et al., 1995).
The complete genome sequencing of numerous poxviruses has revealed that the central regions
of poxvirus genomes are essentially collinear. However, the FPV genome is unusual in that
several major rearrangements of the central region have occurred, resulting in a marked
reduction in collinearity with other poxviruses (Afonso et al., 2000). Comparison of the
complete gene complements of several poxviruses from different genera suggests that the central
core of genes required for viral replication extends from the homologue of the VACV gene F9L
to A34R (Gubser and Smith, 2002). The divergence of poxviruses into genera and species may
have arisen from alterations in gene content, homology and organisation in the variable region
(Gershon et al., 1989). Alterations in the genome can occur via a number of mechanisms:
deletion, recombination, duplication and translocation of sequences, also insertion of foreign
DNA.
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Rafii and Burger (1985) were the first to report deletions within the genome of ORFV.
Comparison of the restriction maps of numerous ORFV low passage tissue culture strains and
wild-type isolates demonstrated that inter-strain variation was at its greatest in the right half of
the genome (Robinson et al., 1987). Heterogeneity in restriction profiles within a species is most
apparent in viruses that have undergone prolonged passage in tissue culture. For example,
serially passaged VACV exhibits genome-length heterogeneity (Wittek et al., 1978b). The
disparity in length was attributed to the deletions of terminal sequence (Panicali et al., 1981).
Many of the genes located towards the genome ends encode proteins that are not essential for
virus replication in tissue culture, and are often associated host range, tissue tropism and
modulation of the host immune response (Moss, 1996b).
Mutants arising from prolonged passage in tissue culture of ORFV strains NZ2, D1701 and orf-
11 have been studied. Characterisation of ORFV-NZ2 revealed that the right terminal 19.3kb
had been duplicated and translocated to the left end of the genome, replacing the left terminal
6.6kb of DNA. The net results were the enlargement of the ITRs to 19.3kb and the deletion of
3.3kb of unique DNA that encodes for at least three non-essential genes designated ORFV E2L,
E3L and GIL (Fleming et al., 1995). Similar duplication/deletion events have occurred within
the genomes of the ORFV strains, orf-11 and D1701, which have been extensively passaged in
tissue culture. In strain orf-11, the ORFV E2L, E3L, GIL and one further non-essential gene
designated ORFV G2L (normally found adjacent to GIL) are deleted (Mclnnes et al., 2001). In
strain D1701, only the ORFV E2L is deleted (Cottone et al., 1998). All three of these ORFV
stains are highly attenuated in vivo, which implies that the deleted genes may be associated with
virulence. The ORFV E2L is predicted to encode a 6KDa protein, which is conserved in several
orthopoxviruses and has compositional similarity to the African swine fever virus plO DNA-
binding protein (Mercer et al., 1996a). The ORFV E3L was originally believed to be a
homologue a retroviral pseudoprotease (Mercer et al., 1989). However later analysis identified it
as a deoxyuridine 5'triphosphate nucleotide hydrolase (dUTPase) and a homologue of the
VACV gene F2L (Fleming et al., 1995). Exactly how dUTPase contributes to virulence is
unknown, although several potential roles have been suggested. dUTPase catalyses the
hydrolysis of dUTP to dUMP, thus reducing the incorporation of dUTP into the replicating viral
DNA genome (Cottone et al., 2002). dUTPase may also increase the pool dTTP available for
viral DNA replication (Fleming et al., 1995). The GIL gene encodes an ankyrin repeat protein of
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unknown function (Sullivan et al., 1995b). The ORFV G2L protein is a homologue of the
uncharacterised VACV F11L protein (Sullivan et al., 1995a).
1.4 REPLICATION CYCLE AND GENE EXPRESSION OF POXVIRUSES
Several infectious forms of poxviruses exist, representing different stages in the morphogenesis
and egress of viral particles. The occurrence of the different forms during the replication cycle of
VACV is summarised in figure 1.1. Immature virus (IV) develop into intracellular mature virus
(IMV), which are the most abundant form of infectious virus and are released upon destruction
of the host cell. A proportion of IMV acquires additional lipid membranes forming intracellular
enveloped virus (IEV). IEV is transported to the cell surface where the majority remains cell
associated (CEV), whilst a small proportion is released to become extracellular enveloped virus
(EEV) (Smith and Vanderplasschen, 1998)
In vitro studies on VACV mutants deficient in EEV production, and comparison of VACV
strains that produce differing amounts of EEV, suggest that EEVs are the main effectors of long
range virus dissemination whilst CEVs are responsible for localised cell to cell spread (Blasco
and Moss, 1991; Blasco and Moss, 1992).
The replication cycle of VACV is reviewed here in section 1.4. However, due to the conserved
nature of the virus replication genes that are located in the central regions of different poxvirus
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1.4.1 Poxvirus attachment, entry and disassembly of protein core
Poxvirus attachment and entry to the host cell is a contentious issue and is complicated by the
apparent difference in the mechanism(s) of attachment and entry of IMV and EEV. Several lines
of evidence support different attachment/entry mechanisms of IMV and EEV. 1) Different
protein compositions of outer membranes of IMV and EEV (Payne, 1978; Jensen et al., 1996).
2) EEV have a higher specific infectivity than IMV (Payne and Norrby, 1978; Vanderplasschen
and Smith, 1997; Locker et al., 2000). 3) A monoclonal antibody that blocks attachment of IMV
to the cell surface does not affect EEV attachment (Chang et al., 1995b). 4) Treatment of cells
with pronase, trypsin and neuraminidase to differentially disrupt cellular surface proteins result
in varying binding efficiencies of VACV EEV and IMV particles, conclusively demonstrating
that IMV and EEV bind to different cellular receptors (Vanderplasschen and Smith, 1997).
Considerable progress has been made in identifying putative IMV attachment proteins. In
VACV, IMV proteins A27L and H3L have been implicated in the attachment of IMV to the
cellular receptor for heparin sulphate and VACV D8L to the cellular receptor for chondroitin
sulphate (Chung et al., 1998; Hsiao et al., 1999; Lin et al., 2000). In contrast to IMV, little is
known about the EEV mechanism(s) of cellular attachment. This is mainly due to technical
difficulties in obtaining pure preparations of undamaged EEV particles for study (Smith and
Vanderplasschen, 1998). Mutant VACVs lacking genes encoding EEV membrane proteins are
being studied. To date, only the EEV membrane protein, A34R has been directly implicated with
EEV infectivity (Mcintosh and Smith, 1996). Whether A34R is critical for EEV attachment is
unclear, as antibody specific for A34R did not inhibit viral infectivity. In addition, monoclonal
antibodies against the EEV membrane B5R also resulted in a reduced infectivity, suggesting that
B5R may also be involved in cellular attachment or entry (Galmiche et al., 1999); however this
is disputed (Vanderplasschen et al., 1997). These data suggest that like IMV, several
mechanisms may exist for the attachment of EEV to a cellular receptor(s), mediated by several
envelope proteins.
Following viral attachment to the surface of the cell, the viral particle is internalised via an entry
mechanism(s), which results in the removal of the EEV and IMV lipid membranes and the
release of the "naked" nucleoprotein core into the cytoplasm. Several possible entry mechanisms
have been proposed, although much of the supporting data is contradictory.
25
An EEV entry mechanism involving the direct fusion of the viral envelope with the plasma
membrane was proposed (Doms et al., 1990). However direct fusion of virions possessing more
than one membrane would not result in the release of naked cores into the cytoplasm (Smith et
al., 2002). Alternatively endocytosis was suggested after viral entry was inhibited in the
presence of cytochalasin drugs, which disrupt the actin/ezrin filament involved in endocytosis
(Payne and Norrby, 1978). However some disagreement exists as to whether entry of just IMV
or both IMV and EEV are affected by cytochalsin drugs (Vanderplasschen et al., 1998; Locker
et al., 2000). Ichihashi proposed that following endocytosis, the EEV membrane is disrupted in
the endosome in a low pH-dependent manner. Subsequent fusion of the remaining membrane
with the endosome membrane would release the viral core into the cytoplasm (Ichihashi, 1996).
In support, Vanderplasschen and Smith (1998) reported that the detection of naked viral cores
within the cytoplasm was reduced following infection of cells with EEV in the presence of
lysosomotropic drugs that increase intracellular pH, however this is disputed by Doms et al.,
1990. Clearly, endocytosis, membrane fusion and pH may all be involved in virus entry,
although more research is required to determine the precise mechanism(s) by which entry
occurs.
Core disassembly results in the release of viral DNA into the cytoplasm. This process is
considered complete when the viral DNA becomes susceptible to the action of DNAase (Joklik,
1964). Proteins isolated by fractionation of infected cell extracts were assessed in vitro for core
uncoating properties. A 23KDa trypsin-like protease was shown to disassemble the viral core in
vitro (Pedley and Cooper, 1987). Cessation of viral transcription and protein synthesis by
treatment with actinomycin D and cyclohexamide prevents uncoating, which suggests that the
core-disassembly protein is virally encoded and synthesised de novo. However the gene
encoding this protein remains unidentified.
1.4.2 Sequential Gene Expression
Poxviruses undergo three distinct phases of gene expression in the replication cycle,
characterised by early, intermediate and late genes (figure 1.1). Sequential expression of these
genes is under the regulation of phase-specific promoters and transcription factors (Moss, 1990).
Early gene transcription begins immediately after infection whilst the viral DNA is still coated
and is carried out by the core associated early transcription machinery (Kates and McAuslan,
1967b; Kates and McAuslan, 1967a; Munyon et al., 1967; Kates and Beeson, 1970; Gershon and
26
Moss, 1990; Ahn and Moss, 1992). Prevention of viral DNA uncoating by cyclohexamide
treatment results in prolonged early transcription (Baldick and Moss, 1993). This has led to the
suggestion that core disassembly and/or DNA replication negatively regulates early transcription
(McDonald et al., 1992; Moss, 1996b). Replication of the viral DNA genome is required for the
replication cycle to proceed to intermediate phase; interruption of DNA replication with
hydroxyurea prevents intermediate transcription (Baldick and Moss, 1993).
Transcription is carried out by two forms of virally encoded DNA-dependent RNA polymerase.
Both RNA polymerase forms consist of eight common subunits: RP0147, 132, 35, 30, 22, 19,
18 and 7, which are encoded by the VACV genes J6R, A24R, A29L, E4L, J4R, A5R, D7R and
G5.5R respectively (Condit and Niles, 2002). However, the RNA polymerase form that
specifically transcribes early genes possesses the additional 94Kda RNA polymerase associated
protein, which is encoded by the VACV H4L gene (Ahn and Moss, 1992; Ahn et al., 1994).
Despite overall differences in genome G+C content, poxvirus genes from different genera are
preceded by conserved phase-specific A+T-rich promoter elements (Davison and Moss, 1989a;
Davison and Moss, 1989b; Fleming et al., 1991; Fleming et al., 1993; Baldick et al., 1992;
Senkevich et al., 1997). Transcription is best characterised in VACV and therefore VACV is
reviewed here, however all of the co-factors and control sequences appear to be conserved
throughout the pox virus family. Known VACV transcription initiation factors and cofactors are
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Gershon and Moss, 1990
Ahn and Moss, 1992
Rosales et al., 1994a
Rosales et al., 1994b
Sanz and Moss, 1999
Morgan et at., 1984
Niles etal., 1989
Keck et a!., 1990
Keck et a!., 1990
Keck et at., 1990
Kovacs and Moss, 1996
Gunasinghe etal., 1998
Morgan et al., 1984
Niles et al., 1989
Schnierle et al., 1992
Gershon et al., 1991
Simpson and Condit, 1995
Xiang et al., 1998
Lackner and Condit, 2000
Latner et al., 2000
see above
Black and Condit, 1996
Deng and Shuman, 1998
Table 1.2 Summary of the VACV transcription factors involved in the initiation and regulation of
early/intermediate and late (E/l/L) transcription and the modification of transcripts. Abbreviations
are defined in the summary of abbreviations (located at the beginning of this thesis).
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1.4.2.1 Early gene expression
Studies on VACV have shown that the conserved promoter core acts as cross-linking site for the
VACV early transcription factor (VETF) (Cassetti and Moss, 1996). The RAP94 subunit of the
early RNA polymerase specifically interacts with the VETF/early promoter complex and
mediates the recruitment of the RNA polymerase complex to the DNA template (Ahn et al.,
1994; Mohamed et al., 2002).
Termination of VACV early transcription occurs approximately 50bp downstream from a
TTTTTNT sequence (Yuen and Moss, 1987). Specific termination results in early transcripts of
a discreet length. Termination of transcription is a complex process that is poorly understood.
However, several RNA polymerase associated factors including the RAP94, the capping enzyme
(section 1.4.2.3) and nucleoside triphosphate phosphohydrolase I (NPH I) (section 1.4.2.4) are
involved in transcription termination and transcript release in response to the UUUUUNU
sequence in the nascent RNA (Shuman et al., 1987; Shuman and Moss, 1988; Luo et al., 1995;
Deng and Shuman, 1998; Mohamed and Niles, 2000; Mohamed and Niles, 2001; Mohamed et
al., 2002).
1.4.2.2 Intermediate and late gene expression
Intermediate and late transcription have several features in common that are different from early
transcription. Firstly, RAP94 is not required for intermediate or late transcription (Wright and
Coroneos, 1995; Condit and Niles, 2002). Secondly, no transcription termination signals have
been identified for intermediate or late genes and probably as a result, intermediate and late
transcripts are heterogeneous in length at the 3'-termini (Weir and Moss, 1984; Baldick and
Moss, 1993). Thirdly, intermediate and late transcripts are polyadenylated at the both ends, 5'
polyadenylation is believed to be the result of an RNA polymerase slippage mechanism (Ahn
and Moss, 1989). Initiation of intermediate and late gene transcription is poorly understood, but
presumably RNA polymerase is recruited to the promoter region via phase-specific transcription
factors as with early transcription.
Three intermediate and five late VACV transcription factors have been identified (table 1.2),
which are all required in combination with RNA polymerase for the activation of transcription in
vitro (Keck et al., 1990; Kovacs and Moss, 1996; Sanz and Moss, 1998). In addition, the capping
enzyme is required for the initiation of intermediate transcription in vitro (Vos et al., 1991).
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Surprisingly, VITF-2 and VLTF-X were also purified from uninfected cells, suggesting that
these factors are cellular proteins (Rosales et al., 1994b; Wright et al., 1998). It was later
established that VLTF-X specifically binds to VACV late promoter DNA (Gunasinghe et al.,
1998). However, the precise function of VLTF-X and its interaction with other VLTFs and RNA
polymerase is yet to be established. Likewise, the VITF(s) involved in VITF/promoter
interaction and the mechanism of RNA polymerase recruitment is also yet to be determined.
1.4.2.3 Transcript modifications
Poxvirus transcripts are capped by methylation of the 5'-purine and are polyadenylated at the 3'-
end. The cap structure is essential for the binding of viral mRNAs to ribosomes and hence
translation. Polyadenylation at the 3'-end is likely to contribute to stability of the mRNA (Moss,
1990). The mechanisms of transcript modification have mainly been investigated in early
transcription; although it is presumed that the same mechanisms function in intermediate and
late phases (Condit and Niles, 2002).
The cap structure is formed on the nascent RNA and is catalysed by the capping enzyme
complex (table 1.2), which is recruited to the 5'-end of nascent RNA by stable association with
the RNA polymerase complex via the RAP94 subunit (Mohamed et al., 2001). Polyadenylation
of the 3'-end of RNA is catalysed by the VACV-encoded heterodimeric poly(A) polymerase
protein (table 1.2) (Gershon et al., 1991).
1.4.2.4 Transcription cofactors
Several VACV proteins have been identified as positive or negative transcription elongation
factors, which prevent premature termination of transcription or extensive read through of genes
(table 1.2). Some of these factors play a role in all phases of infection and some have other
functions besides transcription regulation.
For example the VACV A18R gene is expressed and functions as a DNA helicase during all
phases of infection (Simpson and Condit, 1995). In addition, A18R acts in conjunction with
other as yet unidentified proteins as a negative elongation factor, effecting the release of
intermediate and late transcripts from the transcription complex, thereby preventing extensive
read through of genes (Lackner and Condit, 2000). In contrast, VACV G2R functions as a
positive elongation factor for intermediate and late genes, preventing the premature termination
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of transcription (Black and Condit, 1996). Interestingly, the deletion of the G2R gene appears to
compensate for the deletion of the A18R gene, which suggests that G2R and A18R interact
either directly or indirectly with each other in the regulation pathways of intermediate and late
transcription (Condit et al., 1996). Likewise, in addition to transcription initiation and transcript
modification (sections 1.4.2.2 and 1.4.2.3), the VACV J3R also functions as an intermediate and
late transcription positive elongation factor (Latner et al., 2000). To date, only one putative early
gene elongation factor (NPH I) has been identified. In addition to its role in early gene
termination (section 1.4.2.1), NPH I may also play a non-essential role in RNA elongation by
preventing the early termination of transcription in response to T-rich regions in the template
DNA (Deng and Shuman, 1998; Condit and Niles, 2002).
1.4.3 Virion Development and Release
1.4.3.1 Membrane formation
Assembly of progeny virus occurs in the dense areas of the cytoplasm referred to as the
viroplasm or virus factories. The first stage of virus assembly is characterised by the appearance
of crescent-shaped membranes, which develop into spherical immature virus (IV). Several
authors have reported that the developing crescent membranes are formed de novo (Morgan,
1976; Hollinshead et al., 1999). This is contested by reports that in VACV and ORFV assembly,
the viral crescents are derived from the cellular membranes of the smooth endoplasmic reticulum
(Sodeik et al., 1993; Onwuka et al., 1995). The generation and study of a range of VACV
deletion, temperature sensitive or drug dependent mutants has identified several genes, including
A14L, A17L, D13L and F10L, that are essential for the correct formation of the crescent
membranes (Sodeik et al., 1994; Sodeik et al., 1994; Rodriguez et al., 1995; Rodriguez et al.,
1998; Traktman et al., 1995). Putative roles for these proteins have been suggested, including
protein-protein or protein-membrane interactions that alter the cellular derived membrane and
provide scaffolding-like support for the developing crescents (Sodeik and Krijnse-Locker, 2002).
1.4.3.2 Packaging of nucleoprotein, DNA and IMV development
The electron dense nucleoprotein core material is seen in close association with the developing
crescents, and later becomes encapsulated by the membrane to form IV (Morgan, 1976).
Following packaging, the IV core undergoes what is described as the condensation of the
nucleoprotein material to form IMV (Morgan, 1976; Sodeik et al., 1993). Evidence suggests that
several proteins (A4L, A9L, A30L, A32L, L4R, E10R, J1R and G7R) may be involved in
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packaging of the core and subsequent core protein cleavage to form IMV (Wilcock and Smith,
1996; Cassetti et al., 1998; Risco et al., 1999; Yeh et al., 2000; Senkevich et al., 2000; Chiu and
Chang, 2002; Szajner et al., 2003). It is unknown how the early gene transcription machinery is
packaged into the virus core. It was suggested that the machinery is packaged along with the
viral DNA as a complex, via a VETF/early promoter binding mechanism (Li et al., 1994).
Conversely, Cassetti determined that the transcriptional machinery is also packaged
independently of the DNA (Cassetti et al., 1998).
1.4.3.3 Development of IEV
A proportion of IMV are transported from the viral factories along microtubules to the trans
golgi network, where the IMV are wrapped in additional membranes forming LEV (Sodeik et al.,
1993; Sanderson et al., 2000) (figure 1.1). The IMV cellular attachment protein A27L (section
1.4.1) is also essentia] for the microtubular transport of the IMV to the golgi and the wrapping of
IMV with the additional golgi-derived membranes (Sanderson et al., 2000; Vazquez and
Esteban, 1999). Two EEV membrane proteins F13L and B5R localise to the golgi-derived
membranes (Hiller and Weber, 1985; Ward and Moss, 2000) and are essential for the wrapping
of IMV with additional membranes (Blasco and Moss, 1991; Engelstad and Smith, 1993; Wolffe
et al., 1993). This has lead to the hypothesis that F13L and/or B5R may interact with the IMV
surface via A27L facilitating the efficient wrapping of IMV particles (Sanderson et al., 2000;
Smith et al., 2002). However a direct interaction between A27L and either B5R or F13L has yet
to be demonstrated.
1.4.3.4 Transport of IEV to the cell membrane and release
It was proposed that the movement of IEV to the cell periphery is via propulsion on the tip of a
polymerising actin tail, and upon viral egress, actin-containing filopodia form beneath the CEV
projecting it from the cell surface (Cudmore et al., 1995). Evidence indicates that the IEV
membrane protein A36R is responsible for actin polymerisation in association with the EEV
membrane proteins A33R and A34R (Wolffe et al., 1997; Wolffe et al., 1998; Roper et al.,
1998; Frischknecht et al., 1999; Rottger et al., 1999). Upon the fusion of IEV with the cell
membrane, the A36R protein becomes concentrated in the cytosolic face of the cell membrane
immediately beneath the CEV (van Eijl et al., 2000). As a result, it was suggested that actin
filaments form at the plasma membrane underneath CEV producing the filopodia structure. In
support, VACV mutants deficient in the membrane proteins A33R, A34R and A36R failed to
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induce the formation of actin filaments and filopodia, however these mutants still produced
virus, although the resulting plaques were smaller (Wolffe et al., 1997; Wolffe et al., 1998;
Roper et al., 1998). This suggests that firstly, the formation of actin containing filopodia beneath
CEV particles promotes efficient cell to cell spread (Johnson and Huber, 2002) and secondly,
that the transport of IEV and the egress to form CEV is not dependent upon A33R, A34R or
A36R and hence actin microfilaments. An alternative model of IEV movement was proposed
whereby virus is transported to the cell membrane via microtubules (Hollinshead et al., 2001;
Geada et al., 2001). The evidence provided by Hollinshead and Geada is compelling. Firstly,
actin filaments were observed at the periphery of infected cells but not in the centre. Secondly
the movement of IEV to the cell periphery was inhibited with the microtubule disrupting drug
nocadazole. Studies using F12L deletion mutants implied that the IEV-specific F12L protein is
essential for microtubular movement of IEV to the cell periphery (van Eijl et al., 2002).
1.5 POXVIRUS GENES ASSOCIATED WITH VIRUS VIRULENCE
The genes involved in virus replication (discussed in section 1.4) are generally located towards
the centre of the genome and are conserved in all poxviruses. Towards the ends of poxvirus
genomes, species or genus-specific genes that are not essential for virus replication in tissue
culture are found. Several of these non-essential genes have been characterised and are
associated with virus virulence in vivo. These virulence genes are in addition to the genes
encoding immuno-modulatory proteins, which will be reviewed in context of the immune
response to poxviruses in section 1.6. Examples of virulence genes are the virus-encoded growth
factors, which are found in poxviruses belonging to most genera (table 1.3).
Homologues of the mammalian vascular endothelial growth factor (VEGF-E) were identified in
the ORFV strains NZ2 and NZ7 near to the right ITR junction (Lyttle et al., 1994). The NZ2 and
NZ7 VEGF-Es exhibit little homology to each other at the DNA level and only 41.1% identity at
the peptide level. It was postulated that these genes were acquired from the host, but that the
sequence variation between NZ2 and NZ7 VEGF-Es is the result of separate gene acquisition
events or sequence divergence from an ancestral strain (Wise et al., 1999). The variation
between the two ORFV strains is reflected in the VEGF-receptor (VEGF-R) affinities. Both
ORFV VEGF-Es have a high affinity to VEGF-R2, however ORFV NZ2 VEGF-E also binds to
neurophillin (NP-1) (Ogawa et al., 1998; Wise et al., 1999).
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Mammalian VEGFs promote mitosis of vascular endothelial cells and angiogenesis, and increase
vascular permeability (Risau, 1997). VEGFs from ORFV NZ2, NZ7 and strain D1701 all appear
to be biologically functional. Mitotic activity, increased vascular permeability and chemotactic
migration of epithelial cells have all been demonstrated in vitro with ORFV VEGF-E (Ogawa et
al., 1998; Wise et al., 1999; Meyer et al., 1999). In addition, VEGF-E induced angiogenesis has
been demonstrated in vivo in the cornea of the rabbit (Meyer et al., 1999). Infection of sheep
with a recombinant ORFV, in which the VEGF-E gene was disrupted, resulted in lesions that
were less severe, less vascularised and resolved more quickly than lesions induced with wild-
type virus (Savory et al., 2000). VEGF-E induced vascularisation of ORFV lesions may
contribute to virulence by supporting extended dermal regeneration, thereby providing actively
proliferating epithelial cells for the virus to infect and replicate within (Savory et al., 2000). In
addition extensive infectious scab formation and shedding into the environment may assist in the
transmission of ORFV between individuals.
Genes have been identified in VACV, CPV, MYXV and SFV that encode polypeptides with
structural similarity to mammalian epithelial growth and transforming growth factor alpha
(Twardzik et al., 1985; da Fonseca et al., 1999; Cameron et al., 1999; Wilier et al., 1999).
VACV mutants deficient in VACV growth factor (VGF) were shown to be attenuated (Buller et
al., 1988b). Conversely, wild type VACV with a functional VGF gene were fully virulent and
shown to induce cell proliferation in vivo (Buller et al., 1988a). The VGF is predicted to increase
virus virulence in vivo in similar manner to ORFV VEGF-E by simulating epithelial cells to




Apoptosis NKfunction Complement Cytokines Chemokines Growthfactors
MOCV159Land60 CPVcrmA;VACVB13R MYXV011L MOCV080R VACVC21L VACVhost VACVE3L;ORF20.0 VACVK3L VACVB8R;MYX007LVR VACVB18R CPVcrmB]r D CPVcrmC&D;VACA53R ORFVIL-10;LSD005L ORFVGI MCV053L VACVD7L VACVB15R SWPVK2R MCV148R VACVB29R;MYX001L MYXV007L/R;SFV/R ORFVVEG -E FPV080 VACVC11R;MYX0 0LLSD 016;YLDV15L
InteractswithFADDpreventingcaspaseactivation Inhibitionofcaspase-1andL-1p Inhibitsapoptosisbyeffectingmitochondrialpermeability MFICIhomologue,putativer leinreventingNK Complement3band4bindi gprotei Hostderivedcomplementntrolp ot insiEEV BindsdsRNAandinhibitt ePKRRNAaseLIF -i ducednti-v ralpathways Pseudo-substratefKRph sphorylation SolubleIFNyreceptorhomologu SolubleandenvelopeIFNa/prec ptorhomologu TNFaandFpreceptorhomologues TNFareceptorhomologue HomologuefIL-10,down-regulatesTh1resp ns SolubleGM-CSFandIL-2bindingprotei SolubleIL-18bindingprotein,inhibitsd c dIFNyproductio SolubleIL-18bindingprotein,inhibitsducedFNyproductioandNKctiv ty SolubleIL-1pbindingprote n. SolubleIL-8receptorhomologu CCchemokineantag nist SolubleCCbindingprotein,inhibitsflammatoryce laccumulation IFNyreceptorwhichalsbindsndinhib tC,CXCchemokines SolublehomologuefVEGF,pr motesangiogenesis Solublehomologueftransforminggrowthfact rp Solublehomologufepidermalgr wthfactor/transformingct ra pha
Table1.3Summaryofselectionpoxvirusencodedimmu o-modulatingnvirulencefact rs.D taadaptedrS i h.,( 997);M s at.,(2000);AlcamindKoszi owski,0)H ig(2001).Theide tityfeachvirusindi t dbytsstandarabbreviation(v nReg nmor el al.,2000)orsdefinedithsummaryfabbreviations(locatbeg ningithesi ). 35
1.6 IMMUNITY TO POXVIRAL INFECTIONS
The mammalian host has evolved many complex mechanisms for dealing with viral infections.
A successful immune response results in the clearance of virus and long term immunity, whereas
an unsuccessful response results in clinical disease and recurring infections. The immune
response to infection is characterised by two phases, the innate response and the adaptive
response. Poxviruses have involved many strategies to inhibit or subvert both responses.
Immunity and counter immunity is reviewed here (sections 1.6.1 to 1.6.3) with particular
emphasis on ORFV, however as the immune response to VACV is the most well characterised it
is also included.
1.6.1 Innate response
The innate immune response is antigen non-specific and is characterised by apoptosis,
complement activation, macrophage and natural killer cell (NK) activity and the production of
interferons (IFN) and inflammatory cytokines. Viral inhibition of these responses is predicted to
provide the virus with increased capacity to produce progeny virus early in infection and hinder
the hosts ability to mount a successful adaptive response to infection (Haig, 2001).
Type I interferons (IFNa and IFN3) are produced by virus-infected cells and induce an antiviral
state in neighbouring cells by interfering with protein synthesis pathways (see below). Type II
interferon (fFNy) is produced by activated NK and T-cells and also induces an antiviral cell
state; in addition IFNy is a potent mediator of adaptive immune responses (Goodbourn et al.,
2000). The study of VACV infection in IFNa/(3/y receptor knock out mice has shown that IFNs I
and II are important in reducing VACV viral replication and pathogenesis in vivo (van den
Broek et al., 1995). VACV possesses two genes, E3L and K3L that inhibit the action of IFNs
(Beattie et al., 1991; Watson et al., 1991). The existence of a homologue of the VACV E3L gene
in ORFV (OV20.0L) may explain the resistance of ORFV-infected cultured ovine cells to the
action of type I and II IFNs (Mclnnes et al., 1998; Haig et al., 1998).
Two dsRNA-dependent IFN-induced anti-viral pathways have been described in mammalian
cells (Goodbourn et al., 2000). The first pathway involves the activation of the enzyme Pl/eIF-2
protein kinase (PKR) by a dsRNA-induced autophosphorylation reaction. Activated PKR
phosphorylates the a subunit of the protein synthesis initiation factor (eIF-2a), which in its
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natural non-phosphorylated form is involved in the initiation step of protein translation.
Phosphorylation of the eIF-a subunit by PKR inhibits the eIF-2a function, disrupting protein
synthesis and virus replication. The VACV E3L protein has a high binding affinity for dsRNA
and has been shown to inhibit the activation of PKR in vitro by actively competing with PKR for
dsRNA (Davies et al, 1993). Likewise, the ORFV homologue of the VACV E3L inhibits the
autophosphorylation of PKR in vitro and binds dsRNA in the same manner as the VACV E3L
protein (Haig et al., 1998). The second IFN/dsRNA-induced antiviral pathway is mediated by
2\5'-oligoadenylate synthetase (2-5A). This pathway results in the RNAase L mediated
cleavage of mRNA and rRNA, thereby inducing an antiviral cell state by disrupting protein
synthesis. The VACV E3L also inhibits the 2-5A pathway by competing with 2-5A for dsRNA
(Rivas et al., 1998).
The K3L gene encodes the second VACV protein that is involved in the modulation of the PKR
anti-viral pathway. The K3L protein shares identity with the eIF-2a subunit, particularly over
the serine-51 region, the site of phosphorylation (Beattie et al., 1991). It is hypothesised that
K3L acts as a pseudo-substrate for PKR preventing the phosphorylation of eIF-2oc (Davies et al.,
1992; Davies et al., 1993).
Host cell apoptosis is induced in a variety of ways including: viral entry, cytokines such as
tumour necrosis factor (TNF) and LFN, cell cycle dysfunction (via the p53 pathway), release of
cytochrome C from mitochondria and the overload of the endoplasmic reticulum (Everett and
McFadden, 1999). Activation of PKR and 2-5A has also been linked to apoptosis (Goodbourn et
al., 2000), although it remains to be demonstrated directly if poxvirus interference of these
results in the inhibition of apoptosis (Haig and Mclnnes, 2002). Poxviruses have nevertheless
evolved numerous other mechanisms to inhibit apoptosis mainly by disrupting the apoptosis
signalling pathways (table 1.3 for examples). In addition, many poxviruses encode soluble
cytokine receptor homologues or binding proteins for cytokines such as TNF and IFNs (table
1.3). Sequestration of TNF and IFN not only prevents pro-apoptotic signalling but also subverts
the induction of the anti-viral cell state and immune signalling involved in the activation of
immune cell populations (Haig, 2001).
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Natural killer cells (NK) are important contributors to the innate defence against viruses (Biron
et al., 1999). NK cells are activated by IFNa and IFN(3 and are involved in NK cell-mediated
cytotoxicity and production of cytokines that enhance the innate response and up-regulate
adaptive immunity. Although little is known about the mechanisms NK cells use to recognise
virus-infected cells, an inverse correlation exists between major histocompatability complex I
(MHC I) expression and NK cell killing (Biron et al., 1999). MOCV encodes homologues of
MHC 1 (table 1.3). When expressed, the MHC I homologues are predicted to protect virus-
infected cells from NK-mediated killing (Senkevich et al., 1996).
Complement proteins play a role in limiting spread of many viruses during the viremic stage,
principally by destroying virus-infected cells or by damaging or inhibiting viral particles
(Ochsenbein and Zinkernagel, 2000). VACV EEV are resistant to the action of complement and
this is predicted to be due to an array of host derived complement control proteins (table 1.3),
which are localised on the surface of the EEV envelope (Smith et al., 2002). In addition, the
VACV gene C21L encodes a complement binding protein that interferes with the activation of
the complement cascades (Isaacs et al., 1992).
1.6.2 Adaptive response
The adaptive response is antigen specific and is "learned" from the interaction of B and T-cells
with antigen presented by the antigen presenting cells (APCs) in the lymph node draining the
site of infection. Activated B-cells produce antibody that is specific for viral proteins and
functions to neutralise virus directly or in conjunction with cytotoxic T-cells (TCs), NK cells,
phagocytes and complement. Activated TCs, particularly the T-helper cells (Th), produce
cytokines that enhance B-cell function or that stimulate TC-mediated killing of virus-infected
cells (Haig, 2001).
1.6.2.1 Antibody response
Ovine antibodies to ORFV can be detected at 48 hours post infection by a variety of methods
(Robinson and Balassu, 1981). A number of ORFV immuno-dominant antigens elicit detectable
antibody responses, but whether these antibodies are involved in the clearance of virus is
unknown (McKeever et al., 1988; Mercer et al., 1994; Haig and Mercer, 1998). Although these
antibodies are often detected at very high titres, indicating a seemingly normal humoral response
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to ORFV, animals are susceptible to re-infection (McKeever et al., 1988; Yirrell et al., 1989). In
addition, passively acquired antibodies do not protect lambs from challenge with ORFV (Buddie
and Pulford, 1984; Mercer et al., 1994). Recently however, a positive correlation between
antibody titre and the resolution of ORFV lesions has been reported, suggesting that antibodies
may play a small role in viral clearance, although they do not confer protection against
reinfection (Lloyd et al., 2000).
In contrast, a specific antibody response against the surface proteins of VACV EEV is likely to
be important for immunity (Smith et al., 1997). Protection however, does not appear to be the
result of antibody mediated virus neutralisation. Instead antibodies specific for the EEV surface
protein B5R result in the aggregation of the virus and prevent the release of progeny virus from
infected cells (Vanderplasschen et al., 1997). As EEV is the main effector of long range virus
spread, antibody mediated reduction of EEV may reduce or eliminate viremia. ORFV is a
localised infection and viremia does not occur even when antibody responses are inhibited
(Lloyd et al., 2000), which suggests a humoral response does not play an important role in
preventing dissemination of the virus. The lack of convincing evidence supporting antibody-
mediated protective or passive immunity or a role for antibody in virus containment suggests
that immunity is largely, if not solely, the result of a cellular-mediated response.
1.6.2.2 Cellular immunity and subversion
Infection of the epidermis by ORFV induces an inflammatory response characterised by the
influx of immune cell populations and the expression of cytokines in and around the lesion.
Protective immunity is only partial, as previously infected animals are susceptible to reinfection,
however the resulting lesions are less severe. The immune and inflammatory cell populations
present in ORFV induced lesions have been characterised by histopathological examination with
monoclonal antibody staining. Upon primary infection with ORFV, neutrophil and basophil
numbers rapidly increase and infiltrate lesions. In addition MHC class II+ dendritic cells (DC),
B-cells and several populations of T-cells, including yST-cells, CD4+ and CD8+ T-cells
accumulate in the dermis below the developing lesion. Unusually for a response to a viral
infection the CD4+cells are more numerous than CD8+ T-cells or B-cells (Jenkinson et al., 1990;
Jenkinson et al., 1991; Jenkinson et al., 1992). Re-infection also promotes the same cellular
response, although response times are reduced and the lesion resolves more rapidly.
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The accumulating MHC class II+ DCs forms a dense network below the damaged epidermis and
are hypothesed to act as a barrier preventing the further invasion of the dermis by ORFV. In
addition, this network of DCs may also function as an inflammatory centre for the recruitment of
other cell types (Jenkinson et al., 1991). Reported functions of DCs also include antigen
presentation, activation of T and B cells and stimulation of CD4+ memory cells. They may also
play a role in clonal selection of T-cells in the lymph node. Some DCs have also been shown to
function as phagocytes in vitro (Haig et al., 1999).
The lymphoproliferative response to infection with ORFV was studied in the afferent (draining
the site of infection) and efferent (draining the local lymph node) lymph (Yirrell et al., 1991b;
Yirrell et al., 1991a). The efferent lymph showed an increase in CD4+ T-cells, indicating that
immune cell stimulation in response to ORFV had occurred. Characterisation of afferent lymph
in response to ORFV reinfection demonstrated a biphasic increase in CD4+ T-cells, CD8+ T-
cells, B-cells and DC populations, and as with the skin analysis the CD4+ T-cells were the most
abundant (Haig et al., 1992; Haig et al., 1996a; Lear et al., 1996). In addition there was an
increase in the levels of IFNy and granulocyte macrophage colony stimulating factor (GM-CSF)
and the interleukins, EL-2, IL-1(3 and IL-8 detected in the efferent lymph following ORFV
reinfection (Haig et al., 1992; Haig et al., 1996b; Haig and Mclnnes, 2002). Comparison of
cytokine mRNA expression in primary and secondary lesions demonstrated that TNFa was
expressed during primary and secondary infection, whereas IFNy was only detected following
secondary infection (Anderson et al., 2001). This is consistent with an early memory Thl
mediated response resulting in the activation of T-cells within the dermis and lymph node and
the recruitment of antigen specific cells to the site of infection. The activation and recruitment of
CD8+ T-cells to the lesion corresponds with viral replication levels, which suggests that an
cytotoxic lymphocyte response is effective in limiting viral replication during reinfection (Haig
et al., 1996b). The acquired partial immunity to ORFV can be abrogated by treatment with
cyclosporin A, presumably by eliminating IL-2 and IFNy induced T-cell activation (Haig et al.,
1996c).
A novel ORFV protein (GIF) has been shown to bind and inhibit the biological function of both
ovine GM-CSF and IL-2 in vitro. However no homology was evident to host GM-CSF/IL-2
receptor molecules, suggesting GIF is not a receptor homologue (Deane et al., 2000). GM-CSF
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and IL-2 are present in the lymph draining from ORFV lesions (Haig et al., 1996a). IL-2 is a
multifunctional cytokine promoting proliferation and activation of a variety of T-cells, B-cells,
NK-cells, DCs and monocytes (Roitt et al., 1998). GM-CSF promotes proliferation and
differentiation of granulocytes and macrophages and is crucial for the development of DCs
(Hamilton, 2002). GM-CSF has specifically been implicated with the recruitment of DCs to
ovine skin and the proliferation of afferent lymph DCs in vitro (Haig et al., 1995a; Haig et al.,
1995b). It is possible that the ORFV GIF protein could inhibit any or all of the IL-2 and GM-
CSF functions (Haig, 2001). Deane et al., (2000) proposed that the localised presence of GIF
around the ORFV lesion would interfere in the cell-mediated response to ORFV and may hinder
the development of protective immunity.
A homologue of the ovine cytokine IL-10 has been identified in ORFV (Fleming et al., 1997).
Functional characterisation demonstrated that ORFV IL-10 stimulates ovine and murine
thymocyte and mast cell proliferation (Fleming et al., 1997; Fleming et al., 2000; Imlach et al.,
2002; Haig et al., 2002). However the production of the cytokines TNFa, IL-1(3 and IL-8 by
activated ovine macrophages, monocytes and keratinocytes, and GM-CSF and IFN-y by
peripheral lymphocytes is reduced in response to IL-10 (Fleming et al., 2000; Haig et al., 2002).
Experimental infection of sheep with an ORFV mutant specifically lacking the IL-10 gene
resulted in an increased production of IFNy in and around the lesion site (Fleming et al., 2000).
These data indicate that ORFV IL-10 suppresses the production of pro-inflammatory cytokines
and IFNy (Haig et al., 2002). The exertion of all these effects may skew the immune response
towards a type-2 humoral response, which is an inappropriate defence against ORFV-infected
cells. Recent evidence also indicates that virus-encoded IL-10 inhibits the maturation, migration
and antigen presenting function of murine DCs (Lateef et al., 2003). This may explain why an
acquired immunity to ORFV is incomplete resulting in repeated infections.
A homologue of a chemokine-binding factor has been recently identified in ORFV (Fleming et
al., 2000). Although this binding factor has not yet been characterised, it may function in
conjunction with IL-10 to reduce inflammation and may account for the lack of accumulation of




Poxvirus vaccination strategies often involve the use of one poxvirus species to protect against a
related virus, for example the use of VACV for the protection against VARV (section 1.1). In
contrast, vaccine strategies for the control of ORFV involves the administration of virulent
ORFV (prepared from scab material) to a scarified site, usually on the thigh (Robinson and
Balassu, 1981; Reid, 1991). This form of vaccination results in lesion formation at the site of
scarification, but not around the mouth as is often the case in natural infections. Vaccination
with ORFV does not provide complete protection against challenge, however the resulting
lesions are usually much less severe when compared to primary natural infections. Because
vaccines propagated in animals risk contamination with other viruses or bacteria, the use of live
tissue-culture propagated ORFVs as an alternative to scab derived virus was investigated (Pye,
1990; Nettleton et al., 1996a). Vaccination of sheep with tissue culture propagated ORFV strain
Nara was shown to confer partial protection against challenge, however some ORFV strains did
not (Pye, 1990). The reduced level of protection provided by some tissue-culture propagated
ORFV strains may be due to attenuation occurring during adaptation to tissue culture (Mclnnes
et al., 2001). The use of live ORFV as a vaccine is not satisfactory as infectious virus can be
shed into the environment (Haig and Mercer, 1998). To address this problem, an alternative
vaccine strategy using recombinant VACV that express immuno-dominant ORFV proteins may
have merit (Mercer et al., 1997b). Vaccination with a panel VACV recombinants containing
90% of the ORFV genome provided the same degree of protection as did vaccination with tissue
culture grown ORFV, but without the formation of ORFV-like lesions.
Construction of recombinant poxviruses generally involves insertion of the desired foreign gene
into the thymidine kinase gene (TK) locus of the virus by homologous recombination (Brown et
al., 1986). Experimental vaccination with recombinant VACVs has proved successful in
protecting animals from subsequent challenge with many pathogens including hepatitis, malaria,
rabies and FIIV (Paoletti, 1996). Recombinant poxviruses used to vaccinate their own specific
host species can have the added advantage of providing dual protection. For example,
vaccination of poultry with an attenuated FPV vaccine strain expressing Newcastle disease virus
(NDV) proteins provide dual-protection to subsequent challenge with both FPV and NDV
(Paoletti, 1996).
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Safety issues concerning the use of recombinant VACV have arisen due to the extensive host
range of VACV and side effects of vaccination. This has prompted research into the feasibility
of using severely attenuated and non-replicating VACV strains, for example VACV Ankara, as
vaccine vectors (Moss, 1996a). Alternatively, poxviruses with a limited host range have been
assessed for efficacy as vaccine vector. Expression of rabies, measles and feline leukaemia virus
genes in a Canary poxvirus vector have proved successful when used to vaccinate non-avian
species (Paoletti, 1996). The use of highly attenuated parapoxviruses, such as ORFV strain
D1701, as recombinant vaccine vectors are being considered primarily because they have a
relatively limited host range, produce localised infection without viremia and can promote a
vigorous immune response in natural and non-permissive hosts (Rziha et al., 1999). Due to their
non-essential nature, the ORFV VEGF-E and GIL genes were chosen as a possible sites for
foreign gene insertion (Rziha et al., 1999; Rziha et al., 2000; Mclnnes et al., 2001; Marsland et
al., 2003). Several foreign proteins have been successfully expressed from recombinant ORFVs,
however to date only the humoral response in mice to foreign protein expression has been
assessed (Rziha et al., 2000).
1.8 POXVIRUS DISEASE OF RED SQUIRRELS
1.8.1 Decline of the red squirrel
In the 17th and 18th centuries, deforestation coupled with changes in agricultural and industrial
practices brought the European red squirrel (Sciurus vulgaris) population in some areas of
Britain to the verge of extinction. Red squirrels numbers recovered and became abundant in the
19th and early 20th century (Lloyd, 1983). However since the introduction of the American grey
squirrel (Sciurus carolinesis) in the late 19th century, red squirrel numbers have been decreasing
rapidly (Shorten, 1946; Shorten, 1957; Lloyd, 1983; Gurnell and Pepper, 1993; Pepper and
Paterson, 1998). The prognosis for the survival of the British red squirrel is poor, with extinction
in England possible within ten to twenty years (Kenward and Holm, 1989; Gurnell and Pepper,
1991; Gurnell and Pepper, 1993). The endangered status of the red squirrel has placed it on the
protected species list of the Wildlife and Countryside Act 1981. The cause of the rapid decline of
red squirrels is not fully understood, although it is clear from the literature that the grey squirrel
is implicated, possibly exerting effect by competition and the transmission of disease.
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1.8.1 Species replacement, the role of competition and disease
Ecological replacement of the native red squirrel by the greys is dependent upon a number of
factors including the deciduous or coniferous nature of the habitat and availability of food
resources. Behavioural traits such as direct aggression, interference in red squirrel courtship and
red squirrel passive avoidance of the grey squirrel may all play a role in local replacement
(Skelcher, 1997). Several authors attribute population decline or extinction on a local level to the
presence of SPPV (Middleton, 1930; Edwards, 1962; Scott et al., 1981; Sainsbury and Ward,
1996; Sainsbury et al., 1997; Sainsbury and Gurnell, 1997). Some populations of red and grey
squirrels have co-existed for prolonged periods of time in Ireland, this may be due to the diverse
local habitat, or the absence of SPPV (Tangney and Montgomery, 1995; Skelcher, 1997;
Teangara et al., 1999). Suspected cases of SPPV in Ireland have been reported but not confirmed
(Sainsbury et al., 1997). This lead to speculation that the absence of SPPV in Ireland has
deprived the grey squirrel of a competitive advantage, thus preventing the efficient replacement
of red species, as is so often observed in England (Duff et al., 1996). Coexisting populations are
also evident in Scotland (Bryce, 1999), and this situation has also been attributed to the absence
of SPPV (Sainsbury et al., 2000).
1.8.2 History of viral epidemic disease in the red squirrel
Several dead squirrels were collected between 1904 and 1926 from squirrel populations that
were in decline. Pathological examinations revealed the presence of coccidiosis, which at that
time was proposed to be the cause of population decrease. Middleton (1930) reviewed these
cases and noted the presence of external symptoms not consistent with coccidiosis. He attributed
population reduction to a disease of an unknown nature.
Since Middleton's early work, several outbreaks of epidemic disease in red squirrels resulting in
local extinction have been reported as mange, distemper, scab or myxomatosis (Shorten, 1964;
Edwards, 1962). In all of these reports, there is a consistency in the description of gross
pathology suggesting the same agent is involved. Symptoms usually begin with haemorrhagic
ulceration of the eyelids that quickly spreads to the nasal and buccal regions, the resultant
swelling causes blindness and difficulty in swallowing. Ear lesions often result in decomposition
of the concha. Secondary infection by Staphylococcus aureus commonly causes purulent eye
and nasal discharge. Exudative dermatitis and haemorrhagic crusts develop, particularly
44
effecting the thorax, inguinal area, genital region, hands and feet (Edwards, 1962; Sainsbury and
Gurnell, 1995). Mortality in the wild is estimated to approach near to one hundred percent
(Tompkins et al., 2002).
Post mortem examinations dismissed coccidiosis, mange mites and bacterial disease as the
causative agent and a viral candidate was sought (Edwards, 1962). An RNA virus, which
demonstrated serological cross-reactivity to encephalomyocarditis viruses, was isolated from an
apparently healthy animal captured during an outbreak of disease in Thetford chase (Vizoso et
al., 1964). A virus morphologically similar to the paramyxovirus Newcastle virus disease was
isolated from lung suspensions obtained from squirrels with severe scabs (Vizoso, 1968).
However, the role of these viruses in the aetiology of the scab disease was questioned and fresh
attempts were made to identify and isolate a more likely causative agent (Keymer, 1976). No
progress was made until electron microscopy of scab material taken from an eyelid of an
affected red squirrel revealed SPPV particles present in large numbers (Scott et al., 1981). SPPV
was successfully isolated in red squirrel kidney monolayers (Sands et al., 1984).
1.8.3 The role of the grey squirrel in epidemic disease
Middleton (1930) hypothesed that the grey squirrel may act as a carrier for a disease that is non¬
pathogenic to the grey species but fatal to the red squirrel. To evaluate this proposal the dates of
grey squirrel introduction and the onset of disease in the red populations were studied. The first
recorded introduction of grey squirrels to England was in 1876 at Henbury Park, Cheshire, but
the most important introduction was made at Woburn Park (Bedfordshire) in 1890. Squirrels
from the thriving Woburn population were later used to stock sites across the British Isles,
including London, Yorkshire, Cheshire, Wales and Ireland. Other stocks of squirrels were also
imported from America, independent of the Woburn and Henbury stocks (Middleton, 1930).
A number of authors reported that the onset of disease in local populations coincided with the
appearance of grey squirrels and close interaction been the two species (Edwards, 1962; Scott et
al., 1981). It was suggested that if grey squirrels introduced the virus, the disease would be
observed radiating outwards within the red squirrel population from the points of grey squirrel
introductions. This pattern has not been observed at many points of introduction (Shorten, 1964;
Keymer, 1983). However Vizoso (1968) argued that it is impossible to know where every
45
introduction occurred and suggested the expected pattern would be disrupted if the virus were
maintained within red squirrels.
In 1994 a grey squirrel from Hampshire was found with lesions on the head resembling those
found in red squirrels suffering from SPPV. Electron microscopy of the lesions revealed
parapoxvirus-like particles (Duff et al., 1996). It was postulated that this virus was SPPV and
that SPPV is maintained in the grey squirrel population but clinical manifestation is rare.
Unfortunately this virus was not isolated in culture, nor any scab preserved and therefore it is
impossible to confirm whether this grey squirrel virus was indeed SPPV.
Red and grey squirrel sera from all over the United Kingdom have been tested for antibodies to
SPPV using a direct enzyme-linked immunosorbent assay (ELISA). The results revealed that
grey squirrels have a high sero-prevalence of antibodies to SPPV (discussed further in section
3.1). Furthermore, the geographical distribution of sero-positive grey squirrels correlates well
with the reported disease outbreaks in red squirrels. Conversely, no disease has been reported in
red squirrels where the grey squirrel population is sero-negative for SPPV. The sero-prevalence
in red squirrels was low, which is presumably because of the high mortality caused by the
disease and the difficulty in obtaining sera from red squirrels found dead in the wild. These data
indicate a high occurrence of endemic SPPV infection of low pathogenicity in grey squirrels,
further compounding the role of grey squirrels in the epidemiology of SPPV (Sainsbury et al.,
1997; Sainsbury et al., 2000).
The epidemiology of SPPV may involve the transmission of the virus from clinically unaffected
grey squirrels to susceptible red squirrel populations (Middleton, 1930; Duff et al., 1996).
Alternatively, this disease may be present in both red and grey populations as a sub-clinical
infection. The stress resulting from competition (section 1.8.1) at the interface between the two
species may exacerbate the infection in red squirrels. The resultant increase in red squirrel
mortality rates may enable the grey squirrel to efficiently colonise red territory (Vizoso, 1968;
Duff et al., 1996). In summary, the evidence strongly supports the role of the grey squirrel as a
reservoir host, but this cannot be endorsed until a mode of transmission is determined.
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1.8.4 Present disease status and squirrel conservation strategies
Norfolk has a continuing problem of disease in coexisting squirrel populations and outbreaks in
Lancashire resulted in a significant depletion of the red squirrel populations (Sainsbury and
Gurnell, 1995; Sainsbury and Ward, 1996). More worrying are reports of SPPV in Cumbria,
Northumberland and suspected cases in Scotland, which indicate that the geographic range of
SPPV is expanding northwards, into the last stronghold of the red squirrel (Sainsbury et al.,
1997; Duff et al., 2001).
Red squirrel conservation strategies are based upon creating an environment that benefits the red
squirrel but is sub-optimal for the grey species (Lurz and Garson, 1997). Gurnell and Pepper
(1993) suggested that predominately coniferous forests greater than two thousand hectares with
an existing red squirrel population should gain red squirrel protection area status. For forests that
are at risk of grey squirrel invasion establishing a three-kilometre wide buffer zone consisting of
habitat unsuitable for grey squirrels is advisable (Pepper and Patterson, 1998). Red squirrels gain
far less nutritional value from food derived from oak woodland than grey squirrels (Kenward
and Holm, 1989). Therefore removing oak trees from habitats containing both species of
squirrels or creating coniferous habitats for red squirrels may provide a selective advantage to
red squirrels. The variety of conifers available should be a mix of species that seed at different
times of the year to ensure continuation of food supply for the red squirrels (Gurnell and Pepper,
1991 and 1993; Lurz and Garson, 1997).
Where red squirrel populations are in imminent danger of replacement by grey species, the
removal of grey squirrels by trapping or shooting should be considered as a temporary solution
(Gurnell and Pepper, 1991; Venning et al., 1997). More humane grey squirrel control methods
involving immuno-contraception have been investigated (Moore et al., 1997; Lurz et al., 2002).
However trials in the wild have proved inconclusive and research has been temporarily
abandoned until more information on grey squirrel reproductive biology and immunology is
available (Forestry Commission, 2002).
Fragmentation of red squirrel populations in England and Wales is of concern as it often results
in a reduction in genetic diversity, increasing the risk of population extinction (Wauters, 1997).
Management of the landscape to create corridors of suitable habitat bridging isolated populations
have been shown to substantially increase the genetic diversity by allowing isolated populations
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to mix (Hale et al., 2001). However, forest defragmentation schemes underway in Northern
England that are connecting prime red squirrel habitat to Southern Scotland may ultimately do
more harm than good, by introducing disease to Scotland (Tompkins et al., 2003). Completely
isolated populations such as Jersey and Thetford chase in Norfolk are homogeneous in term of
genetic diversity (Barratt et al., 1997). The genetic diversity of these populations cannot be
managed by linking to other populations using corridors due to geographical distance, however
they can be managed by the selective introduction of genetically diverse individuals.
Unfortunately this method of population management also increases the risk of introducing
disease (Sainsbury and Gurnell, 1995; Hale et al., 2001). Indeed successive attempts to bolster
dwindling populations by reintroducing captive bred squirrels or by translocating wild squirrels
have met with limited success in North Wales and Norfolk due to SPPV disease (Venning et al.,
1997; Jackson, 1999). All of the authors involved in the initial relocation studies agree that the
health of the animals to be released and that of the resident red and grey squirrels should be
examined closely before attempting to re-stock an area.
Supplemental feeding trials have not conclusively shown long-term benefit to red squirrels
(Shuttleworth, 1997), although it is believed to be of benefit in some populations where food is
scarce and population density is low (Warren, 1999). However, food hoppers may increase the
risk of disease transmission, therefore in areas where SPPV has been reported, all food hoppers
should be removed (Warren, 1999; Collins, 1999).
It is estimated that over 2.5 million grey squirrels populate mainland Britain and the coniferous
forests of Scotland may prove to be the only region that red squirrels may survive. However
these areas are now threatened by the influx of grey squirrels and disease (Sainsbury et al.,
1997a; Pepper and Patterson, 1998). Enhancing the survival prospects of the red squirrel by
eradicating the grey squirrel from Britain is no longer a feasible option due to the numbers of
grey squirrels involved and their wide-spread distribution (Gurnell and Pepper, 1993). The
production and application of an effective vaccine may prove to be essential for the successful
reintroduction of red squirrels into areas populated by grey squirrels and ultimately for the
survival of the red squirrel in the UK (Sainsbury et al., 1997; Gurnell et al., 1999).
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1.9 PROJECT AIMS
The formal classification of SPPV as a parapoxvirus suggests that SPPV will have several
features in common with ORFV including, similar route(s) of transmission and an analogous
complement of non-essential genes encoding proteins involved in virulence and immuno-
modulation. However, the classification of SPPV as a parapoxvirus by morphological similarity
alone is not sufficient to substantiate its inclusion into the parapoxvirus genus. The general aim
of this study is to characterise the molecular relationship of SPPV with the parapoxviruses,
thereby providing evidence to support or refute its classification as a parapoxvirus.
The complete genome sequence of ORFV has not yet been determined, despite this the ORFV
genome has been well-characterised (section 1.3). Therefore sufficient data is available for
ORFV to enable a comparison of the SPPV genome with ORFV. The general structure, G+C
content, gene complement and organisation of the two genomes will be compared. Particular
emphasis will be given to identifying parapoxvirus genes in the SPPV genome that are
associated with virulence and immuno-modulation. In addition the phylogenetic relationships
between SPPV and the parapoxviruses will be investigated.
It is envisaged that characterisation of the SPPV genome and its relationship to the







2.1.1 Squirrel Parapoxvirus (SPPV)
2.1.1.1 Tissue Culture Grown SPPV
Virus was isolated at Central Veterinary Laboratory Agency (CVLA) at Weybridge from a red
squirrel lip lesion by culturing in red squirrel kidney cells, it was then adapted to and passaged
six times in sheep choroid plexus cells (Sands et al., 1984). The sample obtained from CVLA
Weybridge was contaminated with Aujeszky's disease virus (ADV), which was subsequently
absorbed out using anti-ADV antiserum (Warns, 1995). Since then, SPPV was adapted to foetal
lamb muscle cells (FLMC) and passaged a further twenty-four times (performed by J.Gilray,
Moredun Research Institute).
2.1.1.2 SPPV scab isolate 1296/99
Scab material was collected at post mortem from a SPPV seropositive squirrel (originating from
the Gateshead SPPV-outbreak, October 1999) which exhibited typical SPPV pathology. The
presence of parapoxvirus particles was confirmed by electron microscopy (EM) performed by
CVLA, Lasswade.
2.1.2 Orf virus (OV) tissue culture strains and scab isolates
2.1.2.1 Moredun Reference Scab
Moredun Reference Scab (MRI) was originally collected from a clinical case during an outbreak
in Scotland (McKeever and Reid, 1986). It has been used to experimentally infect sheep several
times, from which further scab material has been collected. MRI has not been passaged in tissue
culture.
2.1.2.2 Orf-11
Orf-11 was originally isolated from a clinical case in Scotland. It was passaged twenty-nine
times in ovine kidney cell and then subsequently maintained in FLMC (Mclnnes et al., 2001).
2.2 TISSUE CULTURE
2.2.1 Cells and media
Foetal lamb muscle primary cells (FLMC) were cultured in growth media [199 Medium base
supplemented to a final concentration with 10% (v/v) foetal bovine serum (FBS), see section
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2.8.2 for preparation]. After inoculation with virus, cells were maintained in maintenance media
[199 Medium base supplemented to a final concentration with 2% (v/v) FBS, see section 2.8.2
for preparation]. Cells were utilised from passage 3 to 16.
2.2.2 Production of virus in a tissue culture system
2.2.2.1 Infection of FLMC with virus
FLMC monolayers were cultured in 25cm" or 225cm2 tissue culture flask (Nunc) to a confluence
of 50 to 70%. Monolayers were washed twice with warmed phosphate buffer saline (PBS) prior
to infection with virus. Each flask was infected at a multiplicity of infection (MOI) of 0.01 to 1
in a suitable volume of maintenance media (2mls to lOmls), or mock infected with maintenance
media for the negative control flask. The virus was allowed to adsorb to the cells for 1 hour at
37°C before the addition 8mls or 90mls of maintenance media. Monolayers were incubated at
37°C for three to five days and harvested when approximately 90% cytopathic effect (CPE) was
observed.
2.2.2.2 Titration of virus
A serial logio dilution (10"' to 10~6) of the virus was prepared in maintenance media and 25pl of
each virus-dilution was inoculated into 4 wells of a 96 well format tissue-culture plate (Nunc).
Four non-infected cell-control wells received 25pl maintenance media. lOOpl 2 x 10s FLMC/ml
suspension prepared in growth media (supplemented with ImM MgCf) was then added to each
well. Plates were incubated at 37°C for 5 days after which each well was scored for CPE by
visualisation using light microscopy. The log 50% tissue culture infective dose per ml (log
TCID50/ml) was calculated using the Spearman/Karber method (Grist et al.t 1979).
2.2.3 Preparation of virus for EM
2.2.3.1 Tissue culture-grown virus
An infected FLMC monolayer from a 25cm2 tissue culture flask (Nunc) was harvested by
scraping cells into medium. The cells were pelleted by centrifugation at 2000xg for 15 minutes
at +4°C (CS-6R centrifuge, Beckman instruments). The supernatant was discarded and the cell




0.4g scab was ground in PBS with sand using a pestle and mortar, and clarified by centrifugation
at 2000xg for 30 minutes at 4°C (CS-6R centrifuge, Beckman instruments). The clarified
supernatant was layered over a 36% sucrose cushion (w/w in PBS) and the virus pelleted at
71,000xg for 30 minutes at 4°C (SW40ti rotor, Beckman instruments). Virus was suspended in
lml PBS supplemented with lOmg/ml streptomycin and 10 units/ml penicillin. lOOpl of the viral
suspension was sent directly for negative contrast EM (CVLA, Lasswade).
2.3 SEROLOGY
2.3.1 Direct enzyme-linked immunosorbent assay (ELISA)
2.3.1.1 Preparation of SPPV and control antigens
SPPV antigen was prepared using the method adapted by Warns (1995). Briefly, eight 225cm2
flasks of FLMCs were cultured to a confluence of 50% to 70%. Four flasks were infected with
SPPV and four flasks were mock infected with maintenance media using the method described
in section 2.2.2.1. The infected cells were harvested when the CPE reached approximately 90%;
the mock-infected flasks were harvested in parallel and treated in the same way. The media was
decanted and clarified by centrifugation at 2000xg at 4°C for 15 minutes (CS-6R centrifuge,
Beckman instruments). The cell pellets were washed twice in PBS, resuspended in 3mls cell
lysis buffer [IX PBS with 1% (v/v) Nonidet P40 (Sigma)] and then returned to the flasks. The
flasks were incubated at 4°C for 2 hours, then the cell lysates decanted into microcentrifuge
tubes and clarified by centrifuging at 13,000rpm at room temperature for 5 minutes in a bench
top microcentrifuge (Sigma, 1-13). The supernatants derived from the positive and negative
flasks were pooled separately and stored at -70°C. A titration was performed and the working
concentration of the positive (SPPV infected extract) and negative (mock infected extract)
antigens determined to be 1/200 (J. Gilray personal communication).
2.3.1.2 Assessing the suitability of Protein-G
Protein A and Protein G conjugated to Horseradish peroxidase (HRP) have both been shown to
recognise red and grey squirrel IgG (Warns, 1995). However protein G was preferentially used
in an ELISA to detect anti-SPPV antibodies due its higher sensitivity (Sainsbury et al., 2000).
The ability of protein G-HRP to recognise and bind to antibodies present in sera obtained from
wood mice and bank voles was assessed using an ELISA and the appropriate dilution of protein
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G-HRP determined. Briefly, 1/50 dilutions of sera obtained from red squirrels, BALB/c mice,
wood mice and bank voles were made in carbonate-bicarbonate buffer pH 9.6 (section 2.8). 50pl
of each diluted serum was added to ten wells of a 96-well microplate (Dynatech, M129B).
Twelve wells received 50pl carbonate-bicarbonate buffer pH 9.6. The plate was incubated at 4°C
overnight to allow the immunoglobulins to bind. The plates were washed four times with ELISA
wash buffer [IX PBS with 0.05% (v/v) Tween 80 (Sigma)]. Non-specific binding sites were
blocked with bovine serum albumin (BSA) by the addition of lOOpl ELISA dilution buffer [IX
PBS with 1% (w/v) BSA (Sigma)] to each well and incubation at 37°C for one hour. The plate
was washed four times with ELISA wash buffer. A range of dilutions of Protein G-HRP
conjugate (Sigma) in ELISA dilution buffer was added to the plate and allowed to bind at 37°C
for one hour. After washing, lOOpl of prepared orthophenylene diamine (OPD, Sigma) substrate
(section 2.8) was added to each well. The colorimetric reaction was allowed to proceed for
approximately eight minutes and then stopped by the addition of 50pl 2.5M Sulphuric acid
(H2SO4). The optical densities (OD) were read at 492nm in a plate reader (MRX, Dyn-ex
Technologies).
2.3.1.3 Direct ELISA conditions
The ELISA was an adaptation of the method used by Sainsbury et al., (2000) to test red and grey
squirrel sera for anti-SPPV IgG. Duplicate wells in 96 well microplates (Dynatech, M129B)
were coated overnight at 4°C with 50pl of positive and negative antigens (see section 2.3.1.1 for
preparation) diluted 1/200 in carbonate-bicarbonate buffer, pH 9.6. Unbound antigen was
removed by washing the plate four times in ELISA wash buffer. 100pl of test and control sera,
were diluted 1/50 in ELISA dilution buffer and applied in duplicate to wells coated with positive
and negative antigen. The plates were incubated at 37°C for one hour. After washing, lOOpl of
Protein G-HRP conjugate diluted 1/750 in ELISA dilution buffer, was applied to each well and
incubated at 37°C for one hour. After washing, 100pl of prepared OPD was added to each well.
The colormetric reaction was allowed to proceed for approximately 8 minutes before it was
halted by the addition of 50pl 2.5M H7SO4 to each well. The OD of each well was read at
492nm with an ELISA plate reader (MRX, Dyn-ex Technologies) and the corrected optical
densities for each test and control serum calculated by subtracting the mean OD of the negative
antigen wells from the mean OD of the two positive antigen wells.
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2.4 MOLECULAR METHODS
2.4.1 Preparation of viral DNA from scab material
The condition of the carcass prior to post mortem and the temperature of storage both effect the
quality of viral genomic DNA recovered from scab material. DNA recovered from necrotic
scabs or scabs that were stored long term at -20°C were heavily contaminated with fragmented
host/bacterial DNA which was subsequently co-purified with viral particles. Fragmentation of
DNA is a natural process due to apoptosis (Earnshaw, 1995) and the natural decay processes of
DNA (Lindahl, 1993).
Viral DNA isolation was performed using a method adapted from Gilray et ai, (1998). An
additional step was included which involved the pre-treatment of ground scab with
Deoxyribonuclease I (DNAase I) prior to the disruption of viral cores, this is reported to reduce
the level of contaminating degraded-DNA (Mazur et al, 1991).
Briefly, lg scab was ground with sand in 10ml PBS using a pestle and mortar, and centrifuged at
2000xg for 30 minutes at 4°C (CS-6R centrifuge, Beckman instruments). The clarified
supernatant was layered over a 36% sucrose cushion (w/w in PBS) and the virus pelleted at
71,000xg for 30 minutes at 4°C (SW40ti rotor, Beckman instruments). The pellet was
resuspended in 0.5ml DNAase I solution [lpg/ml DNAase I (Sigma) in 2mM MgCB; 80mM
Tris-HCl, pH 7.4] and incubated for 2 hours at 37°C. The virus pellet was washed once in 10ml
PBS and repelleted by centrifugation at 71,000g as before. The washed pellet was resuspended
in 0.5ml GIT [4M Guanidinium isothiocyanate; 50mM Tris-HCl, pH 7.6; lOmM
Ethylenediamine tetraacetic acid disodium salt (EDTA), pH 8; 2% N-lauroylsarcosine; 1% (v/v)
P-Mercaptoethanol]. Following agitation at 37°C for 1 hour to disrupt the viral cores, the
suspension was overlaid on to a 1.5ml 40% (w/v) Caesium chloride cushion [diluted in TE
(lOmM Tris-HCl pH 8; ImM EDTA, pH 8)]. The viral DNA was separated from cellular DNA
by centrifugation at 149,000xg for 16 hours at 20°C (SW55ti rotor, Beckman instruments). The
viral DNA pellet was suspended in 0.8ml TE buffer with O.lmg/ml RNAase (Sigma) and
incubated for 30 minutes at room temperature to digest the RNA. 10p.l of lOmg/ml Proteinase K
(Sigma) and 20p.l of 20% Sodium dodecyl sulphate (SDS) was added [final concentration
125p.g/ml Proteinase K in 0.5% SDS]. This mixture was incubated at 50°C for 4 hours to digest
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the protein. Viral DNA was purified using phenol/chloroform extraction and precipitation with
absolute ethanol (Sambrook et al., 1989). DNA was resuspended in TE buffer.
2.4.2 Preparation of viral DNA from tissue culture-grown virus
This method is an adaptation of the extraction of cytoplasmic orthopoxvirus-DNA (Meyer et al.,
1995). Briefly, five 225cm2 infected FLMC monolayers were harvested by scraping off the cells
into the media and centrifuging at 2000xg for 5 minutes (CS-6R centrifuge, Beckman
instruments). The cell pellets were pooled and washed in 30mls isotonic buffer (lOmM Tris-HCl
pH 8; 150mM NaCl; 5mM EDTA, pH 8) by centrifuging at 2000xg as before. The pellet was
suspended in 18mls of hypotonic buffer (lOmM Tris-HCl, pH8; lOmM KC1 and 5mM EDTA,
pH 8) and incubated on ice for 10 minutes. 15pl of 14.3M P-mercaptoethanol (Sigma) and 1ml
of 10% (v/v) Triton X-100 were added to the suspension and chilled for a further 10 minutes to
solubilize the plasma membrane. Cellular nuclei were removed by centrifuging at 2000xg as
before and the pellet discarded. The virus was concentrated by centrifuging the supernatant at
20,000xg for 30 minutes at 4°C (SW40ti rotor, Beckman instruments). The viral pellet was
suspended in 0.8ml TE buffer with 0. lmg/ml RNAase and incubated at room temperature for 30
minutes. The viral cores were disrupted by the addition of 15pl of 14.3M 3-mercaptoethanol
(Sigma), 50pl of lOmg/ml Proteinase K and 0.2ml of 20% N-Laurosyl sarcosinate and
incubation at 4°C for 30 minutes. 1.4mls of 54% (w/v) sucrose was added and the extract further
incubated at 55°C for 4 hours. 0.4mls 5M NaCl was added and viral DNA extracted by the
addition of an equal volume of phenol/chloroform and isolated by precipitation with absolute
ethanol (Sambrook et al., 1989). DNA was resuspended in TE buffer.
2.4.1 Spectrophotometric quantification of DNA
DNA was quantified by measuring the light absorbed at the wavelengths 260nm and 280nm
(Cecil CE2041 2000 series). An optical density (OD) of 1 at 260nm corresponds to
approximately 50pg/ml double-stranded DNA (dsDNA). A calculated ratio value of 1.8 for
OD260nm/280nm provides an indication that the DNA is pure. Ratio values below 1.8 suggest
contamination with phenol or protein (Sambrook, 1989).
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2.4.2 Complete restriction endonuclease digestion
Restriction endonucleases were purchased from Roche or Promega and used in accordance to the
manufacturer's instructions. Generally 2 to 4pg of DNA was digested in a total reaction volume
of 20pl containing IX reaction buffer and 10U of enzyme (and O.lmg/ml acetylated bovine
serum albumin as appropriate). Incubation times varied from 1 to 3 hours at the appropriate
temperature.
2.4.3 Visualisation of DNA by agarose gel electrophoresis
DNA was visualised using agarose gel electrophoresis and fluorescence under UV. The
concentration of the agarose gels varied between 0.3% and 0.8% (w/v dissolved in
electrophoresis buffer), depending on the size of the DNA fragments to be resolved. The
electrophoresis buffer was IX Tris-Borate EDTA buffer [TBE (90mM Tris base; 90mM Boric
acid; 2mM EDTA, pH 8)] with Ethidium bromide added to a final concentration of 0.5|iig/ml. 6X
DNA loading buffer was added to the DNA samples to a concentration of IX, and approximately
lpg to 4pg DNA was loaded into one track. Minigels (dimensions 8x10cm) were
electrophoresed at 10 volts/cm for 1 to 3 hours. Maxigels (dimensions 20x20cm) were
electrophoresed at 1.5 volts/cm for 24 to 36 hours. Visualisation of the DNA was achieved by
illumination under UV light (wavelength 302nm) and the image captured onto heat sensitive
paper (Mitsubishi video copy processor, UVP) or digitised and stored (Fujifilm thermal imaging
system FT 1-500, Amersham Pharmacia Biotech). The fragment sizes were estimated by
comparison to known standards in a lkb ladder (GibcoBRL) and digested A-phage DNA.
2.4.4 Isolation of DNA from agarose gel
Two commercially available kits were used to isolate DNA from agarose gel: QIAquick gel
extraction kit (QIAGEN) and Geneclean II kit (Bio 101). Both rely upon the solubilisation of the
agarose to release the DNA followed by DNA-binding to a silica matrix. Both kits can
efficiently isolate DNA up to lOkb in size. The kits were used in accordance with the
manufacturer's instructions with the buffers supplied in the kits.
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2.4.4.1 QIAquick gel extraction kit
The desired DNA band was excised from the gel with a scalpel, weighed and 3 gel volumes of
buffer QG was added. The gel slice was incubated at 55°C until the agarose dissolved. 10)0.1 3M
Sodium acetate was added to reduce the pH to less than 7.5, followed by one gel volume of
isopropanol. The solution was applied to the QIAquick column and the DNA was bound to the
column by centrifuging at 13,000rpm for 1 minute (Sigma, 1-13). The column was washed once
with 750|ol buffer PE by centrifuging as before. The column flow through was discarded and the
column centrifuged again to remove traces of ethanol. 30 to 50pl buffer EB was applied to the
column membrane and incubated at room temperature for 1 minute before eluting the DNA into
a clean tube by centrifuging as before. If required DNA was concentrated by ethanol
precipitation.
2.4.4.2 Geneclean II kit
The desired gel band was excised from the gel and weighed. A 0.5 gel volume of TBE modifier
and 4.5 gel volumes of Sodium iodide solutions were added and the gel slice dissolved at 50°C.
5 to 20p,l of silica matrix were added and suspension gently mixed for 5 to 15 minutes to allow
the DNA to bind to the silica matrix. The suspension was centrifuged at 13,000rpm for 1 minute
(Sigma, 1-13) and the silica-bound DNA pellet was washed three times with 200pl of "New
Wash" by centrifuging as before. The pellet was air dried for 1 minute to remove residual
ethanol, then the DNA was eluted by resuspending the pellet in an equal volume (5 to 20p.ls) of
TE and centrifuging as before. The solublised DNA was transferred to a clean tube.
2.4.5 Hybridisation techniques
Several methods are available for labelling nucleic acid probes and visualising the hybridised
nucleic acid. Two labelling methods were employed in this study. DNA probes were labelled
with the beta emitter 32Phosphorous (32P) and hybridisation detected by exposure to X-ray film.
Alternatively, DNA probes were labelled with Digoxigenin-11-deoxyuracil triphosphate (DIG-
11-dUTP) and hybridisation detected via an anti-DIG antibody conjugated to alkaline
phosphatase which catalyses a colormetric reaction in situ.
The "DIG" system was preferentially used whenever possible because DIG-labelled probes can
be stored and used in excess of 1 year, unlike 32P, which has a half-life of 2 weeks. In practice,
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hybridisation with 32P-labelled probes generally produces a more intense visual hybridisation
signal than DIG-labelled probes. In addition, Southern blots hybridised with 32P-lablled probes
can be sequentially washed with increasing stringency conditions. Therefore, in some situations
hybridisation with 32P-labelled probes was the preferential technique.
2.4.5.1 Non-radioactive labelling of dsDNA
Two techniques were used to label dsDNA with DIG-11-dUTP in this study.
2.4.5.1.1 Random primed DNA labelling
Labelling of DNA greater than lOkb in size is generally less efficient than labelling smaller
DNA fragments. Therefore template DNA greater than lOkb was digested with a restriction
endonuclease and purified by phenol/chloroform extraction prior to labelling.
Routinely lpg of template DNA was labelled using the DIG DNA labelling Kit (Roche). Briefly
the template DNA was diluted in distilled water to a total volume of 15pl. The DNA was heat-
denatured in a boiling water bath for 10 minutes then immediately placed on ice. The following
reagents (supplied by Roche) were added in the following order: 2pl 10X hexanucleotide
mixture, 2pl 10X deoxynucleotide triphosphate (dNTP) labelling mixture and 2U of Klenow
enzyme. The reaction was mixed and incubated at 37°C for 1 to 20 hours. The reaction was
stopped by the addition of 2pl 0.2M EDTA, pH 8. Probes were diluted to a working
concentration of 25ng labelled DNA/ml in hybridisation buffer [5XSSC (0.75M NaCl, 75mM
Trisodium citrate); 0.1% (w/v) N-laurosylsarcosine; 0.02% (w/v) SDS; IX blocking reagent
(Roche) J.
2.4.5.1.2 Nick translation labelling
Template DNA was labelled using DIG-Nick Translation mixture (Roche), lpg of template
DNA was diluted in 16pl distilled water. Then 4pl DIG-Nick translation mixture was added,
which contains DNAase I, DNA polymerase I, dNTPs and DIG-dUTP. The reaction was
incubated at 15°C for 90 minutes, then terminated by adding lpl of 0.5M EDTA (pH 8) and
incubating at 65°C for 10 minutes to denature the enzymes.
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2.4.5.2 Radioactive labelling of DNA
2.4.5.2.1 Random prime labelling ofdsDNA using the rediprime II labelling kit
dsDNA templates were labelled in a random-priming reaction with Redivue stabilised [a-32P]
dCTP (Amersham Pharmacia Biotech) using the commercially available "ra/iprime II" labelling
kit (Amersham Pharmacia Biotech).
25ng of dsDNA diluted in 45jnl TE buffer was heat denatured by boiling for 5 minutes, then
quenched on ice. The denatured DNA was transferred to a rediprime II reaction tube and 5ju.l of
[a-32P] dCTP (1.85MBq) was added. The reaction was gently mixed and incubated at 37°C for
30 minutes. The reaction was stopped by adding 5pil 0.2M EDTA, pH 8 and then stored at -20°C
for a maximum of seven days prior to use.
2.4.5.2.2 Polynucleotide kinase mediated labelling of free 5'-hydroxylated termini of
oligonucleotides
Polynucleotide kinase (PNK) is used in labelling reactions to catalyse the transfer of the 32P-
labelled terminal phosphate group of ATP to the 5'-OH terminus of synthetic oligonucleotides or
dephosphorylated nucleic acid.
Oligonucleotides (MWG Biotech) were labelled with the terminal phosphate group derived from
redivue [y-32P] ATP triethylammonium salt (Amersham Pharmacia Biotech) in a PNK catalysed
labelling reaction. 4.5pmol of oligonucleotide was mixed with 9pmol [y-32P] ATP (1.65MBq) in
a 15p,l reaction containing IX phosphorylation buffer and 10U of PNK (both supplied by
Roche). The reaction was allowed to proceed at 37°C for 1 hour before it was stopped by
chilling on ice. The probe was diluted in distilled water to a working concentration of
0.15pmol/|al.
Incorporation of the 32P into the oligonucleotide was determined by chromatography of the
oligonucleotide on polyethyleneimine cellulose (PEI) sheets (Machery-Nagel, Dueren) in the
solvent: 0.75M potassium phosphate buffer, pH 3.5. A 1:50 dilution of the probe was made in
the solvent and 0.5p.l was spotted onto the PEI sheet, 2cm from the bottom edge and air-dried.
The chromatogram was placed into 1cm depth of solvent and left until the solvent front had
migrated at least 8cm. The chromatogram was air dried, wrapped in Saran wrap and exposed to
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medical X-ray film (100NIF, Fujifilm) with an intensifier screen for 1 hour. The film was
developed using a compact X2 automated film processor (X-Ograph imaging systems).
Labelling efficiency was estimated by a visual comparison of incorporated 32P present in the
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oligonucleotide (situated at the loading site) and the unincorporated soluble P, which migrated
with the solvent front.
2.4.5.3 Preparation of blots
2.4.5.3.1 Southern blotting
Identical or homologous DNA sequences can be detected using Southern blotting and DNA
hybridisation techniques. First the digested DNA is separated by agarose gel electrophoresis.
Then after denaturation under alkaline conditions, the DNA is transferred from the gel, to a solid
matrix of nylon or nitrocellulose using a technique pioneered by Southern (1975).
An adaptation of Southern's original method was used in this study, involving the use of a dry
transfer technique. This dry-blot method, although simpler to perform, results in a decrease in
the transfer efficiency of DNA. However, it is adequate for digested plasmid, cosmid and viral
DNA, as target sequences are sufficiently concentrated to overcome detection problems
associated with transfer inefficiencies (Smith and Summers, 1980).
The DNA was separated by agarose gel electrophoresis and photographed. If fragments
exceeded lOkb in length the DNA was depurinated by soaking in 0.25M Hydrochloric acid for
10 minutes. The gel was rinsed in distilled water to remove residual acid. Then dsDNA was
denatured and the depurinated sites cleaved by two washes in denaturing buffer (0.5M NaOH;
1.5M NaCl), each for 15 minutes. The pH of the gel was then reduced by washing twice for 15
minute with Southern neutralisation buffer (0.5M Tris-HCl, pH7.5; 3M NaCl). The gel was
placed on clingfilm and a sheet of nylon membrane (Hybond-N, Amersham Pharmacia Biotech),
pre-wetted in neutralisation buffer was placed on top. This was follow by four pieces of pre-
wetted 3MM paper (Whatman), four dry pieces of 3MM paper and a 3cm-thick pile of paper
towels. A glass plate with a 500g weight was place on top and the blot was left overnight to
allow the DNA to transfer. The blot was disassembled and the membrane air-dried before the
DNA was cross-linked to the membrane by UV fixation. The blot was stored in the dark at room
temperature until used.
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2.4.5.3.2 DNA dot blotting
Commercially available dot-blotting equipment was used to apply DNA samples to a membrane
in a 96 well-format, thus enabling the screening of multiple DNA samples simultaneously by
hybridisation.
Cloned DNA prepared by the alkaline lysis method was diluted to approximately lOng/pl in TE.
200p,l volumes of the DNA suspensions were placed into the wells of a Thermo-fast 96-well
PCR plate (Abgene) and the plate covered with an adhesive sealing foil (Abgene). The plate was
placed in a Touchdown thermo cycler (Hybaid) and the DNA heat denatured at 96°C for 10
minutes, then quenched on ice. Using a multi-channel pipette, 50)0.1 of the denatured DNA
suspensions were applied to a Hybri-dot manifold (Bethesda Research Laboratories), and drawn
through onto a pre-wetted (distilled water) nylon membrane (Hybond-N, Amersham Pharmacia
Biotech) by vacuum. The membrane was briefly rinsed in 2X SSC (0.3M NaCl; 3mM Tri-
sodium citrate), air-dried and the DNA cross-linked to the membrane by UV fixation.
2.4.5.3.3 Colony lifts, in situ lysis and DNA binding to nylon
Bacterial colonies were transferred from the agar plate to a nylon membrane, lysed and the
released DNA bound to the membrane in situ using an adaptation of a method developed by
Grunstein and Hogness (1975). The membrane, when subsequently hybridised with a labelled
probe allowed a large number of transformed colonies to be screened simultaneously.
Bacterial colonies, freshly cultured on Luria-Bertani agar (LBA) plates were chilled at +4°C for
30 minutes. Hybond-N+ membrane (Amersham Pharmacia Biotech) was pre-wetted on a fresh
LBA plate and then placed onto the bacterial colonies for one minute to allow adherence.
Orientation marks were made by stabbing the membrane and agar with a needle. The membrane
was peeled off the agar and directly placed, colony side up, onto a 1ml pool of 10% SDS for 3
minutes. Alternatively, when there was little bacterial adherence, the membrane was cultured
colony side up on a fresh LBA plate for a further 4 to 8 hours prior to treatment with 10% SDS.
The membrane was transferred to 1ml pools of the following solutions for 5 minutes each,
blotting briefly on 3MM paper between each solution: Denaturing solution (0.5M NaOH; 1.5M
NaCl), colony neutralising solution (1M Tris-HCl, pH7.5; 1.5M NaCl) and finally 2X SSC. The
membrane was air-dried and the bacterial debris removed with a tissue-dampened in 2X SSC.
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The membranes were allowed to re-dry and the DNA cross-linked to the membrane by UV
fixation.
2.4.5.4 Hybridisation with digoxygenin-labelled DNA probes
2.4.5.4.1 Hybridisation conditions
Membranes were placed into cylindrical hybridisation tubes (Hybaid) with 20ml of standard
hybridisation buffer [5X SSC; 0.1% N-laurosylsarcosine; 0.02% SDS; IX blocking reagent
(Roche)] and incubated in a hybridisation oven (Hybaid) at 65°C for at least 2 hours. DIG-
labelled probes were diluted in standard hybridisation buffer to a concentration of 25ng/ml, then
heat-denatured in a boiling water bath for 10 minutes. The pre-hybridisation solution was
replaced with 10ml of the diluted-denatured probe, and the membrane incubated at 65°C. After
approximately 16 hours, the probe was decanted and retained for re-use.
2.4.5.4.2 Development ofdigoxygenin blots
Membranes were washed twice for 5 minutes in 2X wash solution (2X SSC; 0.1% SDS) at room
temperature, then twice for 15 minutes in 0.5X wash solution (0.5X SSC, 0.1% SDS) at 65°C to
remove non-specifically bound probe. To reduce background, the non-hybridised region of the
membrane was blocked by incubating for 1 hour in blocking buffer [IX blocking reagent
(Roche) in IX Maleic acid buffer (0.1M Maleic acid; 0.15M NaCl; pH 7.5)]. The blocking
buffer was replaced with 30ml antibody solution [150mU/mi Anti-Digoxigenin-AP (Roche) in
blocking buffer], which was allowed to bind for 30 minutes. Excess antibody was removed by
two washes in IX Maleic acid buffer for 15 minutes each. Membranes were equilibrated for 2
minutes in detection buffer (0.1M Tris-HCl, pH9.5; 0.1M NaCl), then flooded with colour
substrate [45pl of 75mg/ml nitroblue tetrazolium salt (NBT) in 70% (v/v) dimethylformamide
(Roche) and 35pl of 50mg/ml 5-Bromo-4-chloro-3-indolyl phosphate (BCIP) toluidinium salt in
dimethylformamide (Roche), diluted in 10ml of detection buffer] and left to develop in the dark.
The membrane was washed in distilled water to stop the colour development reaction.
2.4.5.5 Hybridisation with "P-labelled DNA probes and development of autoradiographs
Membranes were pre-hybridised at 60°C for 2 hours with 10ml Rapid-hyb buffer (Amersham
Pharmacia Biotech). 32P-labelled DNA probes (see section 2.4.5.2.1 for labelling procedure)
were denatured by boiling for 5 minutes and then quenched on ice for 5 minutes. 25ng of the
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denatured probes were then added to 10ml pre-hybridisation solution and the membranes
incubated at 60°C for approximately 16 hours.
The membranes were then washed twice for 30 minutes each at room temperature with 2X wash
solution (2X SSC/0.1% SDS). The damp membranes were then wrapped in Saran wrap and
exposed to medical X-ray film (100NIF, Fujifilm) with an intensifier screen for 30 minutes. The
autoradiograph film was developed using a compact X2 automated film processor (X-Ograph
imaging systems). If excessive background was visible on the autoradiograph, the damp nylon
membrane was then repeatedly washed at higher stringency, exposed to film and developed.
Higher stringency washes were performed with 2X wash solution (2X SSC/0.1% SDS) at 60°C
and 0.2X wash solution (0.2X SSC/0.1% SDS) at 60°C.
2.4.6 Polymerase chain reaction
A polymerase chain reaction (PCR) was employed to selectively amplify short regions of the
viral DNA genome. The technique developed by Saiki et al., (1988) utilises the thermo-stable
properties of the DNA polymerase isolated from the bacteria Thermus aquaticus (Taq DNA
polymerase) to catalyse the polymerisation of DNA that is flanked by regions of known
sequence. Briefly, the dsDNA template is denatured by heating to 94°C, then two synthetic
oligonucleotide primers that are complementary to the sequence flanking the desired region are
annealed to the ssDNA template by reducing the temperature of the reaction to approximately
5°C below the melting temperature (Tm value) of the primers. Replication of DNA is in a 5' to
3' direction and is initiated at the site of primer binding. Taq DNA polymerase catalyses the
polymerisation of complementary DNA strands across the desired region when the temperature
is raised to 72°C, which is the optimal temperature for Taq DNA polymerase to function.
2.4.6.1 PCR reaction components and conditions
Taq DNA polymerase and the 10X PCR reaction buffer (containing 15mM MgCl2) was supplied
by Roche and used in accordance with the manufacturer's instructions. Deoxynucleotides
(dNTPs) were supplied by Promega and were diluted to a 10X working concentration consisting
of 2mM of each individual dNTP in distilled water. Oligonucleotide primer pairs were designed
from known SPPV and ORFV sequence and were generally 18 to 24 bases in length with
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comparable Tm values. All oligonucleotides were supplied by MWG biotech and diluted in
distilled water to a concentration of lOpM.
All PCR reactions were prepared in 0.5ml microcentrifuge tube (Alpha laboratory supplies) on
ice, in 50pl volumes, containing the following solutions.
10X PCR reaction buffer 5pi
10X dNTP mixture (2mM of each base) 5pl
Primer 1 (lOpM) 5pl
Primer 2 (lOpM) 5pl
Taq DNA polymerase (5units/pl) 0.4pl
DNA template lOOng to lpg
Distilled water to final volume of 50pl
The reactions were gently mixed then overlaid with 50pl of mineral oil (Sigma) to prevent
evaporation of the samples. The reaction tubes were transferred to the heating block of the
OmniGene thermal cycler (Hybaid) and the PCR reactions performed using the following cycle
parameters:
Cycle Denaturation Primer annealing DNA polymerisation
1 94°C for 5 minutes Tm value minus 5°C for 1 minute 72°C for 1 minute
2 to 25 94°C for 1 minute Tm value minus 5°C for 1 minute 72°C for 1 minute
26 94°C for 1 minute Tm value minus 5°C for 1 minute 72°C for 10 minute
The completed PCR reactions were cooled to room temperature and the PCR products visualised
by agarose gel electrophoresis (section 2.4.3).
2.4.7 DNA sequencing
Two methods of DNA sequencing were developed simultaneously in the 1970's (Sanger et al.,
1977; Maxam and Gilbert, 1977). The chain termination method (Sanger et al., 1977) involves
the polymerisation of a DNA strand that is complementary to the target region using a procedure
similar to PCR. The sequencing reaction mixture contains a DNA polymerase and all four
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dNTPs, one of which is radiolabeled, plus one modified dNTP. The modified dNTP is a
dideoxynucleotide (dideoxyNTPs) and is incorporated into the growing DNA strand but results
in the early termination of strand synthesis. Four separate sequencing reactions are performed,
each incorporating a different dideoxyNTP. When the products are electrophoresed on a single
DNA-denaturing polyacylamide gel and exposed to medical X-ray film, the DNA sequence can
be determined from the resulting DNA bands.
The chain termination method has largely been replaced by more efficient automated sequencing
methods, which utilises fluorescent-labelled dNTPs as the DNA strand terminator. The
advantages of this method over Sanger's chain termination method include: dsDNA templates
may be used, only a single PCR reaction is required as opposed to four, no radioactive isotope is
needed and the reading of the sequencing gel is automated and therefore less time consuming.
DNA sequencing was carried out at The Functional Genomic Unit (Moredun Research Institute)
using the ABI Prism Big Dye Terminator system (Applied Biosystems).
2.4.7.1 DNA sequencing protocol.
In a 0.2ml microcentrifuge tube, 250 to 500ng template DNA was mixed with 4pl Terminator
ready reaction mix (Applied Biosystems) and lpl of primer (3.2pmol concentration), distilled
water was added to give a total PCR reaction volume of 10pl. The PCR reaction was amplified
on the Applied Biosystems 9700 thermal cycler using the following cycle parameters: DNA
denaturation at 96°C for 10 seconds, primer annealing at 50°C for 15 seconds and DNA
polymerisation at 60°C for 4 minutes; for twenty-five cycles. The reactions were cooled to 4°C
and the DNA precipitated by the addition of lpl of 3M Sodium acetate and 25pl of 95% (v/v)
ethanol. After incubation at room temperature for 20 minutes the DNA was pelleted by
centrifugation at 13,000rpm for 20 minutes. The DNA pellet was washed in 125pl of 70% (v/v)
ethanol and the DNA resuspended in 2 or 3pl of Sequence loading dye (Applied Biosystems).
The amplified DNA was heat denatured for 2 minutes at 95°C and then loaded onto a 50ml
vertical sequencing gel [5% polyacrylamide (Applied Biosystems Long Ranger XL gel
solution); 6M Urea and IX TBE]. The sequencing gel was electrophoresed in the 377 DNA
Sequencer (Applied Biosystems) at 51°C in IX TBE for 9 hours. The DNA sequence was
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detected automatically during electrophoresis by a laser and the sequence deciphered using
Sequencher software (Applied Biosystems).
2.4.8 Sequence analysis
2.4.8.1 DNA sequence homology searching
DNA sequences were manually checked for errors and edited using Chromas vl.45 graphical
software (Technelysium Pty Ltd). Vector sequences were removed and the DNA sequence
compared to those deposited in the EMBL nucleotide sequence database (Stoesser et al., 2002)
using the FastA 3 algorithm (Pearson and Lipman, 1988). The FastA algorithm was
preferentially used to search the databases for homologous sequences due the greater sensitivity
FastA offers over the alternative algorithms such as BLAST at detecting distant homologies
(Shpaer et al., 1996).
2.4.8.2 Predicted amino acid sequence homology searching
Putative open reading frames (ORFs) were identified using DNASTAR MapDraw v5.00 and
translated using DNASTAR EditSeq v5.00 software (DNASTAR Inc.). Translations of each
putative ORF were compared to protein sequences deposited in the SWALL library [comprising
of SWISSPROT, SPTREMBL and TREMBLNEW databases (Bairoch and Apweiler, 2000)
using the FastA3 algorithm (Pearson and Lipman, 1988) in order to identify homologous
proteins.
2.4.8.3 Multiple DNA sequence alignments
Sequences were aligned with one another using the ClustalW alignment algorithm function
within the DNA MegAlign v5.0 package (Thompson et al., 1994) (DNASTAR Inc.). The
sequences were trimmed at both ends to remove non-overlapping sequence. Individual sequence
alignments were visualised, annotated and shaded using GeneDoc v2.6.001 software (Nicholas
et al., 1997).
2.4.8.4 Phylogenetic analysis
2.4.8.4.1 Multiple amino acid sequence alignment
A preliminary alignment of predicted amino acid sequences was performed using the ClustalW
algorithm function within the DNASTAR MegAlign program and the end of the sequences
trimmed (section 2.4.8.3). Individual trimmed sequences were converted to a FastA (Pearson)
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format using the format conversion program Readseq v2.1.10 (D.G Gilbert) and a compilation
file containing all of the trimmed sequences in a FastA format created. A multiple sequence
alignment was performed with the data contained in the sequence compilation file using the
ClustalW algorithm tool in the UK Human genome mapping resource centre (HGMP) web-
based platform. The interleaved multiple sequence alignment was visualised and the
physiochemical properties of the amino acid shaded using GeneDoc v2.6.001 software (Nicholas
et al., 1997). The percentage of residues that match exactly (percentage identity) between two
aligned sequences were obtained from the statistics report function in GeneDoc.
2.4.8.1.2 Preliminary tree construction
Preliminary analysis was performed on the interleaved multiple sequence alignment with the
TREE-PUZZEL v5.0 maximum likelihood phylogenetic analysis algorithm program (Schmidt et
al., 2002). The TREE-PUZZEL default settings were used for tree creation, except the out-group
sequence was changed to FPV and the model rate of heterogeneity was changed to gamma
distribution and the invariant rate of heterogeneity. The calculated gamma and invariant rate of
change values were used in the tree construction (section 2.4.8.1.3).
2.4.8.1.3 Maximum likelihood tree construction
A maximum likelihood tree was created from the interleaved multiple sequence alignment with
the PHYLIP ProML program (Felsenstein, 1993) using the Jones-Taylor-Thornton model (Jones
et al., 1992). Analysis was performed with FPV as the out-group and the gamma and invariant
rates of heterogeneity values that were calculated by analysis with the TREE-PUZZEL program
(section 2.4.8.1.2). To ensure that the input order of the amino acid sequences did not influence
the inferred phytogenies, the sequence order was randomised (jumbled) ten times. The likelihood
that the tree branching inferred by the ProML program was the most probable was assessed by
global rearrangement. The tree was visualised using the graphical software TreeView vl.6.2.1
(Page, 1996). The tree branch lengths correspond to the genetic distance between sequences.
2.4.8.1.4 Tree evaluation
The repeatability or the accuracy of the inferred tree produced by the ProML program was
assessed using bootstrap analysis (Felsenstein, 1985). The multiple sequence alignment was re-
sampled one hundred times using PHYLIP SEQBOOT program. The SEQBOOT program
randomises the data by shuffling the amino acids within the columns of the multiple sequence
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alignment. The re-sampled data (consisting of 100 multiple sequence alignments) was then
analysed with the PHYLIP ProML program using the same parameters described in section
2.4.8.1.3, except the "analyse multiple sequence data sets" option was activated. The resulting
100 trees were analysed by the PHYLIP CONSENSE program to determine the tree consensus,
which was visualised using the graphical software TreeView v 1.6.2.1 and compared with the
tree produced by the single data set (section 2.1.8.1.3). The bootstrap value calculated for each
individual consensus tree branch is a measure how many of the 100 resampled trees supports
that particular branch. The branch lengths in the consensus tree correspond to the bootstrap value
and not the genetic distance. Therefore the bootstrap values were manually added to the tree
produced by the single data set (section 2.1.8.1.3).
2.5 GENERAL MICROBIAL METHODS
2.5.1 Bacterial strains, their genotype and growth media
Strain Growth media
JM109 Luria-Bertani agar (LBA) and broth (LB) supplemented with 50pg/ml ampicillin
when appropriate.
XL1-BlueMR LBA supplemented with 50pg/ml ampicillin when appropriate. LB
supplemented with 10mM Magnesium sulphate, 0.2% (w/v) maltose and with
50pg/ml ampicillin when required.
Table 2.1 Two E.coli strains were used in this study. Their growth media requirements are
summarised here.
2.5.2 Preparation of JM109 competent cells
Bacterial cells were treated with Calcium chloride (CaCI2) to make them competent for the
uptake up exogenous DNA using an adaptation of Cohen's procedure (Cohen et al., 1972).
A glycerol stock of JM109 cells (Stratagene) was streaked out to a single colony on LBA plates
and a single colony was used to inoculate 10ml of LB, which was grown overnight at 37°C with
vigorous shaking. 2.5ml of the cultured broth was used to inoculate 500ml LB in a 2 litre baffled
Erlenmeyer flask. This was grown at 37°C with shaking to an OD of 0.9 at 600nm. The bacteria
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were pelleted at 4000xg (JA-14 rotor, Beckman instruments) and the supernatant discarded. The
pellet was resuspended in 250ml ice-cold 0.1M CaCh and incubated on ice for 20 minutes. The
bacteria were pelleted at 4000xg (as before) and the pellet resuspended in 5 to 20ml of ice-cold
0.1M CaCl2. Glycerol was added to a final concentration of 10% (v/v), and aliquots were stored
at -70°C.
2.5.3 Preparation of competent XL-1 Blue MR cells
XL-1 Blue MR glycerol stock (Stratagene) was streaked onto a LBA plate to a single colony. A
single colony was used to inoculate 10ml of LB supplemented with lOmM Magnesium sulphate
and 0.2% (w/v) Maltose. The broth was incubated at 37°C with agitation for 4 to 6 hours. The
cells were harvested at 1200xg for 10 minutes (Mistral 2000, MSE Scientific Instruments) and
resuspended in lOmM Magnesium sulphate to an OD of 0.5 at 600nm. The cells were used
immediately after dilution.
2.5.4 Preparation of glycerol stocks
Transformed cells were prepared for long term storage at -70°C in 1.5ml screw top tubes by the
addition of glycerol to a final concentration of 20% (v/v) with the cultured broth.
2.5.5 Preparation of plasmid and cosmid DNA
A number of methods were employed in this study to separate plasmid/cosmid DNA from
bacterial chromosomal DNA and cell debris. All methods are based on the conformation of
different DNA structures under varying pH conditions. Under alkaline conditions of pH 12 to
12.5 the linear bacterial DNA is denatured, whereas the supercoiled plasmid DNA remains
intact. Decreasing the pH by the addition of acid results in the aggregation of the denatured
bacterial DNA, protein and RNA. This aggregated mass is then centrifuged to form a pellet,
leaving a clear supernatant containing the solublised supercoiled plasmid/cosmid DNA. The
plasmid/cosmid DNA can then be purified using phenol/chloroform extraction (Sambrook,
1989). However when DNA preparations free from contaminants were required, for sensitive
techniques such as sequencing, a commercially available anion exchange column was used
[QIAprep miniprep and maxiprep kits (QIAGEN)].
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2.5.5.1 Small scale preparation of plasmid/cosmid DNA by alkali lysis (miniprep)
10ml broth cultures were harvested by centrifugation at 1187xg for 10 minutes (Mistral 2000,
MSE Scientific Instruments). The bacterial pellet was resuspended in lOOpl glucose buffer
(50mM glucose; lOmM EDTA, pH 8; 25mM Tris-HCl, pH 8). 200pl lysis buffer (0.2M NaOH;
1% SDS) was added and the suspension mixed until the bacteria lysed. The majority of protein,
RNA and bacterial DNA were precipitated by the addition of 150pl 3M Sodium acetate (pH 4.8)
and pelleted by centrifugation at 13,000rpm for 5 minutes (Sigma, 1-13). The cleared lysate was
decanted in to a fresh tube and vigorously mixed with an equal volume of phenol/chloroform
and clarified by centrifugation at 13,000rpm for 5 minutes as before. The top aqueous layer was
decanted to a fresh tube and the plasmid/cosmid DNA precipitated with 2.5 volumes of ice-cold
ethanol at -20°C for 1 hour. The DNA was pelleted by centrifugation at 13,000rpm for 10
minutes (Sigma, 1-13) and washed in 70% (v/v) ethanol, then resuspended in 50pl TE buffer
containing 0. lmg/ml RNAase A (Sigma).
2.5.5.2 Large scale preparation of plasmid DNA (maxiprep)
Up to 500pg of plasmid DNA was prepared using the QIAprep maxiprep kit (QIAGEN). The
procedure was carried out in accordance with the manufacturer's instructions with minor
adaptations. All buffers used were provided with the kit except isopropanol, 70% (v/v) ethanol
and TE buffer.
Transformed bacterial cells from a 100ml culture were harvested by centrifugation at 4000rpm
(JA-14 rotor, Beckman Instruments) for 15 minutes at 4°C. The pellet was resuspended in 10ml
of buffer PI and then 10ml of buffer P2 was added. The sample was mixed and left at room
temperature for 5 minutes to lyse the cells. Bacterial debris was precipitated by the addition of
10ml of chilled buffer P3 and incubation on ice for 20 minutes. The mixture was aliquotted into
1.5ml microcentrifuge tubes and centrifuged at 13,000rpm for 10 minutes (Sigma, 1-13). The
supernatant was promptly decanted and applied to the column (QIAGEN-tip 500 pre-
equilibrated with 10ml of buffer QBT) and allowed to run through. The column was washed
twice with 30ml buffer QC and the DNA eluted in 15ml buffer QF. DNA was recovered by
precipitation with 10.5ml isopropanol and centrifuging at 13,000rpm for 10 minutes (in
microcentrifuge tubes as before). The pellets were pooled in 1ml 70% (v/v) ethanol and
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centrifuged as before. The DNA pellet was washed for a second time in 1ml 70% (v/v) ethanol
prior to being air-dried and suspended in 1ml TE buffer.
2.5.5.3 Small scale preparation of plasmid/cosmid DNA (QIAprep miniprep)
The QIAprep spin miniprep kit (QIAGEN) can isolate up to 10pg cosmid DNA and 20pg
plasmid DNA. The procedure was carried out in accordance with the manufacturer's instructions
with the buffers provided with the kit.
Transformed bacterial cells were recovered by centrifugation at 1187xg for 10 minutes (Mistral
2000, MSE Scientific Instruments). The pellet was resuspended in 250pl buffer PI and then
250pl buffer P2 was added to lyse the cells. Protein and bacterial DNA was precipitated by the
addition of 350pl buffer N3 and the precipitate pelleted by centrifugation at 13,000rpm for 10
minutes (Sigma, 1-13). The supernatant was applied to the QIAprep spin column and the column
centrifuged for 1 minute at 13,000rpm (Sigma, 1-13). The column was washed with 500pl buffer
PB, and then with 750pl buffer PE by centrifuging for 1 minute as before. Residual wash buffer
was removed by a further centrifugation for 1 minute. DNA was eluted in 50pl buffer EB (pre-
warmed to 70°C for plasmids and cosmids greater then lOkb in size) which was applied directly
to the column membrane and incubated at room temperature for 1 minute before eluting by
centrifugation.
2.6 VECTORS AND CLONING
2.6.1 Cloning vectors
2.6.1.1 pBIuescript SK' phagemid
pBluescript SK- phagemid vector (Stratagene, figure 2.1) is derived from the pUC19 plasmid
(Short et al., 1988). The vector has a multiple cloning site (MCS) which consists of twenty-one
unique restriction endonuclease sites. The vector can theoretically accommodate DNA fragments
up to 18kb in length. The vector contains an ampicillin resistance gene enabling selection of
transformed colonies by the addition of ampicillin to the agar. In addition, recombinant vector
clones can be selected by blue/white colony screening. The MCS is situated within the plasmid
lacZ gene. Expression of the lacZ gene is repressed in lacl bacterial strains, however expression
can be induced with isopropyl-(3-D-thio-galactopyranoside (IPTG). Addition of the lactose
analogue 5-bromo-4-chloro-3-indolyl-P-D-galactopyranoside (X-gal), which is metabolised by
72
the lacZ product (P-galactosidase), results in the formation of a blue product. If the lacZ gene is
disrupted by insertion of DNA into the MCS, X-gal will not be metabolised and therefore the
colonies will remain white
2.6.1.2 SuperCos I vector
Cosmid vectors are useful in mapping sizeable regions of DNA because they can accommodate
large fragments of contiguous DNA. Historically, cosmids were engineered for studying
mammalian genomes, however they have been utilised extensively in characterising and
manipulating large viral DNA genomes.
The SuperCos I vector (Stratagene, see figure 2.2) was used in this study due to the advantages
this double cos site vector offers over traditional single cos site vectors. The method of preparing
the SuperCos I vector for cloning (see figure 2.3) eliminated the need to dephosphorylate the
vector's cloning site to prevent the formation of cosmid vector concatamers. This allows the
insert DNA to be dephosphorylated, preventing the multiple insertion of fragments into the
cloning site, thus removing the need to size fractionate the insert DNA. As size fractionation
results in a large loss of DNA, this vector is particularly useful when the insert DNA is in short
supply.
Ampicillin and neomycin resistance markers allow for positive selection of transformed cells on
selective agar. The Bam HI cloning site is flanked by the bacteriophage T3 and T7 promoters,
which allow the transcription of end-specific RNA probes.
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Figure 2.1 Circular map of pBluescript SK/+ phagemid vector. The vector is 2958bp in length
and contains a multiple cloning site (MCS) consisting of twenty-one unique restriction
endonuclease sites.
Figure 2.2 Circular map of SuperCos I vector. The cosmid vector is 7.9kb in size and contains
two 12bp recognition cos sites and a MCS with a Bam HI restriction endonuclease cloning site.
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2.6.2 Random cloning of SPPV restriction fragments into pBluescript SK"
2.6.2.1 Preparation of pBluescript SK" plasmid DNA
JM 109 cells transformed with the pBluescript SK" plasmid vector (Stratagene) were streaked
out to single colonies onto a LBA plate containing 50pg/ml ampicillin. A single colony was used
to inoculate 10ml LB supplemented with 50pg/ml ampicillin and grown for 16 to 18 hours.
2.5ml of the culture was used to seed 100ml LB supplemented with 50pg/ml ampicillin and
grown for 16 to 18 hours. Vector DNA was isolated using the QIAprep maxiprep kit (section
2.5.2.2).
2.6.2.2 Restriction endonuclease digestion of plasmid and insert DNA
lpg total viral genomic DNA and 1 fig pBluescript SK" DNA were completely digested with 10
units of Bam HI (Roche), Not I (Roche) or Kpn I (Promega) restriction endonucleases in
accordance with the manufacturers instructions (section 2.4.2). Reactions were incubated at
37°C for 1 hour then stopped by heat denaturation of the enzyme at 65°C for 15 minutes.
2.6.2.3 Ligation of DNA
The compatible ends produced by restriction endonuclease digestion of insert and plasmid DNA
were ligated together to form a covalent bond in a reaction catalysed by T4 DNA ligase (Roche).
Briefly, 50ng of digested vector DNA was ligated with digested genomic DNA in ratios of 1:3 to
1:7 in a total volume of 20ftl containing IX ligation buffer and 1 unit T4 DNA ligase. Reactions
were carried out at 22°C for 4 hours or at 4°C overnight.
2.6.2.4 Transformation of competent JM109 E.coli cells
50ng of ligated vector/insert DNA was mixed with 50gil of competent E.coli (strain JM109) and
incubated on ice for 30 minutes, followed by heat shock treatment for 2 minutes at 42°C.
Transformations were spread onto LBA supplemented with 50fig/ml ampicillin, lOfll 2% (w/v)
IPTG and lOftl 10% (w/v) X-gal per plate. Plates were inverted and incubated overnight at 37°C.
2.6.2.5 Isolation and amplification of a single colony
10ml LB supplemented with 50pg/ml ampicillin was inoculated with a single, white,
transformed bacterial colony. Following 16 to 18 hours of incubation at 37°C with agitation, 1ml
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glycerol stocks were prepared (section 2.5.4) and the plasmid DNA isolated using the alkaline
lysis method (section 2.5.5.1).
Alternately, when a large number of clones were generated, 1ml glycerol stocks were prepared
from the 10ml broth cultures and stored at -70°C. Prior to freezing, 200pl was removed and
placed into the wells of a 96-well tissue culture plate (Nunc), the plate was then sealed with an
adhesive cover and stored at -70°C. When required, LBA plates were inoculated in grid format
by transferring the glycerol stocks to an agar plate using a multichannel pipette.
2.6.3 Cloning the genome into SuperCos I vector
Preparation of the cosmid arms, the ligation of insert DNA and packaging of the cosmid into X
phage capsids are represented schematically in figure 2.3.
2.6.3.1 Preparation of the cosmid arms
10pg of circular SuperCos I vector was digested with 90U of Xba I restriction endonuclease
(Roche) at 37°C for 1 hour. A small aliquot of the digest was electrophoresed on a 0.8% (w/v)
agarose gel to check for complete digestion. The linearised Xba I-vector was extracted once with
phenol/chloroform and precipitated in ethanol. The DNA was washed in 70% (v/v) ethanol and
suspended in 10pl distilled water.
To prevent the vector Xba I sites from re-annealing during the subsequent ligation reaction, the
Xba I sites were dephosphorylated. Briefly, 10pg of the Xba I-digested vector (8pmol termini)
was dephosphorylated with 0.8U of calf intestinal alkaline phosphatase (CIAP, Stratagene) in
20pl reaction containing 1XCIAP buffer (50mM Tris-HCl, pH 8; lOOmM EDTA, pH 8). The
reaction was stopped after 30 minutes at 37°C by raising the EDTA concentration to 15mM and
heating at 68°C for 10 minutes. The DNA was purified by phenol/chloroform extraction and
ethanol precipitation as before.
The Xba I-CIAP-vector DNA was then digested with 40U Bam HI for 1 hour at 37°C. A small
aliquot was electrophoresed on a 0.8% (w/v) agarose gel to check for complete digestion. DNA
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Figure 2.3 Schematic representation of the preparation of SuperCos I arms and ligation with the
partially digested and dephosphorylated SPPV/carrier DNA.
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2.6.3.2 Preparation of insert DNA
Due to the limited quantity of SPPV DNA, a carrier DNA was used. The carrier DNA source
was rainbow trout (Oncorhynchus mykiss). This was selected due to the low G+C content, which
is generally 40 to 50% G+C (R. Sharif personal communication) and the abundance of fish
tissue in the laboratory where this study was performed.
2.6.3.2.1 Isolation ofSPPV DNA
DNA from SPPV scab isolate 1296/99 was prepared using the protocol detailed in section 2.4.1.
2.6.3.2.2 Isolation of salmonid carrier DNA
Approximately 2g of trout kidney was ground in liquid nitrogen using a pestle and mortar and
suspended in 15ml of lysis solution (lOmM NaCl; 20mM Tris-HCl, pH 8; ImM EDTA, pH 8;
0.5% SDS; 100pg/ml proteinase K). The suspension was incubated at 50°C for 12 hours without
agitation. An equal volume of phenol/chloroform was added and the mixture was gently inverted
for 10 minutes and then centrifuged at 1187xg (Mistral 2000, MSE Scientific Instruments). The
aqueous layer was decanted to a fresh tube and 3M Sodium acetate was added to a final
concentration of 0.3M. Two volumes of ethanol were layered over the aqueous layer and the
DNA gently spooled from the interface with a fine glass rod. The precipitated DNA was gently
washed in 70% (v/v) ethanol, drained without centrifugation and air-dried. The DNA was
allowed to suspend in TE buffer with O.lmg/ml RNAase at 4°C for 2 days without agitation.
2.6.3.2.3 Partial digest of insert DNA with Sau3A I and dephosphorylation
Bam HI has a 6bp recognition sequence and Sau3A I has a 4bp recognition sequence. Both
enzymes produce a 4bp 5'-extension of the sequence GATC, therefore Sau3A I digested insert
DNA can be ligated into the Bam HI site of the cloning vector. Sau3A I partial digest conditions
were optimised for both SPPV and carrier DNA to obtain fragments in the region of 30 to 42kb
in size.
SPPV and carrier DNA were diluted to 0. lp-g/pl in IX reaction buffer and digested with 0.05U
Sau 3A I/pg DNA at 37°C. Aliquots of the SPPV reaction were stopped after 15, 30 and 45
seconds incubation by the addition of lpl 0.5M EDTA (pH 8) and heating to 68°C for 10
minutes. The carrier DNA reaction was stopped at 30, 45 seconds and 1 minute. The partial
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digests were pooled together in a ratio of 1:4 pg SPPV to carrier DNA. The DNA was
phenol/chloroform extracted once, ethanol precipitated and resuspended in TE buffer.
20pg of partially digested SPPV/carrier DNA was dephosphorylated in a 20pl reaction
containing 20U CIAP in IX CIAP buffer. The reaction was incubated at 37°C for 1 hour before
it was stopped by raising the EDTA concentration to 15mM and heating at 68°C for 10 minutes.
The partially digested and dephosphorylated DNA was phenol/chloroform extracted once,
ethanol precipitated and resuspended in TE buffer ready for use.
2.6.3.3 Ligation and packaging of DNA
2.5pg of the partially digested and dephosphorylated insert DNA was ligated into lpg prepared
SuperCos I vector in a 20pl reaction containing IX ligation buffer and 1U T4 DNA ligase
(Roche). The reaction was performed at 4°C for 24 hours.
Ligated DNA was packaged into A phage capsids contained in the Gigapack III Gold packaging
extract (Stratagene). Briefly 0.7pg ligated DNA was gently mixed with one thawed packaging
extract. The packaging reaction was incubated at 22°C for 2 hours. Then 500|il SM buffer
(lOOmM NaCl; 50mM Tris-HCl, pH 7.5; 8mM Magnesium sulphate heptahydrate; 0.01% (w/v)
gelatine) and 20pl chloroform were added. The solution was gently mixed and pulsed in a
microcentrifuge to sediment the debris.
2.6.3.4 Titration of the packaging reaction
The packaging reaction was titrated prior to library amplification (section 2.6.3.5). The
packaging reaction was used at three concentrations: undiluted, 1:10 and 1:50 (diluted in SM
buffer). 25p) of each concentration was mixed with an equal volume of XL-1 Blue MR
competent cells (see section 2.5.3 for preparation). The transduction mix was incubated at 22°C
for 30 minutes to allow the phage to attach to the bacterial cell membrane. 200pl of LB was
added, and the broth incubated at 37°C for 1 hour to allow the pre-expression of ampicillin
resistance. Using a glass spreader each broth was plated onto a LBA plate supplemented with
50pg/ml ampicillin and grown overnight at 37°C. The colonies were counted and the titre of the
packaging reaction was calculated as colony forming units per ml (cfu/ml).
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2.6.3.5 Amplification and titering the cosmid library
Transducing the packaging reaction and amplifying the library enables the library to be stored
long term as glycerol stocks and subsequently to be screened many times.
A volume of the packaging reaction containing 40,000cfu was mixed with an equal volume of
XL-1 Blue MR competent cells (see section 2.5.3 for preparation) and incubated at 22°C for 30
minutes. Four volumes of LB were added and the transducing mix incubated at 37°C for 1 hour
with agitation. The cells were harvested by centrifugation at 1187xg for 10 minutes (Mistral
2000, MSE Scientific Instruments) and the pellet suspended in 1.5ml of LB. Using a glass cell
spreader, the bacterial cells were spread onto a 225mm x 225mm LBA plate supplemented with
50pg/ml ampicillin. The plate was incubated overnight at 37°C. The library was harvested by
washing and scraping the colonies off the agar into two 3ml volumes of LB supplemented with
50pg/ml ampicillin. The agar washes were pooled and glycerol was added to a final
concentration of 20% (v/v). The library was aliquotted and stored at -70°C.
The library titre was established by plating out 50 pi of 10~2, 10~4 and 10"6 serial dilutions of the
library onto LBA plates supplemented with 50pg/ml ampicillin. After incubation at 37°C
overnight, a colony count was performed and the cfu/ml was calculated.
2.7 COSMID RESTRICTION ENZYME MAPPING WITH 32P-LABELLED
PROBES
2.7.1 Linearisation of the cosmids with lambda-terminase
Cosmid DNA isolated using QIAprep spin miniprep kit (QIAGEN) was linearised with a
commercially available A-terminase (Amersham Pharmacia Biotech) in the following lOpl
reaction performed at 30°C for 1 hour.
Cosmid DNA 0.6pg
5X basal buffer 2pl
A.-terminase (4U/pl) 2pl
Distilled water to 10pl reaction volume
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2.7.2 Partial digest of linearised cosmids with restriction endonucleases
Linearised cosmid DNAs were partially digested separately with the restriction enzymes, Bam
HI, Hind III, Eco RI and Kpn I. Generally 0.3pg of cosmid DNA was partially digested with
0.15U of restriction enzyme in a total reaction volume of 10)0,1, containing a IX concentration of
the appropriate reaction buffer. Reactions were pre-warmed at 37°C before the addition of the
enzyme, then allowed to proceed for approximately 2 minutes. The addition of 0.5(0.1 of 0.5M
EDTA (pH 8) and heat denaturation of the enzyme at 68°C for 10 minutes stopped the reaction.
2.7.3 Preparation of digested A-phage DNA standards
DNA standards were created by digestion of genomic A-phage DNA with restriction
endonucleases to produce cos-end fragments of known sizes.
Non-methylated linear )i-phage DNA (Sigma) was completely digested in separate reactions
with Bam HI, Cla I, Hind III, Kpn I, Stu I and Xho I. The enzymes were inactivated and 0.5pg of
each digest was pooled together with 0.25pg uncut A,-phage DNA. The mix contained twelve
DNA end fragments ranging in size from 2kb to 33.4kb and the whole genome of 48.5kb.
2.7.4 Liquid hybridisation of linearised partially-digested cosmids and A-phage
standards with 32P-labelled oligonucleotides
Linearised-partially digested cosmid DNAs were hybridised separately with two 32P-labelled
oligonucleotides (ON-L and ON-R, see section 2.4.5.2.2 for labelling procedure) in the
following liquid reaction:
A.-terminase-partially digested cosmid DNA 0.15ug
1M Sodium chloride 0.8pl
ON-L/ON-R (0.15pmol/p,l) lpl
Distilled water to 8p,l reaction volume
The reaction was heated to 75°C for 5 minutes to disassociate the cos ends then incubated at
45°C for 30 minutes to allow the oligonucleotides to hybridise.
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Hybridisation of the labelled oligonucleotides to the A-phage DNA standards was performed
using the same conditions as the cosmids, except that both ON-L and ON-R were hybridised









Distilled water to 8pl reaction volume
2.7.5 Visualisation of the hybridised cosmid fragments
6X DNA loading buffer (section 2.8.1) was added to all samples and standards to a final
concentration of IX. 0.15p,g hybridised cosmid DNA and lOng standards were loaded into the
wells of a 0.45% (w/v) agarose gel (for ON-R hybridised samples) and a 0.6% (w/v) agarose gel
(for ON-L hybridised samples) and electrophoresed at 2 volts/cm for 16 to 30 hours in IX TBE
Gels were briefly rinsed in IX TBE then dried onto DE-81 chromatography paper (Whatman).
The dried gel was wrapped in Saran wrap and exposed to medical X-ray film (100NIF, Fujifilm)
with an intensifier screen for 24 to 48 hours. The autoradiograph was developed using a compact
X2 automated film processor (X-Ograph imaging systems).
2.7.6 Construction of cosmid restriction endonuclease maps
Autoradiographs were scanned and digitised using an Image Scanner and ImageMaster Labscan
v3.00 software (Amersham Pharmacia Biotech). Images were imported into the ID image
analysis program in ImageMaster TotalLab vl.00 package (Amersham Pharmacia Biotech).
Molecular size calibration was performed between the A.-phage standards and a curve was
plotted. Cosmid band sizes were estimated from the curve and the size difference between the
bands calculated. Cleavage maps were constructed for each cosmid from the data created from




2.8.1 Commonly used reagents
6X DNA loading buffer
Bromophenol blue sodium salt, M.wt. 691.9 (BDH) 0.025g
Xylene cyanol FF, M.wt. 538.6 (Sigma) 0.025g
Glycerol, M.wt. 92.09 (Sigma) 3ml
Distilled water 7ml
1M Ethylene diamine tetraaacetic acid (EDTA), pH 8
EDTA disodium salt, M.wt. 372.2 (Sigma) 186. lg
Distilled water 400ml
Mix and pH to 8 with 10M NaOH. Make up the volume to 500ml with distilled




20% (w/v) N-Lauroyl sarcosine
N-Lauroyl sarcosine sodium salt, M.wt. 293.4 (Sigma) lOg
Distilled water up to 50ml
Phenol/Chloroform
Phenol saturated with TE buffer, pH 7.4 (GibcoBRL) 200ml
Chloroform (Fisher chemicals) 198ml
Isoamyl alcohol (Sigma) 2ml
5M Sodium chloride (NaCl)
Sodium chloride, M.wt. 58.44 (Fisher Chemicals) 29.22g
Distilled water up to 500ml
Autoclave to sterilise.
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1M Sodium hydroxide (NaOH)
Sodium hydroxide, M.wt. 40.0 (Fisher Chemicals) 20g
Distilled water up to 500ml
Autoclave to sterilise.
20% (w/v) Sodium dodecyl sulphate (SDS)
Sodium dodecyl sulphate (sodium salt), M.wt. 288.4 (Promega) 40g
Distilled water up to 200ml
10X TBE buffer (0.9M Tris-borate/2mM EDTA)
Tris base, M.wt. 121.1 (Promega) 108g
Boric acid, M.wt. 61.83 (Sigma) 55g
0.5M EDTA, pH 8 40ml
Distilled water up to 1000ml
Autoclave to sterilise.
TE buffer (lOmM Tris-HCl/lmM EDTA)
1M Tris-HCl, pH 8.0 5ml
0.5M EDTA, pH 8.0 1ml
Distilled water 494ml
Autoclave to sterilise.
1M Tris-HCl, pH variable.
Tris base, M.wt. 121.1 (Promega) 121.lg
Distilled water 800ml
Mix and pH to the desired value with concentrated Hydrochloric acid (HC1). Make up to 1000ml
volume with distilled water. Autoclave to sterilise.
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2.8.2 Tissue culture reagents
199 media base
10X Medium 199 (Gibco BRL) 50ml
29.5g/litre Tryptose phosphate broth (Moredun Scientific Services) 50ml
80g/litre Sodium bicarbonate (Moredun Scientific Services) 3ml
0.1M Glutamine (Moredun Scientific Services) 5ml
250pg/ml Amphotericin B (Sigma) 1.5ml
10,000U/ml Penicillin, lOmg/ml Streptomycin solution 2.5ml
lOOU/ml Polymixin B Sulphate 1.5ml
Distilled sterile water 337ml
Growth 199 media
199 media base 450ml
Foetal bovine sera* (GibcoBRL) 50ml
* Heat inactivated at 56°C for 30 minutes
Maintenance 199 media
199 media base 450ml
Foetal bovine sera* (GibcoBRL) 10ml
Distilled sterile water 40ml
10X Phosphate buffered saline (PBS)
1.4M Sodium chloride, M.wt. 58.44 (Fisher Chemicals) 80g
2.7mM Potassium chloride, M.wt. 74.55 (Sigma) 2g
0.1M Di-Sodium hydrogen orthophosphate, M.wt.141.96 (Sigma) 11.5g
1.9mM Potassium phosphate monobasic, M.wt. 136.1 (Sigma) 2g







Filter through a 0.45p,m filter (Millipore) to sterilise.
2% (w/v) Isopropyl-p-D-thio-galactopyranoside (IPTG)
IPTG (Bioline) 200mg
Distilled water 10ml
Filter through a 0.45p,m fdter (Millipore) to sterilise.
Luria-Bertani broth (LB) (Moredun Scientific Services)
Bacto tryptone (DIFCO) lOg
Bacto yeast extract (DIFCO) 5g
Sodium chloride (Fisher Chemicals) lOg
Distilled water 1000ml
Mix and pH to 7.0, then autoclave to sterilise.
Luria-Bertani agar (LBA) (Moredun Scientific Services)
Luria-Bertani broth (Moredun Scientific Services) 500ml
Bacto agar (DIFCO) 15g
Autoclave to sterilise.
10% (w/v) 5-bromo-4-chloro-3-indolyl-P-D-galactoside (X-gal)
X-gal (Bioline) lOOmg
N,N-dimethylformamide, (Sigma) 1ml
Filter through a 0.45(xm filter (Millipore) to sterilise.
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2.8.4 Enzyme-linked immunosobent assay (ELISA) reagents
Carbonate-bicarbonate buffer
0.2M Sodium carbonate (Sigma) 7.9ml
0.2M Sodium hydrogen carbonate (Sigam) 17.1ml
Distilled water 75ml
Correct pH the solution to 9.6 by the addition of 0.2M Sodium carbonate or 0.2M Sodium
hydrogen carbonate.
ELISA diluent buffer
ELISA Wash buffer 100ml
Bovine serum albumin (Sigma) lg
ELISA wash buffer






Orthophenylene diamine (OPD substrate)
0.1M Citric acid (Sigma) 121.5ml
0.2M Di-Sodium hydrogen orthophosphate (Sigma) 128.5ml
Distilled water 250ml
Adjust the pH of the solution to 5.0 using either of the above solutions as required, then to
100ml of the solution add:
Orthophenylene diamine 80mg tablet (Sigma) IX 80mg tablet
30% Hydrogen peroxide (Sigma) 80p.l
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2.8.5 DNA hybridisation reagents
Denaturing buffer (0.5M NaOH/1.5M NaCl)
Sodium hydroxide, M.wt. 40.0 (Fisher chemicals) 20g
Sodium chloride, M.wt. 58.44 (Fisher chemicals) 87.66g
Distilled water up to 1000ml
Colony neutralisation buffer (1M Tris-HCl, pH 7.5/1.5M NaCl)
Sodium chloride, M.wt. 58.44 (Fisher chemicals) 87.66g
1M Tris-HCl, pH 7.5 1000ml
DIG colour substrate
75mg/ml NBT in 70% (v/v) dimethylformamide (Roche) 45|iil
50mg/ml BCIP toluidinium salt in dimethylformamide (Roche) 35p,l
Detection buffer 10ml
Detection buffer (0.1M Tris-HCl, pH 9.5/0.1M NaCl)
1M Tris-HCl, pH 9.5 100ml
Sodium chloride, M.wt. 58.44 (Fisher chemicals) 5.84g
Distilled water up to 1000ml
10X DIG blocking reagent
Blocking reagent (Roche) lOg
5X Maleic acid buffer 20ml
Distilled water 80ml
Mix and gently heat in a microwave until the blocking reagent dissolves.
Autoclave to sterilise.
5X Maleic acid buffer (0.1M Maleic acid/0.15M NaCl)
Maleic acid, M.wt. 116.08 (Fisher chemicals) 58.04g
Sodium chloride, M.wt. 58.44 (Fisher chemicals) 43.83g
Distilled water up to 1000ml
Mix and pH the solution to 7.5 with concentrated Sodium hydroxide and autoclave
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Southern neutralisation buffer (0.5M Tris-HCl, pH 7.5/3M NaCl)
1M Tris-HCl, pH 7.5 500ml
Sodium chloride M.wt. 58.44 (Fisher chemicals) 175.32g
Distilled water up to 1000ml
20X SSC buffer (3M NaCl/0.3M Sodium citrate)
Sodium chloride, M.wt. 58.44 (Fisher chemicals) 175.32g
Tri-Sodium citrate, M.wt. 294.10 (Fisher chemicals) 88.2g
Distilled water up to 1000ml
Correct pH to 7.0 with concentrated Sodium hydroxide.
Standard hybridisation buffer
20X SSC 250ml
10% (w/v) N-lauroylsarcosine 10ml
20% (w/v) SDS 1ml
10X DIG blocking reagent 100ml
Distilled water 739ml
Wash solutions
Wash solution 20X SSC 20% (w/v) SDS Distilled water
2X 100ml 5ml 895ml
0.5X 25ml 5ml 970ml
0.2X 10ml 5ml 985ml
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CHAPTER 3.0
CHARACTERISATION OF THE TISSUE CULTURE




The causative agent of the epidemic scab disease that causes high mortality in red squirrels was
tentatively identified by electron microscopy as a parapoxvirus by Scott et al., (1981).
Experimental infections subsequently confirmed that the Squirrel parapoxvirus (SPPV) was the
agent responsible for the scab disease in red squirrels (Tompkins et al., 2002). Virus from a
single animal was isolated in cell culture in the early 1980's (Sands et al., 1984) and to this day
it remains the only isolated strain of SPPV as subsequent isolation attempts have failed.
The availability of a tissue culture system for the production of virus would offer numerous
advantages for the characterisation of SPPV over virus derived from scab material. For example,
large quantities of virus can be produced in tissue culture and several methods for the extraction
of poxviral DNA from tissue culture exist. In contrast, only small amounts of scab material can
be recovered from an individual animal and the passage of SPPV in red squirrels to produce
more virus for study is rarely allowed due to ethical considerations and the protected status of
red squirrels in the UK. The availability of a tissue culture system would also enable viral gene
expression, viral development and the function of individual genes to be characterised.
Therefore, due to the limited quantities of scab material recovered from infected wild red
squirrels, characterisation of SPPV was attempted in the first instance, using virus purified from
tissue culture.
Sainsbury et al., (2000) successfully developed an enzyme-linked immunosorbent assay
(ELISA) for the detection of anti-SPPV antibodies in red and grey squirrels sera using Nonidet
P40 (Sigma) extracts of the tissue culture grown SPPV virus isolate as antigen (section 2.3.1.1).
The origin of SPPV is not clear, however grey squirrels are suspected to be the source as no
clinical disease was recorded until the introduction of grey squirrels to Britain in the late 19th
century (Sainsbury and Gurnell, 1995). Using the ELISA, Sainsbury reported that 61% of 223
apparently healthy grey squirrels sampled from across the UK had antibodies to SPPV
(Sainsbury et al., 2000). The high sero-prevalence suggests that the grey squirrel may act as a
reservoir for SPPV, providing that the virus is maintained in the grey squirrel and can be
transmitted to the red species. It was postulated that transmission of SPPV might be via a similar
route to the parapoxviruses (Sainsbury and Gurnell, 1997). To date there has only been one
confirmed report of SPPV induced disease in a wild grey squirrel (Duff et al., 1996) and
experimental infections of captive grey squirrels failed to induce clinical disease (Tompkins et
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al., 2002). The apparent absence of SPPV-induced scab lesions in grey squirrels raises several
questions regarding the transmission of the virus from the grey to red squirrels. Grey to red
squirrel transmission is unlikely to be via direct contact with infectious scab material shed into
the environment, which is considered to be the main route of transmission for other
parapoxviruses (Robinson and Balassu, 1981; Nettleton et al., 1996b). However the
epidemiology of parapoxviruses is poorly understood, and the transmission potential of
individuals with subclinical ORFV infections has not been discounted (Yirrell et al., 1994;
Nettleton et al., 1996b). Further studies are required to assess the transmission potential of
subclinically infected grey squirrels. In addition other routes of transmission cannot be ruled out,
such as the involvement of other host species. To address this question, sera was collected from
other rodent species (wood mice and bank voles) from a geographical location where persistent
SPPV infection is a problem. The sera was analysed using the ELISA (Sainsbury et al., 2000)
for antibodies to SPPV and the possible role of other rodent species in the epidemiology of
SPPV is discussed (section 3.3).
3.2 MORPHOLOGY OF SPPV
Virus was prepared from FLMC monolayers infected with virus previously passaged 25 times in
FLMCs (sections 2.2.2.1 and 2.2.3.1) and from scab material (isolate 1296/99) (section 2.2.3.2).
The prepared samples were stained with 2% phosphotungstic acid and visualised using negative
contrast electron microscopy (performed by CVLA, Lasswade). SPPV (tissue-culture strain)
viral particles were observed at a concentration in excess of lxlO6 particles per ml. The
estimated size of tissue culture strain SPPV particles was 270nm in length by 206nm in width,
which is somewhat different when compared to other parapoxviruses (refer to table 3.1). SPPV
had a similar length to ORFV, BPSV and PVNZ, but was much shorter than PCPV and much
longer than PVNZ. However SPPV was wider than all of the accepted members of the
parapoxvirus genus by approximately 35nm to 45nm giving the appearance of a slightly more
rounded or barrel-shaped particle when compared to ORFV particles (figures 3.1A and C). In
contrast, the dimensions of SPPV viral particles prepared from scab material (isolate 1296/99)
were similar to other parapoxviruses and the overall shape was ovoid (figure 3. IB).
SPPV resembled the parapoxviruses in term of general surface morphology of. The virus
possessed a regular basket-weave surface pattern, however a difference was noted in the
appearance of the basket-weave pattern when compared to other parapoxviruses (figure 3.1),
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which supports previous observations described by Scott (Scott et al., 1981). In SPPV scab and
tissue culture preparations the surface striations appear to cross at approximately 120°, whereas







SPPV tissue culture strain 270 205 This thesis
SPPV wild type isolate 1296/99 275 175 This thesis
ORFV 263 157 (Nagington and Home, 1962)
BPSV 277 169.5 (Nagington et al., 1962)
PCPV 300 150 (Cohen et al., 1964)
PVNZ 250 160 (Horner et al., 1987)
Sealpoxvirus3 316 192 (Simpson et at., 1994)
VACV 303 240 (Nagington and Home, 1962)
Western grey squirrelpox 308 247 (Regnery, 1975)
Table 3.1 The dimensions and axis ratios of the accepted and tentative (a) species of
parapoxvirus genus with the Western grey squirrelpox and VACV for comparison. Sizes were
estimated from negatively stained virus preparations examined by electron microscopy. Two
forms of sealpoxvirus were described by Simpson et al., (1994), only the sizes of parapox-like
virus are both presented here.
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Figure3.1Negativecon rastelect onmicrog phsfp xvirusa ticlst in dw thh sphotungstica d.(A)SPPVt ul rtaipassag26
inFLMC),(BSPPVwildtypeisolate1296/99anCORFstrainrf-11c ur syfDrPeterNettleton).
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3.3 Epidemiology of SPPV
Protein A and G conjugated to horseradish peroxidase (Protein G/A-HRP) were shown to
recognise and bind red and grey squirrel IgG in an ELISA system (Warns, 1995). The ELISA
was further developed by incorporating an antigen binding step to produce an assay capable of
detecting anti-SPPV IgG antibodies in sera obtained from red and grey squirrels (Sainsbury et
al., 2000). Protein G-HRP was the conjugate of choice in the squirrel ELISA because it
exhibited a greater sensitivity when compared to Protein A. The squirrel ELISA was used to test
wood mice and bank vole sera collected in July and August 2000 and 2001 from Manor Woods
(Wirral, Merseyside) for anti-SPPV antibodies.
3.3.1 ELISA development
Before the squirrel ELISA system could be used to screen rodent sera obtained from wood mice
and bank voles, the ability of Protein G-HRP to bind to sera from these rodent species was
assessed. Sera obtained from a red squirrel (pooled from three animals), a BALB/c mouse, two
wood mice (B821 and B826) and two bank voles (B017 and B825) were coated onto a
microplate at a 1/50 dilution (section 2.3.1.2). Reciprocal dilutions of Protein G-HRP were
added to the plates and allowed to bind to the coating antibodies. The optical density (OD) of
each well following the addition of the HRP substrate orthophenlyene diamine (OPD) were
measured and the resulting data used to assess the sensitivity of protein G-HRP in detecting
serum antibodies derived from the different rodent species.
The mean OD value of each duplicate was calculated and the results are presented in table 3.2.
Protein G-HRP reacted with the sera from all the different rodent species, but differences
between different rodent species were noted. The OD values with protein G-HRP at a
concentration of 1/500 ranged from 0.221 to 1.941, with bank vole and red squirrel sera
producing the highest OD values and BALB/c mouse the lowest.
The OD values decreased proportionately with decreasing concentrations of Protein G-HRP until
a point was reached were the concentration of Protein G-HRP was too low to detect the rodent
antibodies. This pattern is most obvious with the strongly reacting sera. For example with bank
vole B017 the OD values decreased from 2.805 to 1.082 with the Protein G-HRP dilution range
1/250 to 1/750. A similar pattern was also observed with the red squirrel and wood mice sera,
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1 2 3 4 5 6 7 8 9 10 11 12
Protein G-HRP
dilution
A 1.866 0.370 0.617 0.397 2.805 0.773 1/250
B 1.424 0.221 0.363 0.307 1.941 0.576 1/500
C 1.062 0.162 0.229 0.222 1.182 0.359 1/750
D 0.234 0.072 0.097 0.096 0.144 0.109 1/1000
E 0.143 0.068 0.083 0.070 0.163 0.073 1/1500


















Table 3.2 Summary of the OD values produced by the sera from different rodent species with
varying concentration of Protein G-HRP using the method described in section 2.3.1.2. The
OD4g2nm values presented are the mean values of the duplicate wells. The rows A to E of a 96-
well plate were coated overnight with sera obtained from the different rodent species (indicated
in the bottom row of the table). Different concentrations of Protein G-HRP added to each row
(concentrations are indicted in the right end column). Control row F is a OPD control, row F was
coated overnight with carbonate-bicarbonate buffer (pH 9.6) and did not received protein G-
HRP. Strongly positive OD values are shaded in grey.
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despite overall lower OD values than bank vole sera. All of the wood mouse and bank vole sera
produced OD values in excess of 0.2 with a protein G-HRP dilution of 1/750, however with
protein G-HRP diluted to 1/1000 OD values were less than or approximately 0.2. Therefore it
was determined that the lowest dilution of protein G-HRP that produced a strongly positive
reaction for wood mice and bank vole sera was 1/750. Hence a dilution of 1/750 of protein G-
HRP was used in the ELISA to detect anti-SPPV antibodies in wood mice and bank vole sera;
and a nominal OD value of 0.2 was decided upon as a cut off value to discriminate between
positive and negative antibody detection.
3.3.2 Bank vole and wood mice assay results
A total of 43 wood mouse and 130 bank vole sera were screened for anti-SPPV antibodies using
the ELISA protocol described in section 2.3.1.3. The mean corrected OD values were calculated
by subtracting the negative antigen mean OD values from the mean positive OD values. The
positive control samples (seropositive grey squirrel serum) were consistently positive (corrected
OD values ranged from 1.223 to 1.482) and the negatively controls (seronegative grey squirrel
and BALB/c mouse) all had corrected OD values less than 0.1. Likewise, all the corrected OD
values for the wood mice and bank vole sera were less than 0.1 and therefore seronegative for
SPPV.
The 173 rodent sera were previously screened using an immuno-fluorescence assay and 43 sera
were seropositive for antibodies specific for Cowpox virus (CPV) (performed by K. Tolliday,
University of Liverpool). No cross-reaction between anti-SPPV and anti-CPV antibodies was
detected.
Red and grey squirrel sera collected from 1994 to 2003 from several locations in the counties of
Merseyside and Lancashire were also tested as part of the ongoing, UK-wide survey of red and
grey squirrel sero-prevalence to SPPV. The ELISAs were performed using the same assay
conditions as Sainsbury (Sainsbury et al., 2000). 29 grey squirrels from a sample size of 42
individuals tested positive for SPPV antibodies, which indicates that approximately 69.0% of
grey squirrels in the Northwest of England are seropositive for SPPV antibodies. In direct
contrast, only 4 red squirrels tested positive for SPPV from a sample size of 23 animals, which
corresponds to a 18% seroprevalence in red squirrel populations (results courtesy of P.
Nettleton).
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3.4 MOLECULAR CHARACTERISATION OF TISSUE CULTURE GROWN
SPPV
3.4.1 SPPV-DNA extraction from infected foetal-lamb muscle cells (FLMCs)
Several attempts were made to extract high-quality viral DNA from SPPV-infected FLMC
monolayers using an adaptation of the method described by Meyer (section 2.4.2)(Meyer et al.,
1995). Confluent FLMCs monlayers contained in five 225cm2 tissue-culture flasks were infected
with the tissue-cultured strain of SPPV at a MOI of 1 (sections 2.1.1.1 and 2.2.2.1). Viral DNA
was harvested from infected FLMCs that were approaching 80% cytopathic effect (CPE).
Consistently, very little DNA was recovered, with an average of only 8pg of DNA in total from
five flasks. In addition, when the viral DNA was digested with the restriction endonuclease Eco
RI and electrophoresed on an agarose gel, no defined viral DNA bands were visible and the
sample appeared to be heavily contaminated with ovine genomic DNA and ribosomal RNA
(figure 3.2). Digestion with the restriction endonucleases Hind III and Kpn I also did not
produced defined viral DNA bands (results not shown). In contrast, viral DNA recovered from
ORFV (orf-11) infected FLMCs (performed in parallel with SPPV extractions) produced defined
viral DNA bands with very little contamination (figure 3.2). Furthermore, ORFV DNA extracted
solely from viral particles isolated from the cell supernatant appeared to have a greater purity
than cytoplasmic DNA extracts. Therefore SPPV DNA was extracted from cell supernatant in an
attempt to produce a purer preparation of viral DNA. However, only 1.8pg of DNA was
recovered from the media decanted from five 225cm2 flasks and the purity of the viral DNA was
still poor when compared to the ORFV DNA extracts (results not shown).
3.4.2 Random cloning of SPPV DNA extracted from infected FLMCs
Despite the poor purity and low concentration of viral DNA extracted from tissue culture grown
virus, the random cloning of SPPV Kpn I restriction endonuclease fragments was attempted
(section 2.6.2). When transformed cells were spread onto agar plates containing IPTG and X-gal,
the resulting bacterial colonies were predominantly blue in coloration. Very few white bacterial
colonies were observed, which suggests that the ligation of the plasmid vector with viral DNA
was inefficient. The few white colonies were isolated in culture and plasmid DNA extracted and
digested with Kpn I to cut the cloned viral DNA out of the vector. When electrophoresed on an
agarose gel, only one clone (designated Kl-TC) appeared to possess a cloned restriction









Figure 3.2 Agarose gel electrophoresis of SPPV and ORFV (orf-11) viral DNA extracted
from FLMCs. ORFV DNA was purified from the cytoplasmic extract of FLMCs (ORFV cyto)
and from cell supernatant (ORFV sup). Viral DNA was digested with Eco Rl and digest
products electrophoresed on a 0.8% (w/v) agarose gel along with undigested viral DNA and
DNA size markers (1 kb ladder supplied by Gibco BRL). The two bands indicated by the
arrows on the gel are likely to be ribosomal RNA.
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ends of Kl-TC by sequencing with oligonucleotide primers (T7 and T3) specific for the vector
sequence that flanks the cloning site (section 2.4.7). The average G+C content of the two
sequences was extremely high at 71%, which suggests that the clone is not mammalian in origin.
The nucleotide sequences were compared to those deposited in the EMBL databases using the
FastA algorithm to search for homologous sequence (section 2.4.8.1). The most significant
match for both sequences was with the G+C-rich genome sequence of MOCV (GenBank
accession number U60315), indicating that Kl-TC is likely to be poxviral in origin. The
percentage nucleotide homology of the left and right ends of Kl-TC with MOCV was 65.5% and
69.3% respectively.
3.5 DISCUSSION
The dimensions and barrel shape of the SPPV particles isolated from tissue culture corresponded
with those reported by Scott (Scott et al., 1981). However the viral particle derived from scab
material (isolate 1296/99) appeared to be more elongated than the tissue culture grown virus and
was characteristically parapoxvirus-like in shape. The barrel shape of the tissue-culture grown
strain of SPPV is not due to adaptation of the virus to tissue culture, as all wild type SPPV
isolates examined by electron microscopy to date are barrel shaped (Scott et al., 1981; J. Stewart
personal communication). This suggests that the ovoid shape of the scab isolate 1296/99 particle
may be an aberration. However, as only one virus particle from this isolate was clearly
photographed this cannot be confirmed. Despite the apparent variation in overall virion shape,
the appearance of the surface striations of SPPV prepared from both scab and tissue-culture were
comparable, suggesting that they are the same species of virus. Differences in the surface
morphology of SPPV when compared to the other parapoxvirus species, enables SPPV to be
distinguished from other parapoxviruses (Nagington and Home, 1962; Nagington et al., 1962;
Cohen et al., 1964; Wilson and Sweeney, 1970; Falk, 1978; Homer et al., 1987; Tryland et al.,
2001). Regular surface striations have also been reported for several unclassified poxviruses
including a Western grey squirrel virus of North America and crocodile and caiman poxviruses
(Regnery, 1975; Gerdes, 1991). The Western grey squirrel virus resembles SPPV in shape,
although the surface striations are much narrower and more closely packed than seen in SPPV.
The surface morphology of SPPV is indistinguishable from the caiman poxvirus.
Productive use of the tissue culture strain has enabled antigen to be prepared for ELISA. The
high incidence of squirrels that tested positive for SPPV antibodies by ELISA and the reports of
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clinical disease in the red squirrel populations of Ormskirk, Rufford, Southport and Formby
(Sainsbury and Ward, 1996; P. Nettleton personal communication) suggests that SPPV is
endemic in squirrel populations in the Northwest of England. All of the wood mouse and bank
vole sera tested proved to be negative for SPPV antibodies which indicates that these rodent
species do not play a role in the maintenance and transmission of SPPV. However this result
may not be conclusive as the geographical region the samples were collected from was limited.
It is possible that other rodent species may play a role in the transmission of SPPV, but remains
to be demonstrated.
Extraction of high quality viral DNA from tissue culture grown SPPV using methods previously
described for orthopox and parapox virus DNA purification proved unsuccessful. The amount of
DNA recovered from SPPV was consistently less and of poorer quality when compared with
ORFV DNA extracts. The growth of SPPV and ORFV in FLMCs was shown to be comparable
by immuno-fluorescent test (IFT) using the parapoxvirus and SPPV cross-reacting IC7
monoclonal antibody (Housawi, 1997) (results not shown). Therefore the low recovery of viral
DNA from SPPV infected cells is not the result of poor growth in tissue culture. A method must
be established to extract concentrated, pure viral DNA from infected cell monolayers if work is
to continue on tissue culture adapted SPPV. It is possible that some fundamental difference in
the development and egress of SPPV in vitro may hinder the purification of viral cores from the
cytoplasm of infected cells and hence result in the poor recovery of viral DNA. Closer
examination of the extraction method may reveal a step where virus is inadvertently discarded.
Cloning of the Kpn I fragments produced by digestion of viral DNA prepared from cytoplasmic
cell extracts was unproductive and only one clone (Kl-TC) was isolated. Disproportionate
numbers of clones consisting of just plasmid vector DNA were produced, suggesting that the
ligation of the plasmid vector with the Kpn I digested viral DNA was inefficient. Sequence
analysis of the clone Kl-TC revealed a G+C content of approximately 71% and homology at the
DNA level with MOCV in excess of 65%. Taken together, these data indicate that the genome of
SPPV is likely to be comparable in G+C content and share sequence homology with the G+C
rich viruses belonging to the molluscipox and parapox virus genera (Wittek et al., 1979;
Senkevich et al., 1997). This is discussed further in chapter 4.0.
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Tissue-culture work was abandoned in favour of working with the wild type virus for several
reasons. 1) Sufficient high quality viral DNA could not be recovered from tissue culture to
enable the SPPV genome to be cloned into a plasmid vector. 2) Adaptation of parapoxviruses to
tissue culture often initiates genomic rearrangement including duplication, translocation and
deletion events particularly in the terminal regions of the genome (Senkevich and Moss, 1998;
Fleming et al., 1995; Cottone et al., 1998; Mclnnes et al., 2001). Genomic rearrangement is
often accompanied by a decrease in virulence and pathogenesis. As one aim of this study is to
identify possible genes associated with virulence in vivo, it was therefore considered
appropriated to study the fully virulent wild type virus. Isolation of viral DNA and the
construction of restriction endonuclease maps of the wild type isolate 1296/99 genome are
discussed in chapter 4.0.
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CHAPTER 4.0




Restriction endonuclease maps have been published for the parapoxvirus species ORFV, PCPV
and BPSV (Menna et al., 1979; Gassmann et al., 1985; Mercer et al., 1987; Robinson et al.,
1987; Cottone et al., 1998; Mclnnes et al., 2001). Restriction endonucleases employed in the
mapping of parapoxvirus genomes include, Eco RI, Hind III, Hpa I, Bam HI and Kpn I.
Due to the shortage of highly purified viral DNA, as explained in section 4.2.1, restriction
endonuclease maps of SPPV could not be determined from single, double or partial restriction
digests of genomic DNA. Therefore SPPV Not I, Bam HI and Kpn I restriction fragments were
randomly cloned into a plasmid vector and the maps constructed using the cloned fragments.
The restriction endonucleases, Not I, Bam HI and Kpn I were selected for the following reasons.
Sequence analysis of the Kpn I clone (Kl-TC) produced from tissue-culture grown SPPV
suggested a G+C content of approximately 71% (section 3.4.2). The recognition sites of Not I,
Bam HI and Kpn I restriction endonucleases are G+C rich, hence these enzymes were predicted
to cleave the G+C rich SPPV genome frequently to produce fragments of a size that could be
easily cloned into a plasmid vector.
The genomes of 12 ORFV strains and isolates were shown to each comprise of between 20 and
24 Kpn I fragments (Robinson et al., 1987; Mclnnes et al., 2001). Analysis of the SPPV Kpn I
restriction profile (figure 4.1) indicated the SPPV genome is comprised of 14 or more Kpn I
fragments, of which the largest was estimated to be 17kb by comparison to known fragment
sizes in digested Orf-11 DNA (figure 4.1). This data indicated that it would be theoretically
possible to clone all the SPPV Kpn I fragments into the pBluescript plasmid, with the exception
of the two terminal fragments which were assumed to contain a terminal hairpin loop at one end
rather than a Kpn I site.
The genomes of 12 ORFV strains and isolates were shown to each comprise of only 9 to 11 Bam
HI fragments of which two or three fragments were of a size difficult to clone into a plasmid
vector. However, Bam HI sites appear to be more abundant in SPPV than ORFV. Analysis of the
Bam HI restriction profile (figure 4.1) suggest that 13 or more Bam HI fragments exist, with the
largest being approximately 15kb in size. Therefore it was assumed the majority of the genome
could be cloned into pBluescript SK" again with the exception of the terminal fragments.
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Not I restriction maps have not been published for any parapoxvirus species. Nevertheless Not I
was selected for use in cloning the SPPV genome because the recognition site consists solely of
G and C bases. It was hypothesised and later confirmed from the agarose gel depicted in figure
4.1 that Not I would cleave the SPPV genome with a greater frequency than Bam HI and Kpn I.
Strategic cloning and mapping of the smaller fragments produced by Not I was carried out to
effectively increase the number of locations available for DNA sequencing, without the need to
subclone the larger Bam HI or Kpn I clones.
For the reason discussed in section 4.7.1, the restriction endonuclease maps of SPPV could not
be completed solely with the restriction fragments cloned into a plasmid vector. Therefore, a
second cloning and mapping strategy was employed to complete the Bam HI and Kpn I maps.
The use of a cosmid vector allowed larger contiguous lengths of the genome to be cloned, with
individual cosmid clones being mapped with ease using an end-labelling and partial digest
method outlined in section 4.4.4. The use of cosmid clones enabled further characterisation of
the SPPV genome by mapping the restriction endonuclease sites Hind III and Eco RI without the
need to clone individual restriction fragments.
4.2 RESTRICTION ENDONUCLEASE MAPPING THE SPPV GENOME USING
CLONED RESTRICTION FRAGMENTS
4.2.1 Preparation of viral genomic DNA and the cloning strategy
Wild type SPPV genomic DNA was prepared from the scab isolate 1296/99 using the method
described in section 2.4.1. lg of scab (trimmed to remove surrounding healthy tissue) yielded a
total of 45|i,g of viral DNA. Single digests of 2pg of viral DNA were performed with Not I, Bam
HI and Kpn I and the digested DNA visualised by agarose gel electrophoresis (figure 4.1). The
SPPV restriction profile was difficult to interpret due to the low amount of SPPV DNA present
and extensive contamination by squirrel genomic DNA, which completely obscured viral DNA
fragments less than 6kb in size. In an attempted to enhance the restriction profiles of SPPV a
Southern blot was prepared and hybridised with a DIG-labelled probe prepared from the
extracted viral SPPV DNA. Although hybridisation with the genomic probe intensified the viral
DNA bands, it was not sufficient to clearly visualise the profiles (figure 4.2). Therefore the
SPPV DNA was deemed too poor in both quality and quantity to enable successful mapping of
the genome using single, double or partial restriction digests.
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4.2.2 Cloned restriction fragments
Three genomic libraries were produced consisting of 238 Kpn I, 235 Bam HI and 182 Not I
cloned fragments. Each cloned DNA fragment was given an identification number that was
preceded by the letter K for Kpn I, B for Bam HI or N for Not I (e.g. K21-1). For clarity in the
text that follows, plasmid clones have been given the additional "p" prefix in order to distinguish
between the entire plasmid (e.g. pK21-l) and the cloned SPPV DNA fragment.
It was predicted that not all of the clones would contain genomic SPPV DNA, a proportion was
likely to be derived from contaminating squirrel DNA. In total 16 Kpn I, 23 Bam HI and 34 Not I
clones were identified as being derived from the SPPV genome during subsequent mapping
procedure.
Clones containing SPPV DNA were digested with the appropriate restriction endonuclease to
excise the insert and the DNA bands resolved by agarose gel electrophoresis. The size of each
cloned restriction fragment was estimated by comparison to X phage DNA singularly digested
with various restriction endonucleases and a commercially available lkb DNA ladder (figure
4.3). Table 4.1 provides a summary of the cloned SPPV-derived restriction fragments and their
approximate sizes.
The approximate sizes of the cloned Kpn I fragments totalled 79.55kb. As parapoxvirus genomes
vary in length between 130kb to 150kb (van Regenmortel et al., 2000), it was predicted that only
approximately half of the genome was represented by the Kpn I clones. As expected many small
Not I restriction fragments were cloned. These ranged from 0.25kb to 10.lkb in length and had a
combined size of 105.84kb. The combined size of the twenty-three cloned Bam HI restriction
fragments was 121.95kb. Therefore the cloned Bam HI restriction fragments represented a
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Figure 4.3 A selection of unique clones, digested with the appropriate restriction endonuclease
to excise the cloned DNA fragment and electrophorised on a 0.6% agorose gel. Estimation of
the sizes of cloned DNA fragments were made by comparison to known DNA standards present
in a 1 kb ladder and A-phage DNA digested with Xho I, Kpn I and Bgl II. Note the 2.96kb vector
band is not visible on this gel as it is smaller than the lowest marker.
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Kpn I Fragments Bam HI Fragments Not I Fragments
Clone Size (kb) Clone Size (kb) Clone Size (kb)
K45-1 17.5 B7D-1 15.8 N9B-1 10.1
K18-1 7.1 B19-1 13.8 N42-2 7.75
K31-1 6.8 B3-1 13.3 N7-1 7.25
K46-1 6.55 B25-1 11.35 N5-1 6.6
K21-1 5.9 B8-1 9.9 N22A-1 5.75
K47-1 5.25 B11-1 6.3 N10B-1 5.45
K13-1 4.9 B51-2 5.7 N4-1 5.3
K43-1 4.8 B16C-1 4.75 N13-1 5.15
K1-TC 4.65 B5-2 4.65 N26A-1 4.7
K32-1 3.9 B98-2 4.6 N16-1 4.3
K1-1 3.25 B164-2 4.1 N65-2 4.15
K4-1 2.8 B6A-1 3.9 N12-1 3.75
K11-2 2.05 B13-1 3.15 N14D-1 3.3
K19-1 1.8 B1A-1 3.15 N15D-1 3.1
K11-1 1.6 B26-1 3.05 N3-1 2.8
K24-1 0.55 B20B-1 2.95 N5-2 2.4
B20A-1 2.65 N55-2 2.4
Total 79.55kb B7C-1 2.6 N24-1 2.35
B30-2 2.55 N9A-1 2.3
B70-2 1.15 N30-1 2.3
B12-1 1.1 N1-1 2.15
B2-1 0.8 N11A-1 1.55
B24-1 0.65 N6-1 1.5
N15H-1 1.35










Table 4.1 Summary of the unique Bam HI, Not I and Kpn I SPPV fragments cloned into
pBluescript SK plasmid vector and their approximate sizes.
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4.2.3 Mapping Strategy
Partial restriction endonuclease maps of the SPPV genome were determined using a strategy,
which is explained schematically in figure 4.4, to identify and align overlapping cloned
restriction fragments. Details of the methods used are presented in sections 4.2.3.1 to 4.2.3.3 and
an example of map construction of a small region of the SPPV genome is described in detail in
section 4.2.3.4.
4.2.3.1 Selection ofmap anchors
Several Not I and Bam HI clones were randomly selected from the genomic libraries and the
DNA sequenced derived from both ends of the clone analysed (sections 2.4.7 and 2.4.8.1). 8 Not
I fragments were selected for use as map anchors on the basis of DNA homology with other
poxviruses. All eight Not I anchor fragments exhibited at least 58% sequence homology to
MOCV or ORFV DNA at one or both ends (table 4.2) and alignment to the MOCV subtype 1
genome (accession number U60315) indicated that the Not I anchor fragments were likely to
span the SPPV genome (figure 4.5). One Bam HI fragment, B7C-1, was used as an anchor
fragment. B7C-1 did not however exhibit DNA homology with any poxvirus sequence and its
use as an anchor fragment is explained in section 4.3.2.1.2.1.
The cloned DNA fragments were excised from the plasmids by digestion with Not I and purified
from agarose gels. These were labelled with DIG using the random priming or nick translation
methods (section 2.4.5.1).
4.2.3.2 Hybridisation to identify overlapping cloned fragments
The DNA of a selection of Not I, Kpn I and Bam HI clones were spotted onto nylon membrane
(section 2.4.5.3.2) and screened with DIG-labelled restriction fragments. In the event of the
probe failing to hybridise with any of the clones, a greater number of clones were screened. This
was achieved by the screening transformed bacterial colonies prepared by the methods detailed
in sections 2.6.2.5 and 2.4.5.3.3. All of the hybridisation data used in the construction of SPPV
restriction maps is presented in appendix I (located at the end of this thesis), tables Al.l to A1.6.
The tables summarise hybridisation data derived from dot blots, Southern blots and colony
screening. However, it should be noted that some cloned fragments were not utilised as probes
as they would not have extended the mapped regions.
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STEP 1 - Identify overlapping Bam HI clones:
DIG-labelled Not I
fragment A (5kb) f
Probe Bam HI
clones Two Bam HI clones identified:
1 (2.5kb) and 2 (3.75kb).
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location of the Not I (^) and
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the overlap sizes of the Not I
and Bam HI clones and aligned
the fragments.
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Not I (+) and Bam HI (A) sites
confirmed with restriction digests
and the fragments aligned as in
step 2.
Ill
Figure 4.4 Schematic representation of the technique used to identify overlapping clones and
their alignment to produce a restriction endonuclease map of SPPV.
Step 1) A cloned Not I fragment (anchor fragment) predicted to be viral in origin by sequence
analysis was labelled with digoxygenin (DIG) and used to identify overlapping cloned Bam HI
fragments by hybridisation. Step 2) The overlapping fragments were then accurately aligned to
the map anchor by a series of restriction endonuclease digestions to calculate the size of the
overlaps. Step 3) The overlapping fragments were labelled with DIG and used to identify, by
hybridisation, the overlapping Not I fragments, Step 4) which were subsequently aligned using
data from restriction endonuclease digests. This technique enabled the small mapped sections
of the SPPV genome to be gradually extended by identifying adjacent and overlapping
fragments.
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Table 4.2 Summary of the sequence data from the selected cloned map anchor fragments. In
column 3, data in the brackets ( ) represents the region of the MOCV genome that is
homologous with SPPV. Column 4 provides the percentage DNA homology of SPPV with
MOCV, calculated from the alignment of sequences by the FastA algorithm (section2.4.8.1).
MOCV Genome
0 50 100 150 190
I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
N16-1 N13-1 N6-1
— " SPPV Not I
fragments
N24-1 N12-1 N22A-1 N1-1 N7-1
Figure 4.5 Preliminary alignment of SPPV Not I anchor fragments to MOCV subtype 1 genome,
based upon the sequence homology of the SPPV Not I fragments with MOCV (table 4.2).
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4.2.3.3 Alignment of overlapping fragments
Hybridising fragments were accurately aligned using restriction endonuclease digests to
determine the extent of overlap. This was achieved by comparing their restriction profiles to
identify fragments that are common in size (figure 4.8 for an example). The sizes of the
fragments produced by single digestion of each Kpn I clone with Not I and Bam HI were
determined, and the data is summarised in appendix I, table A 1.7. The data from the digestion of
the Bam HI clones with Kpn I and Not I are summarised in table A1.8. Likewise, the data from
the digestion of the Not I clones with Bam HI and Kpn I is presented in table A 1.9.
4.2.3.4 Example of restriction endonuclease map construction
The progressive steps involved in the construction of restriction endonuclease maps are
explained here in the form of a detailed explanation of the mapping of a small region of the
SPPV genome.
The DIG-labelled Not I fragment 5-1 (N5-1) hybridised with pK21-l, pB7D-l and the duplicates
pB51-2 and pB22-2 (figures 4.6 B, G and I). In figures 4.6 A and D, DIG-labelled B51-2
hybridised with pK21-land pN5-l. In figures 4.6 C and F DIG-labelled B7D-1 hybridised with
pK21-l and pN5-l. In figures 4.6 E and H, DIG-labelled K21-1 hybridised with pN5-l and
pB7D-l; the hybridisation of K21-1 with pB51-l was not tested. These results indicate that N5-1
and K21-1 overlap each other and both overlap B7D-1 and B51-2, in the arrangement depicted
in figure 4.7.
Establishing the size of the overlap between the fragments by comparing restriction profiles of
the clones enabled the fragments to be accurately aligned. pN5-l was singularly digested with
Bam HI or Kpn I, likewise pB7D-l and pB51-2 were singularly digested with Not I and Kpn I;
and finally pK21-l singularly digested with Not I and Bam HI (figure 4.8).
Bam HI digestion of pN5-l produced two bands of approximately 7.0kb and 2.55kb. As a unique
Not I, Bam HI and Kpn I vector restriction sites are located within the multiple clone site of
pBluescript SK"; when pN5-l is digested with Bam HI the DNA is cleaved at the vector site and
once within N5-1 producing two fragments. However, the vector DNA remains attached to one
end of the cleaved N5-1 DNA. The 7.0kb fragment must include the plasmid vector because the




















Figure 4.6 Hybridisation examples of overlapping fragments. Blots A to H are of plasmid DNAs
spotted onto nylon membranes and screened with DIG labelled probes. A, B and C are duplicate
blots of a selection of Kpn I clones screened with DIG-labelled B51-2 (blot A), N5-1 (blot B)
and B7D-1 (blot C), all three probes hybridised with pK2I-l. Blots D, E and F are duplicate
blots of a selection of a selection of Not I clones screened with DIG-labelled B51-2 (blot D) and
K21-1 (blot E) and B7D-1 (blot F), all three probes hybridised with pN5-l. G and H are
duplicate blots of a selection of Bam HI clones screened with DIG-labelled N5-1 (blot G) and
K21-1 (blot H), both probes hybridised with pB7D-i. Blot I shows the immobilised transformed






Figure 4.7 Schematic representation (not drawn to scale) of the initial alignment of N5-1, B7D-1,
B51-2 and K21-1 based upon dot blot and colony screening hybridisation data. The double black
arrows (|) represent hybridisation analysis that was positive both ways. The single black arrow












Figure 4.8 pN5-1, pB7D-1, pB51 -2 and pK21 -1 singularly digested with Bam HI, Not I or Kpn I and
electrophoresed on a 0.6% (w/v) agarose. The fragment sizes were estimated by comparison to
known standards present in the 1 kb ladder (Gibco BRL). In order to estimate the size of the larger
fragments, the gel was electrophoresed further to resolve the high molecular weight fragments (gel
not shown).
117
subtracted from the 7.0kb band, the remaining N5-1 fragment was estimated to be approximately
4.05kb. N5-1 hybridises with two Bam HI fragments identified as B51-2 and B7D-1; therefore
N5-1 must overlap with one Bam HI fragment by 4.05kb and with the other Bam HI fragment by
2.55kb. It then it follows that single digestions of pB51-2 and pB7D-l with Not I must each
produce a fragment corresponding in size to 4.05kb or 2.55kb. Not I digestion of pB51-2
produces two fragments of approximately 3.25kb and a 5.5kb. When the size of the vector is
subtracted from the 5.5kb band it corresponds to the 2.55kb overlap with N5-1, indicating that
the overlap between N5-1 and B51-2 is 2.55kb (figure 4.9).
As N5-1 only possessed one Bam HI site it can be predicted that N5-1 will overlap B7D-1 by
4.05kb. In support digestion of pB7D-l with Not I produced a number of bands of the
approximate sizes: 8.0kb, 4.4kb, 4.05kb and 2.35kb. The 4.05kb pB7D-l Not I band corresponds
in size to the predicted overlap of N5-1 to B7D-1, confirming the alignment of restriction
fragments depicted in figure 4.9.
The arrangement is supported by the alignment of a third fragment, K21-1. DIG-labelled N5-1,
B51-2 and B7D-1 all hybridised with pK21-l confirming that like N5-1, K21-1 also overlapped
B51-2 and B7D-1. Digestion of pK21-l with Not I produced a single band of approximately
8.8kb. Thus it can be concluded that K21-1 does not possess any Not I sites and therefore must
be situated completely within the N5-1 fragment. Furthermore, digestion of pN5-l with Kpn I
produced three fragments, the 5.9kb fragment corresponds in size to K21-1, which is situated
internally within N5-1. The remaining fragments 0.5kb and 0.15kb (the 3.1kb fragment minus
the vector) in size must therefore represent the ends of N5-1, which flank K21-1. Digestion of
pK21-l with Bam HI produced two fragments, 2.1kb and 6.7kb in size. The 6.7kb fragment must
contain the vector. Therefore K21-1 must overlap one Bam HI fragment by 2.1kb and the other
Bam HI fragment by approximately 3.75kb. Kpn I digestion of pB51-2 produced three bands,
one of which corresponds to the predicted 2.1kb overlap with a Bam HI fragment. Hence if K21-
1 overlaps B51-2 by 2.1kb, K21-1 must overlap B7D-1 by 3.75kb. The size of the K21-1 and
B7D-1 overlap was confirmed by digestion of pB7D-l with Kpn I. Five bands were produced, of
which one was approximately 6.7kb, or 3.75kb when the size of the vector was subtracted.
Hence the accurate alignment of N5-1, B51-2, B7D-1 and K21-1 could be determined (figure
4.10).
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2.55kb . . 4.05kb . Bam HI digested N5-1
I ' ' fragment sizes
N5-1
B51-2 P < B7D-1
1 ► Not I
digested
i i i i i i 651-2 and
3.25kb 1 1 2.55kb 1 1 4.05kb 1 ' 4.4kb B7D-1
fragment
sizes
Figure 4.9 Schematic representation of the fine alignment of N5-1, B7D-1, B51-2 based upon
restriction digest and hybridisation data (drawn approximately to scale). The black arrows
indicate fragments which hybridise with each other and the black bars (I 1) represent the
DNA fragments produced when N5-1 is digested with Bam HI and when B51-2 and B7D-1 are
digested with Not I. Fragment B7D-1 extends beyond the depicted region, which is indicated by
the arrow.
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0.5Kb 5 9Kb 0.15Kb Restriction
|—1| 1H fragments of N5-1
digested with Kpn I
. B51-2 and B7D-1 digested
'
2.1Kb 3.75Kb 1 with Kpn I and K21-
1 digested with Bam HI
Figure 4.10 Schematic representation of the fine alignment of N5-1, B7D-1, B51-2 and K21-1
based upon hybridisation and restriction digest data (drawn approximately to scale). Fragment
B7D-1 extends right, beyond the region depicted in this figure. The broken black bars ^ |)
represent DNA fragments produced when K21-1 is digested with Bam HI and when B51-2 and
B7D-1 are digested with Kpn I. The solid black bars (| 1) represent the fragments produced
by digestion of N5-1 with Kpn I, the alignment of N5-1 to the Bam HI fragments is depicted
previously in figure 4.9.
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The majority of mapping was completed successfully using DNA hybridisation and restriction
profile data, however situations did arise where just these two techniques alone were inadequate
to resolve the map. Sequencing was often employed to confirm the presence of a restriction site
near to the end of a cloned fragment, where the overlap between 2 fragments was too small to be
detected by hybridisation. Southern blotting was often used to resolve difficult areas of the map
where the size of the overlap was difficult to determine from the restriction profile data alone.
Bam HI, Not I and Kpn I restriction maps were determined for the SPPV genome. However, they
were incomplete and consisted of four clusters (termed clusters 1, 2, 3A and 3B), each composed
of adjacent and overlapping restriction fragments. Clusters I and 2 are presented in sections
4.2.4 and 4.2.5 respectively. Clusters 3A and 3B are presented together in section 4.3.
4.2.4 Cluster 1
A schematic representation of the cluster 1 map is presented in figure 4.11. Cluster 1 has a total
length of 79kb. A number of restriction fragments have been mapped that are designated as
"missing", because no representative clone containing that fragment had been obtained. For
clarity in the text that follows, each "missing" fragment has been designated a code consisting of
the first letter of the restriction enzyme, M for missing and an identification number, for
example; KM1. In addition each area that proved difficult to map and requires explanation has
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Regions 1.1 to 1.6
The annotated regions 1.1 to 1.6 refers to the "missing" restriction endonuclease fragments;
KM1, 2, 5, 9, 10 and NM2 that have all been mapped to locations that are situated completely
internal within a larger cloned fragment. The size and location of the missing fragments were
determined with relative ease by restriction mapping the larger clone.
For example, in region 1.1, an uncloned Kpn I fragment (designated KM1) was mapped to a
location internally within B51-2 and adjacent to K21-1. This was established from restriction
profile data obtained from pB51-2 digested with Kpn I. Three pB51-2IKpn I fragments were
produced of the sizes: 2.45kb, 2.1kb and 4.15kb. Only the 4.15kb DNA fragment is the only one
large enough to accommodate the vector. Hence, the size of the vector was subtracted from
4.15kb leaving approximately 1.2kb of B51-2 DNA, which extended from the left end of B51-2
(as depicted in figure 4.12) to the first internal Kpn I site. As previously explained (section
4.2.3.4), the 2. lkb Bam HI fragment overlapped the left end of K21-1, the corresponding 2.1kb
fragment being produced by Kpn I cleaving pB51-2 at the internal Kpn I site and the vector Kpn
I site. Therefore the terminal Kpn I fragments of B51-2 corresponded to the 1.2kb and 2.1kb
DNA fragments. It then follows that the 2.45kb DNA band must correspond to fragment KM1,
which is located internally within B51-2.
The location of the Kpn I sites in region 1.3 was determined in a similar manner, however it
required the analysis of the two overlapping fragments: B20B-1 and N42-2 (figure 4.13 for a
schematic representation). Digestion of pB20B-l with Kpn I produced DNA bands: 3.5kb,
1.45kb and l.Okb. The 3.5kb band comprised of the vector and a 0.55kb terminal Kpn I fragment
which corresponded in size to a Bam HI digest product of pK45-l; this suggests that the right-
end of K45-1 overlaps the left-hand end of B20B-1 by 0.55kb. The order of the remaining
pB20B-l Kpn I fragments and the size of the Kpn I fragment (KM5) located internally within
B20B-1 could not be determined from pB20B-l restriction data alone. As N42-2 spans B20B-1,
a Kpn I fragment situated internally within B20B-1 must also be situated internally within N42-
2. Consequently singular digestions of pN42-2 and pB20B-l with Kpn I produced a common
fragment 1.45kb in size, identifying it as the uncloned Kpn I fragment, KM5, located internally
within B20B-1 and N42-2. It then follows that the remaining l.Okb fragment from the Kpn I
digestion of B20B-1 must represent the size of the right terminal Kpn I fragment.
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Figure 4.12 Kpn I and Bam HI restriction endonuclease map of pB51-2 (not drawn to scale)
constructed to determine the size of KM1 (region 1.1). The outer bars represent the
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Figure 4.13 Schematic representation of region 1.3, demonstrating how the missing 1.45kb
Kpn I fragment (KM5) was mapped using restriction digest data from the overlapping
fragments: N42-2 and B20B-1. The horizontal black bars (| 1) represent the fragments
produced when the overlapping clones were digested with Kpn I, the details in the box above
each bar gives the fragment size and overlap information.
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Region 1.7
Region 1.7 refers to an uncloned Kpn I fragment (KM6) predicted to overlap the two adjacent
Bam HI fragments: B20B-1 and B98-2. The approximate size of KM6 was determined by first
establishing the Kpn I maps of B20B-1 and B98-2 and then determining the distance between the
right Kpn I site in B20B-1 and the left Kpn I site within B98-2 as depicted in figure 4.14. As
previously established (region 1.3) the right terminal Kpn I fragment of B20B-1 was l.Okb. The
position of the single Kpn I site located within B98-2 was determined by Kpn I restriction
digestion of pB98-2. The two fragments produced were of the approximate sizes: 3.65kb (with
the vector subtracted) and 0.9kb. Therefore there were two possible locations of the single Kpn I
site in B98-2, either 0.9kb or 3.65kb from the left end. The Kpn I site was confirmed to be
3.65kb from the left end of B98-2 by the absence of a third Kpn I site situated internally within
N42-2 and the presence of an internal Kpn I site within N3-1. The addition of the l.Okb right
terminal Kpn I fragment of B20B-1 and the 3.65kb left terminal Kpn I fragment of B98-2
equalled 4.65Kb, the size of the uncloned Kpn I fragment.
The tissue culture-adapted SPPV DNA derived clone, pKl-TC, hybridised to B20B-1, B98-1,
N42-2 and N3-1 indicating that Kl-TC may be representative of KM6 wild type fragment. The
size of Kl-TC was approximately 4.65kb, which correlated with the calculated size of KM6. In
addition, the Bam HI and Not I restriction profiles of pKl-TC matched those predicted for KM6.
Taken together these indicate that fragment Kl-TC may be highly conserved in both the tissue
culture-adapted strain and the wild-type isolate 1296/99. However, a divergence in the DNA
sequence between the wild type and tissue culture-adapted virus within this region may exist.
Region 1.8
Region 1.8 refers to the order of Kpn I sites within the two adjacent Bam HI fragments: B98-1
and B164-2. Like region 1.7, the Kpn I map was deduced by examining Kpn I restriction profiles
of the two overlapping Bam HI clones.
Firstly an "missing" Kpn I fragment, (KM8) 0.9kb in size, was shown to lie adjacent to Kll-2
and internally within B164-2 by mapping the Kpn I sites in pB 164-2 using the method outlined
in regions 1.1 to 1.6 (figure 4.14). It was deduced from the B164-2 Kpn I restriction map that the
2.95kb of DNA to the left of KM8 would overlap the right terminus of a "missing" Kpn I
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3.65kb region to the left of the B98-2 Kpn I site overlapped KM6, then the 0.9kb region to the
right of the Kpn I site must overlap the left end of KM7. Therefore the size of the right terminal
Kpn I fragment of B98-2 (0.9kb) and the left terminal Kpn I fragment of B164-2 (2.95kb), when
combined, equals 3.85kb which represents the size of KM7.
Region 1.9
Fragments N12-1 and N13-1 were suspected to be adjacent by the alignment of sequence
obtained from the right end of N13-1 and from the left end of N12-1 to the MOCV genome. The
sequences were made contiguous at the Not I site and then compared with those deposited in the
EMBL database using the FastA search algorithm (section 2.4.8.1). The contiguous SPPV
sequence aligned with the MOCV subtype 1 complete genome (EMBL accession number
U60315) over its full 308nt length and demonstrated a 68.8% homology with MOCV (figure
4.15).
N12-1 and N13-1 did not hybridise to any common Bam HI or Kpn I fragments, and therefore no
fragments that overlap both N12-1 and N13-1 were identified in this manner. However N12-1
hybridised with pB16C and N13-1 hybridised with pB 11-1. N13-1 was shown to possess one
Bam HI site situated near to the right end of N13-1 by restriction digestion and DNA sequencing
(figure 4.15). Based on the strength of the hybridisation signal and restriction analysis, B11-1
was predicted to overlap the majority of N13-1. In contrast N12-1, which hybridised with B16C-
1, lacked a Bam HI site. Therefore N12-1 must be situated internally within B16C-1. B16C-1
hybridised with pN12-l and pN9A-l. N9A-1 contained one Bam HI site and must therefore
overlap one end of B16C-1. Since N12-1 and N13-1 are predicted to be adjacent, N13-1 must
overlap the opposite terminus of B16C-1 to N9A-1, however no hybridisation between B16C-1
and N13-1 was detected to confirm this. Nevertheless the presence of a Bam HI site just 29bp in
from the right terminus of N13-1 suggested an overlap did exist between B16C-1 and N13-1, but
that it was too small to produce a visible signal with hybridisation. The predicted overlap
between N13-1 and B16C-1 and the adjacent position of N12-1 and N13-1 was confirmed by the





52520 52530 52540 52550 52560 52570
40 50 60 70 80
N13/N12-1 CGGGGA-CGCGTGACCGCGCTCTTCAACGCCGCGCCCGAGAC-CGTGAAGCGCTTCGACG
MOCV CGCCGAGCGCTTTGCCGCGCTCTTCAACGCGCAGCCAGAGGCGCGTG-CGCGTTTTGACG
52580 52590 52600 52610 52620 52630
Ram HI
90 100 110 120 130 140
N13/N12-1 AGATGCCCATGAACTCCACCTTCGTCTCGCGCATGGTCTACGGATCCGCCGACGTGGACC
MOCV ACATGGACGTCAACACAACCTTTGTCTCACGGATGGTCTACCAGACGCCGGACCTGGACC
52640 52650 52660 52670 52680 52690
150 Not{ 160 170 180 190 200
N13/N12-1 TCGCGGCCGCGTGGCGC-AGTACACCTGCCAGATCTACCACGAGGACACGCTCTACCACA
MOCV TGCTCGCGCTGGAGCGCAACCGCATGTGCCAAATCTACAGCGAGGACACGCAGTACTATG
52700 52710 52720 52730 52740 52750
210 220 230 240 250 260
N13/N12-1 TCCGCGAGTACAACACCTACCTCTTCCTCAACGAGGAGGACCCGCTCGTCCTCGACGCGG
MOCV TGAAGGAGTATAACACCTTCTTGTTCCTGCACGAGGACGACCCTGTGGTCATCGACGAGG
52760 52770 52780 52790 52800 52810
270 280 290 300
N13/N12-1 GCGTCCTGGTGCGGCTCTCCTACGTGCCCGCCGCCCGGCGC
MOCV GCGCACTGGTTCGGTTGTCAAGCGTGCCAAGCGAGCGGCGCCGCTTGCTCTTTAGCGAGC
52820 52830 52840 52850 52860 52870
Figure 4.15 FastA alignment of N13-1 (red font) and N12-1 (blue font) nucleotide sequence,
made contiguous at the Not I site (highlighted in grey), to MOCV subtype 1 complete genome
















Figure 4.16 Sequence alignment of the clones N13-1, N12-1 and B16C-1. The adjacent clones
N13-1 and N12-1 are both overlapped by B16C-1. The common Not I and Bam HI sites are
highlighted in black and grey respectively.
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Region 1.10
Once the alignment of B16C-1 to N12-1 and N13-1 had been established, the Not I map to the
immediate right of N12-1 could be determined. As previously mentioned, N9A-1 was predicted
to overlap the right terminus of B16C-1 (region 1.9). The size of this overlap was calculated to
be 0.85kb by the comparison of pN9A-l digested with Bam HI and pB16C-l digested with Not I
to identify the common sized fragment. This arrangement does not account for a 0.17kb
fragment produced by pB16C-l digested with Not I. No Not I clone of that size had been
obtained during the library screening, so it was assumed that this represents an uncloned
fragment (NM1). The location of NM1 was deduced by a process of elimination using a Not I
restriction map constructed for pB16C-l (figure 4.17). Briefly, N13-1 overlaps the left terminus
of B16C-1, N12-1 is situated immediately to the right of N13-1 and N9A-1 overlaps the right
terminus of B16C-1, so the only remaining place NM1 could be situated was between N12-1 and
N9A-1.
Region 1.11
Once the order and alignment of the Not I and Bam HI fragments had been established for
regions 1.9 and 1.10, the Kpn I map (region 1.11) could be determined.
B11-1, B16C-1 and B13-1 each possessed one Kpn I site, indicating that there were two
"missing" Kpn I fragments {KM3 and KM4) overlapping B16C-1. Using restriction profile
analysis, the location of the Kpn I site in B11-1 was easily determined by establishing that the
overlap with K46-1 was 4.6kb. Likewise, the location of the Kpn I site in B13-1 was determined
by establishing that the overlap with K45-1 was 2.35kb. However, the position of the Kpn I site
in B16C-1 was more difficult to map and required the use of the previously constructed Not I
map of pB16C-l (figure 4.17) to establish the orientation of the B16C-1 fragment within the
vector. Digestion of pB16C-l with Kpn I produced two fragments, 1.4kb and 6.3kb in size. As
the 6.3kb fragment must contain the vector, the Kpn I site must be located approximately 1.4kb
from the vector Kpn I site, which corresponds to 1.4kb in from right terminus of B16C-1.
The sizes of the uncloned Kpn I fragments, KM3 and KM4, were estimated by calculating the
distance between the Kpn I sites mapped within B11-1, N16C-1 and B13-1 (figure 4.18). The

























Figure 4.17 Kpn I and Not I restriction endonuclease map of pB16C-1 (not drawn to scale)
constructed in order to deduce the position of the Not I and Kpn I sites in regions 1.10 and
1.11. The outer black bars represent the fragments produced upon digestion with Not I and the








K46-1 , KM3 , KM4 , K45-1
1.7kb + 3.35kb = 5.05kb 1.4kb + 0.85kb
= 2.25kb
Figure 4.18 Schematic representation region 1.11 (drawn approximately to scale), constructed
from data obtained from the restriction profiles of pB11 -1, pB13-1 and pB16C-1 digested singly
with Kpn I. The solid black bars ( | 1 ) represent the fragments produced when the Bam HI
fragments are digested with Kpn I and the vector is subtracted from the fragment sizes.
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Region 1.12
The order of the Not I and Kpn I fragments within region 1.12 was determined by hybridisation
between fragments, restriction profile analysis and Southern blotting. Region 1.12 is represented
schematically in figure 4.19 and is described in the text that follows.
B3-1 hybridised with the Kpn I clones pKl 1-2 and pK47-l. By comparing the restriction profiles
of pK47-l and pKll-2 digested with Bam HI to that of pB3-l digested with Kpn I, it was
deduced that K47-1 and Kll-2 overlapped the ends of B3-1 by 3.2kb and 1.8kb respectively.
Using the methods explained in regions 1.1 to 1.6, a "missing" Kpn I fragment (KM9) internal to
B3-1 was shown to separate K47-1 and K11-2 by approximately 8.4kb.
B3-1 also hybridised with the Not I clones: pN22A-l, pN15D-l and pN15A-l. N22A-1 and
N15D-1 both possessed a Bam HI site indicating that they overlapped the ends of B3-1. pN22A-
1 when digested with Bam HI produced two fragments approximately 3.2kb and 5.7kb in size,
one of which contains the vector. The 3.2kb fragment corresponds in size to a fragment obtained
from pB3-l digested with Not I, suggesting that N22A-1 overlaps B3-1 by 3.2kb. The predicted
overlap was confirmed by probing a Southern blot of pB3-l that was digested with Not I with
DIG-labelled N22A-1. As expected N22A-1 hybridised with the 3.2kb band (figure 4.20),
confirming the overlap between B3-1 and N22A-1 is 3.2kb.
pB3-l when digested with Not I produced 5 fragments; 7.4kb, 3.4kb, 3.2kb, 1.25kb and 1.05kb
in size. As previously established, the 3.2kb overlap with N22A-1 constitutes the left terminal
Not I fragment of B3-1. As the 3.2kb-left terminal fragment did not contain the vector, it was
assumed that the vector would be attached to the Not I fragment that is situated at the right end
of pB3-l, which constitutes the overlap with N15D-1. Only the 7.4kb and 3.4kb pB3-l Not I
fragments were large enough to include the vector, however the 7.4kb fragment was larger than
the combined size of N15D-1 and the vector. Therefore N15D-1 must overlap B3-1 by 0.45kb
(3.4kb minus the size of the vector). In support, the predicted 0.45kb overlap approximately
corresponds in size with a 0.47kb band produced by the digestion of pN15D-l with Bam HI.
The remaining fragments from pB3-l digestion with Not I were 1.25kb, 1.05kb and 7.4kb, as
none of these overlap the ends of B3-1 they must represent Not I fragments that are situated
internally within B3-1. As K47-1 overlapped the right terminus of B3-1 by 3.2kb, DIG-labelled
K47-1 was used to probe a Southern blot of pB3-l digested with Not I in order to determine the
order of the Not I fragments situated internally within B3-1. K47-1 hybridised with the 7.4kb,
3.4kb and one further fragment, which was impossible to determine if it was 1.05kb or 1.25kb in
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size from the Southern blot (figure 4.20). The 3.4kb fragment (including the vector) was
assumed to correspond to the 0.45kb overlap of B3-1 with N15D-1. N15A-1 has a size of
approximately 1.05kb and hybridised with K47-1, but as N15A-1 does not possess a Kpn I site,
it was predicted to be located internally within K47-1 and hence adjacent to N15D-1. In support,
digestion of pK47-l with Not I also produced a 1.05kb band corresponding in size to N15A-1.
The final pB3-l Not I band hybridised by K47-1 was 7.4kb in size, this Not I fragment (NM4)
must therefore be located adjacent to N15A-1 and overlap the left terminus of K47-1. The only
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Figure 4.20 DNA fragments of pB3-1 DNA that was singly digested with Kpn I and Not I were
resolved on a 0.8%(w/v) agarose gel and Southern blotted onto nylon membrane. Each digest
was probed separately with DIG-labelled K47-1 and N22A-1.
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4.2.5 Cluster 2
A second cluster of approximately 40kb was mapped using the techniques described in section
4.2.3. The complete map of cluster 2 is presented in figure 4.21. The regions that were difficult
to determine and require further explanation are numerically annotated on figure 4.21, these
numbers corresponds with the following descriptions.
Region 2.1
Region 2.1 refers to the order, arrangement and size of five Not I fragments that are situated
internally within, or overlapping the ends of K32-1 (figure 4.22).
DIG-labelled N6-1 hybridised with pK32-l and K4-1. As K32-1 and K4-1 possessed two or
more Not I site they were predicted to overlap the ends of N6-1. As digestion of N6-1 with Kpn I
and digestion of K32-1 with Not I both produced fragments approximately 1.45kb in size, it was
predicted that N6-1 and K32-1 overlap by 1.45kb. As the 1.45kb fragment produced by digestion
of pK32-l with Not I did not include the vector, it was assumed that the opposite terminal Not I
fragment of pK32-l would. Digestion of pK32-l with Not I produced five fragments of the sizes:
3.2kb, 1.45kb, 1.1 kb, 0.65kb and 0.45kb, of which only the 3.2kb fragment was large enough to
contain the vector. After the size of the vector was subtracted from the 3.2kb fragment, the
remaining 0.25kb represented the extent of the overlap with the uncloned Not I fragment (NM5).
The remaining fragments of pK32-l digested with Not I are: l.lkb, 0.65kb and 0.45kb; these
represent three uncloned Not I fragments situated internally with K32-1 (annotated as NM6,
NM7 and NM8). Unfortunately, due to the absence of Bam HI or Kpn I fragments that partially
overlap these Not I fragments, their order could not be determined using the methods of
hybridisation and restriction profiling.
Region 2.2
Two Kpn I sites were identified in the DNA sequence derived from the right end of N6-1, which
are situated 117nt and 146nt from the right terminus of N6-1 (figure 4.23). Based on the
sequence data, it was predicted that a 33bp Kpn I fragment (KM11) is situated between K32-1
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N6-1 : GAAGGGGGAGCTGACCGAGGTCTTCCAGGGGTCCTCCTTCCGGTTCCTGG :50
KpnI Kpn I
N6-1 : TACCGGTCGGGTTCTTCGCGGGCCTCCCGGTACCGCCCCGCGGGCGGCGC :100
N6-1 : TTCCGCCGGCCCGCCAACCCCATGCCCGACGCGGAGAAGGTGTCGGTGCC :150
Not I
N6-1 : CGAGCTGTACCCGGTGCAGCGCCCGTGGTCGAGGAGGTGGAGGCGGCCGC :200
Figure 4.23 The nucleotide sequence derived from the right end of N6-1 (presented in the 5' to
3' direction of the genome). Two Kpn I sites (highlighted and underlined) are present, starting at
nucleotide positions 117 and 146.
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Region 2.3
The order and size of the "missing" Bam HI fragments (BM1, BM2 and BM3) in region 2.3 were
established by analysing the Bam HI restriction profiles of the cloned Not I and Kpn I fragments
which span this region. Region 2.3 is illustrated schematically in figure 4.24 and is explained in
more detail in the text that follows.
Firstly, the sizes of the overlap of B8-1 with N5-2 and Kl-1 were determined to be 2.4kb and
0.85kb respectively, by the comparison of the Kpn I, Bam HI and Not I restriction profiles of
pB8-l, pN5-l and pKl-1 to identify fragments that are common in size. Digestion of pN5-2 with
Bam HI produced fragments of 3.35kb, 0.95kb, 0.85kb and 0.17kb in size. As previously
established, the 0.85kb fragment corresponds to the right end of N5-2 and the overlap with B8-1.
The 3.35kb fragment must contain the vector and a 0.4kb left terminal Bam HI fragment of N5-
2. The remaining pN5-2 Bam HI fragments, 0.17kb and 0.95kb must represent two "missing"
Bam HI fragments (BM2 and BM3) which are situated internally within N5-2.
The order of the BM2 and BM3 fragments was determined by examining the restriction profile of
pKl-1. When digested with Bam HI, pKl-1 produced two fragments, 3.8kb and 2.4kb in size. As
previously established the 2.4kb band represents the overlap with B8-1. Therefore the 3.8kb
band must include the vector and overlap with BM3. The arrangement was confirmed by
examining the Bam HI restriction profile of K4-1. When digested with Bam HI, pK4-l produced
three fragments of the sizes 2.97kb, 2.7kb and 0.17kb. The 0.17kb fragment corresponded to the
predicted size of BM2, which is situated within N5-2 and K4-1 (see above). The location of the
BM2 fragment within K4-1, rather than Kl-1, confirmed that its location was to the left of the
BM3 fragment. As Nl-1 and N6-1 did not possess any Bam HI sites, the 2.7kb pK4-l Bam HI
fragment must overlap these Not I fragments. Furthermore, the 2.97kb fragment produced by
Bam HI digestion of pK4-l was the only fragment large enough to include the vector. When the
size of the vector was subtracted from 2.97kb the 80bp remaining must represent the overlap of
K4-1 with BM3.
As there are no Bam HI sites present in any of the overlapping Not I and Kpn I fragments
situated to the left of BM2, it can be concluded that a large Bam HI fragment (BM1) greater than
6.6kb extends left from BM2 to beyond the mapped region. As a consequence, the size of BM1
could not be determined.
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Region 2.4
Region 2.4 (figure 4.21) refers to a large uncloned Kpn I fragment (KM12) situated between Kl-
1 and K24-1 that spans B26-1 and overlaps B8-1 and B6A-1. The size of KM12 was estimated to
be 11.7kb by mapping the Kpn I sites within the overlapping fragments, B8-1, B26-1 and B6A-
1, and then determining the distance between the Kpn I site located in B8-1 and the left Kpn I
site located in B6A-1.
Region 2.5
Region 2.5 refers to the order of the Not I fragments within and overlapping B8-1 (figure 4.21).
DIG-labelled B8-1 hybridised with pN4-l, pN5-2, pN15H-l, pN26A-l, N34-1 and Kl-1.
Digestion of pB8-l with Not I produces a number of fragments; 5.3kb, 4.0kb, 1.35kb, 1.05kb,
0.85kb, 0.25kb and 0.14kb in size. As previously established, N5-2 overlaps the left terminus of
B8-1 by approximately 0.85kb (region 2.3), which corresponds to the 0.85kb pB8-l Not I
fragment. The 5.3kb pB8-l Not I fragment corresponds in size to N4-1. As Kl-1 hybridised with
pN5-2 and pN4-l, N4-1 was placed adjacent to the right of N5-2. N26A-1 contained two Bam
HI sites and hybridised with pB8-l, pB26-l and pB6A-l and was therefore predicted to overlap
the right terminus of B8-1. The 4.0kb fragment from the digestion of pB8-l with Not I
corresponds with a 4.0kb fragment produced by digestion of pN26A-l with Bam HI, when the
vector size was subtracted from both fragments it indicated the overlap between these two
fragments was l.Okb. Of the remaining fragments from the digestion of pB8-l with Not I the
1.35kb and 1.05kb fragments correspond in size with the hybridised fragments N15H-1 and
N34-1. These two fragments were predicted to be situated internally within B8-1 along with two
"missing" Not I fragments 0.25kb (NM9) and 0.14kb (NM10) in size. Because the Not I
fragments NM9, NM10, N15H-1 and N34-1 are all situated internally within B8-1 and KM12, it
was not possible to order the fragments using hybridisation and restriction profiles.
Region 2.6
Digestion of pB6A-l with Not I produced three bands corresponding to the fragment sizes; 5.6kb
(2.65kb with the vector subtracted) and two 0.65kb fragments. It was determined by comparison
of restriction profiles that N7-1 overlapped the right terminus of B6A-1 by 2.65kb and that
N26A-1 overlapped the left terminus by 0.65kb. Therefore, the remaining 0.65kb Not I fragment
(NM11) must be situated internally within B6A-1 between N26A-1 and N7-1 (figure 4.21).
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Region 2.7
Region 2.7 refers to the order of Not I and Kpn I fragments along the length of B19-1 and the
size of the "missing" fragment, NM12. The details used to order the fragments along B19-1 are
schematically represented in figure 4.25 and are explained in the text that follows.
B19-1 hybridised with pK18-l, pK31-l and pK19-l. It was predicted that K18-1 and K19-1
overlap the ends of B19-1, as they both possess an internal Bam HI site, whereas K31-1 does
not. Comparison of the fragment sizes produced when pK18-l and pK19-l were digested with
Bam HI, with that of pB19-l digested with Kpn I confirmed that K18-1 and K19-1 overlap the
ends of B19-1 by 6.4kb and 0.65kb respectively. As K31-1 did not possess a Bam HI site and
corresponded in size to a fragment produced by digestion of pB19-l with Kpn I, K31-1 was
predicted to be located internally with B19-2 between K18-1 and K19-1.
The order of the Not I fragments along B19-1 was more difficult to determine. B19-1 hybridised
with pN7-l, pN14A-l, pN14C-l and pN14D-l, which identified them as internal to, or
overlapping with B19-1. Digestion of pB19-l with Not I produced five bands; 6.65kb, 4.6kb,
3.3kb, 1.3kb and 0.9kb. The 3.3kb, 1.3kb and the 0.9kb bands correspond in size to the
fragments, N14D-1, N14A-1 and N14C-1, which were all subsequently shown to lack a Bam HI
site. Therefore it was predicted that these Not I fragments are located internally within B19-1. In
contrast, pN7-l contained one Bam HI site and hybridised with pB6A-l and pB19-l.
Comparison of pN7-l digested with Bam HI, with pB19-l and pB6A-l digested with Not I
confirmed that N7-1 overlapped the left terminus of B19-1 by 4.6kb and the right terminus of
B6A-1 by 2.65kb.
The order of the internal Not I fragments was determined by hybridisation between overlapping
fragments and comparison of restriction profiles. Briefly, K18-1 hybridised with pN7-l, pN14A-
1 and pN14D-l. Therefore either N14A-1 or N14D-1 is situated adjacent to N7-1. As N14D-1
also hybridised with K31-1 and possesses an internal Kpn I site it was determined that N14D-1
overlaps both K18-I and K31-1 by 0.6kb and 2.7kb respectively. Hence N14A-1 must be
situated internally within K18-1 between N7-1 and N14D-1. The size of N14C-1 corresponds in
size to the 0.9kb fragment produced by digestion of pB19-l with Not I and as previously
established is situated internally within B19-1. Therefore N14C-1 must be located adjacent and
to the right of N14D-1. The remaining 6.65kb band (3.7kb with the vector subtracted) must
therefore represent the 3.7kb right terminal Not I fragment of B19-1, which constitutes the
overlap between B19-1 and NM12.
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This arrangement of the Not I fragments was supported by the result of a Southern blot shown in
figure 4.26. As K19-1 overlapped the right terminus of B19-1 by 0.9kb, a Southern blot of
pB19-l doubly digested with Not I and Bam HI was hybridised with DIG-labelled K19-1. K19-1
hybridised with a 3.7kb band confirming it as the right-hand Not I fragment of B19-1, which
represents the 3.7kb overlap with NM12. A duplicate Southern blot was probed with DIG-
labelled K31-1, which hybridised with three bands, 3.7kb, 3.3kb and 0.9kb. The 3.7kb band
represents the overlap of B19-1 with NM12, the 0.9kb was the internal N14C-1 fragment and the
3.3kb band represents N14D-1.
The size of NM12 was determined to be 4.1kb by mapping the Not I sites within K31-1 and
K19-1, then calculating the distance between the Not I site within K19-1 and the right-hand Not I
site within K31-1.
4.2.6 Ordering Clusters 1 and 2 by alignment to MOCV
The positions of the SPPV clusters 1 and 2 within the SPPV genome were estimated by their
alignment to the MOCV genome. Sequences derived from the ends of 20 cloned restriction
fragments were compared to those deposited in the EMBL database (section 2.4.8.1). Thirteen of
the twenty fragments exhibited greater than 60% homology to MOCV subtype 1 complete
sequence at one or both termini (table 4.3). The SPPV clusters 1 and 2 were aligned to MOCV
using by mapping the locations of homologous sequence (figure 4.27). Cluster 1 approximately
corresponds with the MOCV genome between 33kb to 112kb and cluster 2 between 130kb to
170kb.
Due to the collinear nature of poxvirus central regions the preliminary position of clusters 1 and
2 was considered indicative of their actual position within the SPPV genome. Hence, the size of
unmapped region situated between clusters 1 and 2 was estimated to be approximately 18kb with
the distance between the left-hand end of cluster 1 to the right-hand end of cluster 2 was
estimated to be 137kb. Parapoxviruses genomes are generally between 130kb to 150kb in size
(van Regenmortel et al., 2000). Therefore it would suggest that the ITR regions were likely to be
situated within or close to the left-hand and right-hand ends of clusters 1 and 2 respectively.
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Figure 4.26 pB19-1DNA doubly-digested with Not I and Bam HI was electrophoresed on a
0.6% agarose gel and the DNA transferred, in duplicate, to nylon membrane. One Southern
blot was probed with DIG-labelled K31-1, which hybridised with three bands of the approximate
sizes 3.7kb, 3.3kb, and 0.9kb. The second Southern blot was probed with DIG-labelled K19-1,
which hybridised with one band estimated to be 3.7kb in size. The sizes of the bands were
determined by comparison to known standards in a 1 kb ladder (Gibco).
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Clone Primer G+C % Homology to MOCV nucleotide
sequence
% Homology
N1-1 T3 68.5 MOCV region 142.4kb - 143.2kb 72.2%/762 nt
T7 71.4 MOCV region 144.6kb - 144.9kb 60.9%/324 nt
N2-1 T3 65.7 No MOCV homology
T7 65.5 No MOCV homology
N3-1 T3 69.6 MOCV region 92.46kb - 92.85kb 68.6%/404nt
T7 69.2 MOCV region 89.90kb - 90.18kb 61,8%/304nt
N4-1 T3 68.0 No MOCV homology
T7 66.6 MOCV region 147.6kb - 147.9kb 71,4%/357nt
N5-1 T3 72.6 No MOCV homology
T7 59.6 No MOCV homology
N6-1 T3 63.3 MOCV region 142.0kb - 142.4kb 66.7%/409 nt
T7 69.4 MOCV region 141.0kb - 141.5kb 58.5%/535 nt
N7-1 T3 69.2 No MOCV homology
T7 70.7 MOCV region 157.9kb - 158.3kb 66.2%/370 nt
N12-1 T3 65.4 MOCV region 55.4kb - 56.1 kb 73.9%/762 nt
T7 61.7 MOCV region 52.7kb - 53.2kb 65.9%/518 nt
N13-1 T3 66.4 MOCV region 52.1 kb - 52.7kb 71,6%/564 nt
T7 65.0 MOCV region 40.8kb - 41.3kb 71,0%/518 nt
N14C-1 T3 71.1 No MOCV homology
T7 65.5 No MOCV homology
N16-1 T3 64.4 MOCV region 30.3kb - 30.5kb 69.5%/220 nt
T7 63.8 MOCV region 24.1 kb - 24.3kb 58.8%/255 nt
N22A-1 T3 63.5 MOCV region 93.0kb - 93.6kb 82.4%/550 nt
T7 65.8 MOCV region 99.1 kb - 99.4kb 67.7%/279 nt
N24-1 T3 63.3 MOCV region 30.5kb - 30.9kb 61,3%/424 nt
T7 63.8 No MOCV homology
N26A-1 T3 70.3 No MOCV homology
17 65.9 No MOCV homology
N33-1 T3 65.9 No MOCV homology
T7 63.2 No MOCV homology
B1A T3 66.7 MOCV region 113.0kb - 113.5kb 72.6%/449 nt
B11-1 T3 69.2 No MOCV homology
B16C-1 T3 65.2 MOCV region 52.7kb - 53.2kb 64.2%/506nt
17 63.9 MOCV region 56.4kb - 56.9kb 71,1%/543nt
K19-1 13 65.0 No MOCV homology
K45-1 13 67.3 MOCV region 82.1 kb - 82.3kb 71.1%/149 nt
Table 4.3 Summary of sequence homology data of 20 cloned restriction fragments to MOCV.
Thirteen of the 20 fragments analysed using the FastA algorithm exhibited greater than 60%
nucleotide homology with the complete genome MOCV subtype 1 (EMBL accession number
U60315) at one or both termini. The homologous regions present in MOCV that were used to
align SPPV clusters 1 and 2 to the MOCV genome (see figure 4.27) are indicated in column 4.
The calculated G+C % of each sequence is presented in column 3. The average percentage
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4.3 MAPPING THE ITR REGIONS OF SPPV
4.3.1 Examination of clusters 1 and 2 for the presence of ITR sequence.
The left-hand region of cluster 1 and the right-hand region of cluster 2 lacked obvious restriction
site symmetry, which suggested that the putative ITR was absent from one or both clusters.
Furthermore, there was no evidence of cross-hybridisation between the terminal fragments.
Hence it was concluded that ITR sequence is absent from one or both clusters.
4.3.2 Construction of partial restriction maps of the putative ITR regions
4.3.2.1 Selection of an anchor fragment
A selection of previously uncharacterised and unmapped Bam HI DNA fragments were used to
screen the genomic libraries in order to identify Not I and Kpn I fragments located out with
clusters 1 and 2. Only one fragment, B7C-1, hybridised with previously unidentified Not I
fragments. Sequence obtained from both ends of B7C-1 revealed the base pair composition was
G+C rich at approximately 63%, suggesting that it is likely to be viral in origin. However no
homology with other poxviruses could be detected at the nucleotide level, suggesting that B7C-1
could be located out with the conserved central core.
4.3.2.2 Clusters 3A and 3B
B7C-1 was used as an anchor fragment, enabling the restriction maps of two clusters (3A and
3B) to be constructed. Clusters 3A and 3B exhibit a degree of restriction site symmetry and are
therefore predicted to partially span the ITR regions and extend into heterogeneous unique
regions. Construction of the two clusters was achieved using hybridisation and restriction
profiles of overlapping fragments and is explained schematically in figures 4.28 to 4.31 and in
the text that follows.
B7C-1 hybridised with the Not I fragments; N11H-1, N55-2 and N65-2, but did not hybridise to
any cloned Kpn I fragments. Alignment of the three Not I fragments with B7C-1 was achieved
using restriction profile analysis of the cloned fragments (as described for clusters 1 and 2),
which is summarised in figure 4.28. However, as the fragments N11H-1 and NM13 are both
situated internally with B7C-1, their order could not be determined.
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The DIG-labelled fragments N11H-1, N55-2 and N65-2 were used as probes to screen Bam HI
and Kpn I genomic libraries. A number of Bam HI fragments hybridised with the Not I
fragments, however no hybridising Kpn I fragments were found (summarised in figure 4.29).
Alignment of B2-1 and B70-2 to N55-2 (summarised in figure 4.30) was achieved by comparing
the Bam HI restriction profile of N55-2 with the Not I restriction profiles of B2-1 and B70-2
using methods previously described for the construction of cluster 1 and 2. Likewise, B12-1 and
B30-2 were mapped as located internally within N65-2, however their order could not be
determined from restriction digest data.
B7C-1 and B5-2 are differently sized individual Bam HI fragments, however they produce
identical hybridisation patterns with the Not I fragments. In addition, comparison of the Not I
restriction profiles of pB7C-l and pB5-2 revealed that three of the four fragments produced by
each clone are identical in size: 1.2kb, 0.45kb and 0.55kb (after the size of the vector was
subtracted). The three commonly sized Not I digest products correlate in size to N11H-1, NM13
and the overlap with N55-2 (figure 4.30). These data are highly suggestive of a number of
conserved Not I sites and indicate that both B7C-1 and B5-2 overlap N55-2 and span NM13 and
N11H-1. Despite hybridising with both B7C-1 and B5-2, N65-2 only contained a Bam HI site
which corresponded to the left-hand end of B7C-1 but not with left hand end of B5-2 (depicted
in figure 4.30). Therefore N65-2 cannot overlap B5-2. It was therefore considered likely that
B7C-1 and B5-2 are located at opposite ends of the genome and overlap the putative ITR
fragments (N11H-1, NM13 and N55-2), the ITR junctions and extend into the unique regions.
The ITR junctions must therefore be located between the right-hand end of N65-2 and the left-
hand end of B7C-1 and within the corresponding region of B5-2 (figure 4.30). Hence two
separate clusters could be deduced representing the regions containing the ITR junctions at
either end of the genome (figure 4.31). At this stage clusters 3A and 3B could not be positioned
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Figure 4.28 Alignment of B7C-1 with the uncloned Not I fragment NM13 and the Not I
fragments: N11 H-1, N55-2 and N65-2. The solid black horizontal bars (| 1) represent the
size of the restriction fragments produced by Bam HI digestion of the Not I fragments.
Likewise, the broken black horizontal bars (| j) represent the size of the restriction
fragments produced when B7C-1 is digested with Not I. The size of each DNA fragment is
indicated in the black box above or below each bar.
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Figure 4.29 The hybridisation pattern of DIG-labelled N11H-1, N55-2 and N65-2 with the
cloned Bam HI fragments: pB2-1, pB5-2, pB7C-1, pB12-1, pB30-2 and pB70-2. Likewise,
hybridisation of the cloned Not I fragments: pN 11 H-1, pN55-2 and pN65-2 with DIG-labelled
B7C-1 and B5-2. Hybridisation is indicated by the solid black arrows.
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Figure 4.30 Schematic representation of the alignment of the Bam HI fragments: B2-1, B7C-1,
B12-1, B30-2 and B70-2 aligned with the Not I fragments N11H-1, N55-2 and N65-2. The
horizontal black bars (| 1 ) represent the fragments produced by Not I digestion of the Bam
HI fragments and likewise Bam HI digestion of the Not I fragments. The order of the fragments
indicated with the arched arrows (\^V) may be situated in an opposite order. B5-2 and B7C-1
cross-hybridisation with the same Not I fragments (figure 4.29). However, according to
restriction digest data B5-2 does not align with N65-2. The ITR junction (shaded in grey) is
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Figure 4.31 Schematic representation of clusters 3A and 3B. The regions predicted to
contain the ITR junction is shaded in grey. The order of the fragments indicated by arched
arrows (\f^) may be in an order opposite to that which is shown on the diagram.
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4.4 RESTRICTION ENDONUCLEASE MAPPING OF THE SPPV GENOME
USING COSMID CLONES
For the reasons discussed in section 4.7.1, the restriction endonuclease maps of the SPPV
genome could not be completed with the plasmid clones. Therefore a second strategy was
employed, were larger contiguous DNA fragments were cloned into a cosmid vector. The
restriction endonuclease maps were completed by individually mapping overlapping cosmid
clones that contained SPPV genomic DNA that spanned the entire length of the genome.
4.4.1 Cosmid library construction
SPPV genomic DNA (isolate 1296/99) was cloned into SuperCos I vector (Stratagene) using the
method detailed in section 2.6.3. Briefly, 2.5pg of SPPV/carrier DNA (in a ratio of 1:4) partially
digested with Sau 3AI was ligated with lpg of cosmid arms. The whole ligation reaction was
packaged into lambda phage and then used to transduce E.coli to produce the primary cosmid
library. The titre of the primary library was determined to be 80,000 colony forming units per ml
(cfu/ml). The primary library was amplified and glycerol stocks of the amplified library
prepared. The titre of the amplified library was determined to be 1.38 x 10locfu/ml.
4.4.2 Screening the cosmid library
The SuperCos I library was plated onto 90mm Luria-Bertani agar (LBA) plates supplemented
with 50pg/ml ampicillin at a density of 150 colonies per plate. Colonies were transferred to
nylon membranes and prepared for hybridisation with DIG-labelled DNA probes (section
2.4.5.3.3).
Seven cloned restriction fragments were selected to screen the cosmid library on the basis of
their location within clusters 1, 2, 3A and 3B (summarised in table 4.4). The five fragments
located within clusters 1 and 2 were chosen because they evenly distributed (figure 4.32) and it
was thought likely that screening the cosmid library with these fragments would identify
overlapping cosmid clones that span the genome.
A further two fragments, B2-1 and B12-1, previously mapped within clusters 3A and 3B were
used to screen for cosmids containing the ends of the SPPV genome. Fragment B2-1 is located
within the putative ITRs (section 4.3.2.2.2.2). Therefore it was expected that each cosmid clone
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hybridising with B2-1 would contain DNA from the left or right ITR. B12-1, a unique fragment
of cluster 3A, was used to distinguish between clones overlapping clusters 3A or 3B.
Eighty-seven hybridised colonies were selected, grown in culture and cosmid DNA prepared
using the alkaline lysis method (section 2.5.5.1). The cosmid DNAs were singularly digested
with Not I, Bam HI or Kpn I and the products electrophoresed on an agarose gel. Southern blots
were prepared and hybridised with the same DIG-labelled restriction fragments used to screen
the cosmid library in order to confirm the positive hybridisation status of each cosmid clone. A
total of seventy-four clones were confirmed as containing SPPV genomic DNA (summarised in
table 4.4).
4.4.3 Selection of overlapping cosmid clones
The approximate position of each clone within the SPPV genome could be deduced from the
location of the hybridising restriction fragment in the previously mapped regions: clusters 1, 2,
3A and 3B. However, the clone may extend up to 42kb left or right of the hybridising restriction
fragment (figure 4.32).
Ten cosmid clones were selected on the basis that they were predicted to overlap each other and
span the whole genome with the exception of the terminal hairpin loop structures. Selection was
based upon restriction profiles of the clones when singularly digested with Not I, Bam HI and
Kpn I in order to identify fragments of common size and by comparison to the restriction maps
of clusters 1, 2, 3A and 3B. The gel depicted in figure 4.33 shows the 10 selected clones digested
with Bam HI; the fragment sizes are summarised in table 4.5.
To further characterise the location of each clone within the SPPV genome and confirm overlap
between the cosmid clones, several previously mapped cloned restriction fragments were
individually hybridised with each cosmid clone (figure 4.34). The restriction profile and
hybridisation data enabled the position of each clone within the SPPV genome to be clarified
(figure 4.35). This is described in more detail in the text that follows.
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Restriction fragment Approximate position within the
SPPV genome
Number of positive cosmid
clones hybridised
B 51-2 unique LHS 9
K46-1 unique LHS 2
K 32-1 unique Central 13
B1A-1 unique Central 9
N 2-1 unique RHS 15
B12-1 unique RHS or LHS 14
B2-1 ITR 12
Table 4.4 Summary of the SPPV restriction fragments used to screen the cosmid library, their
approximated location with the SPPV genome and the number of cosmid clones hybridised
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Cosmid clone Bam HI fragment sizes (kb)
3 1.6, 3.1, 3.05, 4.5, 8.5, 11.8, 13.3
5 0.65, 2.65, 2.95, 4.2, 4.6, 9.9, 10.5, 13.3
9 0.17*, 0.9, 3.05, 4.5, 8.5, 12.5, 14.0
24 0.17*, 0.9, 3.05, 3.9, 8.1, 9.5, 13.0
28 0.8, 1.1, 1.15, 1.6, 2.55, 2.6, 3.05, 3.9, 12.5, 13.8
43 4.65, 5.7, 9.0, 15.8
51 0.65, 2.65, 3.15, 4.75, 6.3, 11.35, 12.0
54 4.65, 5.7, 6.3, 11.5, 15.8
81 0.8, 1.1, 1.15, 1.6, 2.55, 2.6, 3.05, 3.9, 13.8, 16.0
86 0.8, 4.65, 5.7, 5.85, 6.85, 15.8
Table 4.5 Summary of the estimated fragment sizes produced by the cosmid clones digested
with Bam HI. The asterisk (*) refers to fragments too small to be visualised in the gel depicted in
figure 4.33.
Cosmid clone identification number




















Figure 4.34 0.3pg of DNA from each cosmid clone (prepared by QIAprep spin miniprep kit,
QIAGEN) immobilised onto nylon membrane and hybridised with a selection of DIG-labelled
SPPV restriction fragments.
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Clones 51 and 5 span a region contained completely within cluster 1. Clone 51 hybridised with
K46-1 and B20B-1 (figure 4.34) and must therefore span the region between these two
fragments. In support, digestion of clone 51 with Bam HI produced fragments of 6.3kb, 4.75kb,
3.15kb, 11.35, 0.65kb and 2.65kb (table 4.5), which correspond in size to the contiguous
fragments B11-1, B16C-1, B13-1, B25-1, B24-1 and B20A-1. No fragments were produced that
corresponded in size to B7D-1 or B20B-1, which flank the contiguous stretch. As clone 51
hybridised with B20B-1, clone 51 must therefore partially overlap B20B-1, but not extend
passed the right-terminal Bam HI site. Therefore the remaining 12.0kb fragment produced by
digestion of clone 51 with Bam HI must include the vector and the terminal regions of clone 51,
which overlap B20B-1 and B7D-1.
Likewise clone 5 hybridised with B20B-1 and B1A-1. Digestion of clone 5 with Bam HI
produced eight fragments, of which six corresponded in size to the contiguous fragments: B24-1,
B20A-1, B20B-1, B98-1, B164-2 and B3-1. The remaining two fragment are 9.9kb and 10.5kb,
as neither fragment correspond in size to B25-1 or B1A-1 (which flank the contiguous
fragments), therefore clone 5 must extend into these fragment but not span them. One of the
remaining fragments must contain the cosmid vector and one terminus of clone 5. If the size of
the vector is subtracted from the 9.9kb fragment, the remaining 3.05kb fragment is small enough
to overlap B1A-1 but not beyond the right Bam HI site. The remaining 10.5kb, which is too large
to overlap with B1A-1 without spanning both Bam HI sites must therefore overlap with B25-1.
In the case of clone 5 it appears that the left Sau3A I recognition site (GATC) was converted to a
Bam HI site (GGATCC) during the cloning procedure. Conversion to a Bam HI site can happen
when a cytosine base (C) is located to the right to the Sau3A I site (GATCC) or a guanine base
(G) is located to the left of a Sau3A I site (GGATC). Hence when ligated into the Bam HI site of
the vector a functional Bam HI site is formed. In the case of the terminal sequence of clone 5 the
left terminal Sau3A I site was transformed into Bam HI site and upon digestion with Bam HI the
terminal 10.5kb fragment was cleaved from the vector.
Clones 24, 28, 54, 43, 81 and 86 were all aligned to clusters 1 and 2 using the procedure
explained for clones 5 and 51. Clones 43 and 86 are located towards the left of the genome and
restriction profile analysis indicated that both clones overlap B51-2 and B7D-1 and extended
left, beyond cluster 1 toward the left end of the genome. Likewise, clones 28 and 81 are located
at the right of the genome overlapping B26-1, B6A-1 and B19-1 and extend beyond the right
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terminal region of cluster 2. Clones 28, 43, 81 and 86 were all predicted to extend into the
putative ITR by hybridising with the putative ITR fragment B2-1. Clones 28 and 81 produced
almost identical Bam HI restriction profiles, five fragments corresponded in size to B12-1, B30-
2, B7C-1, B2-1 and B70-2, which had been previously mapped within cluster 3A. Hence cluster
3A is located at the right end of the genome. In support, clones 28 and 81 also hybridised with
the cluster 3A fragment B12-1, whilst clones 43 and 86 located at the left of the genome did not.
It then follows that cluster 3B must be located at the left of the genome. Digestion of clone 86
with Bam HI produced two fragments, 0.8kb and 4.65kb in size, which correspond in size with
the cluster 3B fragment B2-1 and B5-2. Clone 43 did not produce a Bam HI fragment
corresponding in size to B2-1, however a hybridisation signal was visible between clone 43 and
B2-1. A possible explanation for this may be that clone 43 terminates within B2-1 or that clone
43 does not overlap B2-1 but repeated sequence may be present within the ITR resulting in
hybridisation.
Clone 9 hybridised with B1A-1, K32-1 and Kl-1 and was therefore predicted to span the
unmapped region situated between clusters 1 and 2. Clones 3 and 24 were predicted to overlap
clone 9 and extend into the unmapped region situated between clusters 1 and 2.
4.4.4 Restriction Endonuclease Mapping of the Cosmid Clones
4.4.4.1 Bam HI, Kpn I and Eco RI restriction endonuclease maps of the cosmid clones
Restriction endonuclease maps of the SPPV genomic DNA cloned into the SuperCos I vector
were determined using a method originally devised for mapping DNA cloned into X phage
vectors (Rackwitz et al., 1984), which was later adapted for mapping cosmid clones (Rackwitz
et al., 1985). The method (section 2.7) relies upon the action of A-phage-derived terminase,
which cleaves the vector at the cos site, producing 12bp 5'-cohesive extensions. The linearised
cosmid clone is then partially digested with the desired restriction endonuclease to produce
fragments of varying lengths. The fragments are then labelled at one end, by hybridisation with a
32P-labelled oligonucleotide (ON-L or ON-R), which is complementary in sequence to one of the
12bp cos 5'-extensions:
ON-L 5' - AGGTCGCCGCCC- 3'
ON-R 5' - GGGCGGCGACCT - 3'
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When the labelled products are electrophoresed and the dried agarose gel exposed to medical X-
ray film a laddered banding pattern is visible (figure 4.36 for an example). The image was
analysed using TotalLab ID (vl.OO) image analysis software (Pharmacia biotech) to determine
the approximate size of each labelled fragment. The restriction map of each cosmid clone could
then be determined from the partially digested fragment sizes.
For example, when clone 9 is partially digested with Bam HI and labelled with ON-L the
smallest visible band is 4.94kb (figure 4.36). The size of this fragment represents the distance
between the ON-L labelled vector cos site and the nearest Bam HI site situated at the left end of
the cloned DNA. When the size of the adjoining vector DNA (0.27kb) is subtracted from the
total size of the band, the remaining 4.7kb represents the size of the left end of clone 9, up to the
first internal Bam HI site. The next band in size is approximately 5.83kb. The difference between
the sizes 5.83kb and 4.94kb is 0.89kb, which correspond in size to the 0.9kb fragment produced
by complete digestion of clone 9 with Bam HI (table 4.5); this represents the size of the first
complete Bam HI restriction fragment adjacent to the 4.7kb terminal fragment. The next band
size is 5.99kb and when the 5.83 is subtracted the remaining 0.16kb is the size of the next
adjacent Bam HI fragment. This analysis was repeated with all the partial digest fragments of
clone 9 hybridised with ON-L and ON-R, and when compared to the fragment sizes produced by
complete restriction digestion with Bam HI a complete Bam HI map of clone 9 was deduced.
Using this technique the ten selected clones were mapped with Kpn I, Bam HI, and Eco RI.
Where possible the Kpn I and Bam HI restriction endonuclease maps of the cosmid clones were
confirmed by comparison to previously mapped regions in clusters 1, 2, 3A and 3B. Likewise,
the locations of the Eco RI sites were confirmed by digestion of the previously cloned Bam HI
and Kpn I fragments with Eco RI (results not shown).
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Figure 4.36 Cosmid clones 3, 5, 9, 24 and 28 linearized with A-terminase and partially
digested with Bam HI. DNA fragments were then hybridised with the end-labelled
oligonucleotide ON-L and electrophoresed on a 0.6% agarose gel. The gel was dried onto
DE-81 chromotography paper (Whattman), exposed to medical X-ray film for 48 hours with
an intensifier screen and then developed. The size of each fragment was estimated using
TotalLab 1D image analysis software (Pharmcia biotech) by comparison to known standard
present in iL-phage DNA digested with Bam HI, Cla I, Hind III, Kpn I, Stu I, Xho I and uncut X-
phage DNA (all end-labelled with ON-L and ON-R).
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4.4.4.2 Hind III restriction endonuclease maps of the cosmid clones
Hind III restriction sites were shown to be present in clones 3, 5, 28 and 81 by restriction
endonuclease digestion of all the selected cosmid clones with Hind III (figure 4.37). Clones 3, 5,
28 and 81 produced two bands when digested with Hind III, therefore each clone possessed one
Hind III site within the cloned insert and one site within the vector. As only one Hind III site is
located within each of the four clones, a different approach to mapping the Hind III sites was
used. The cloned Kpn I and Bam HI restriction fragments that are contained within the four
cosmid clones were digested with Hind III in order to identify which restriction fragments
contained Hind III sites. Clones 3 and 5 overlap with each other by approximately 18kb and the
Hind III site is located in the region of overlap within fragment B3-1. Likewise, clones 28 and
81 overlap extensively with each other and the single Hind III site is located in the region of
overlap within fragments B19-1 and K31-1.
The precise locations of the Hind III sites within B3-1, K31-1 and B19-1 were determined by
single and double restriction endonuclease digests of the plasmid clones (figure 4.38). Digestion
of pB19-l with Hind III produced two fragments; the smallest being approximately 2.1kb and is
produced by the enzyme cutting at the vector site and the site internal within fragment B19-1.
Hind III also cleaves K31-1, which situated internally within B19-1 at the right hand end,
therefore the Hind III site must be located 2.1kb in from the right terminus of B19-1. In support
the 1.5kb fragment produced by double digestion of pK31-l with Hind III and Kpn I correspond
with the distance between the right Kpn I site of K31-1 and the predicted position of the Hind III
site (figure 4.39A).
The Hind III site within B3-1 was mapped in a similar manner. Single digestion of pB3-l with
Hind III and double digestion of pB3-l with Bam HI and Hind III both produced fragments
5.5kb in size (figure 4.38). This 5.5kb fragment is produced by Hind III cleavage of the vector
site and the site internally within B3-1, therefore the Hind III site must be situated 5.5kb from
the left or right terminus of B3-1. The precise location was clarified by comparison of restriction
profiles produced by pB3-l singularly digested with Kpn I and doubly digested with Kpn I and
Hind III (figures 4.38 and 4.39B).
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Figure 4.37 Cosmid clones digested with Hind III electrophoresed on a 0.6% agarose gel.


















Figure 4.38 Single and double restriction endonuclease digests of restriction fragments




















Figure 4.39A Schematic representation demonstrating the location of the Hind III site within
B19-1 and K31-1, constructed from fragments produced by single and double restriction
digests of pB19-1 and pK31-1 (see figure 4.39). The solid black bars (f 1) represent
fragment produced by double digestion of pB19-1 with Hind III and Kpn I . Likewise, the
broken black bars (| 1) represent fragments produced by of double digestion of pK31-1














Figure 4.39B Schematic representation demonstrating the location of the Hind III site within
B3-1 and KM9, constructed from fragments produced by single and double restriction digests
of pB3-1 (see figure 4.39). The solid black bars (I 1) represent fragment produced by
digestion of pB3-1 with Hind III. Likewise, the broken black bars (| 1) represent fragments
produced by of double digestion of pB3-1 with Kpn I and Hind III.
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4.5 STRUCTURE OF THE TERMINAL REGIONS
4.5.1 Establishing the location of the genome ends
The very ends of the genome could not be cloned presumably due to hairpin loop structures that
form the termini of all poxvirus genomes. In the absence of a clear restriction profile, the end
fragments could not be identified nor their sizes estimated. Therefore the end fragments were
identified and their sizes estimated using DNA hybridisation. Digestion of the cloned restriction
fragments that are predicted to be located near to the genome ends indicated that no Kpn I sites
are located in the ITRs. Therefore genomic DNA digested with Kpn I was Southern blotted and
hybridised with DIG-labelled ITR fragment B2-1 (figure 4.40). Two Kpn I fragments, which
hybridised with B2-1 were estimated to be 5.3kb and 9.0kb in size. The sizes of these fragments
were plotted onto the restriction maps of the terminal regions (figure 4.41). The terminal Kpn I
fragments were predicted to extend from the Kpn I sites nearest the genome ends to 0.35kb and
0.5kb beyond the furthermost mapped Bam HI sites. To confirm that these locations did
correspond to the ends of the genome rather than a Kpn I site situated within the ITR the
procedure was repeated using Dra I sites. Dra I sites nearest to the termini were mapped by
restriction profile analysis of cloned terminal restriction fragments. Genomic DNA digested with
Dra I was Southern blotted and probed DIG-labelled B2-1. Again two fragments that hybridised
with B2-1 were identified and were estimated to be approximately 11.2kb and 12.2kb in size.
The sizes of these Dra I fragments were plotted onto the restriction map of the terminal regions
(figure 4.41). The Dra I fragments were predicted to extend from the Dra I sites nearest the
termini to 0.4kb beyond the mapped Bam HI sites. Thereby confirming the location of the
genome termini as being between 0.35 and 0.5kb (average 0.4Ikb) beyond the previously















Figure 4.40 Southern blot analysis of genomic SPPV DNA (isolate 1296/99) singly digested
with Kpn I and Dra I, hybridised with DIG-labelled B2-1 (figure 4.41 for probe location). The
hybridising Kpn I fragments were estimated to be 9.0kb and 5.3kb and the Dra I fragments to
be 12.2kb and 11.2kb.
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4.5.2 Inverted Terminal Repeats of SPPV
The cloned Bam HI fragments B7C-1 and B5-2 (corresponding to fragments designated V and K
in figure 4.45 and table 4.6) were predicted to be located at opposite ends of the genome. Both
fragments were predicted to span the ITR junction and therefore contain ITR sequence at one
end and unique sequence at the other end (section 4.3.2.2.2.2). To confirm the presence of ITRs
within fragments B7C-1 (V) and B5-2 (K), sequence was obtained from left end of B5-2 and the
right end of B7C-1, with respect to their orientation within the SPPV genome, and both
sequences aligned with each other using the ClustalW (section 2.4.8.3). The two sequences were
identical confirming that SPPV possess ITRs (figure 4.42A). As poxvirus ITRs are inverted and
complementary with respect to each other (Baroudy et al., 1982), the sequence derived from
B7C-1 is essentially the complement and reverse of sequence obtained from B5-2.
4.5.2.1 Location of the ITR junctions and ITR size
The position of the ITR junctions were predicted to lie within a 0.45kb region located between
area of restriction site conservation and restriction site divergence within the fragments B7C-1
(V) and B5-2 (K) (refer to figure 4.31). To determine the actual location of the ITR junctions,
DNA sequences were obtained from the 0.45kb region of B7C-1 (V) and B5-2 (K) and were
aligned with each other using ClustalW (section 2.4.8.3). The sequence alignment (figure 4.42B)
demonstrates the two sequences are identical over 439bp and diverge at the ITR junction, which
is located 22bp from the unique Bam HI site of B7C-1.
The sizes of the ITRs were estimated to be 4.96kb by calculating the distance between the ITR
junctions and the predicted ends of the genome (figure 4.43).
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* 20 * 40 *
B5-2 : GGATCCGTGGCCTCGTCCCCTCTTCCCTCTCCGAGGAGGGAGCGAGGAGGACATCGACT : K
B7C-1: GGATCCGTGGCCTCGTCCCCTCTTCCCTCTCCGAGGAGGGAGCGAGGAGGACATCGACT : V
60 * 80 * 100 *
B5-2 : CGGGATGGATGCACCCGCTCCCTCATGGACGGAGTGGAGCGAGTAGGACATCGACTCGG : K
B7C-1: CGGGATGGATGCACCCGCTCCCTCATGGACGGAGTGGAGCGAGTAGGACATCGACTCGG : V
Figure 4.42A Sequence derived from the left end of cloned fragment B5-2 (fragment K) and the
right end of cloned fragment B7C-1 (fragment V) aligned using the ClustalW algorithm (section
2.4.8.3). The Bam HI sites, common to both ends of the SPPV genome, are shaded in grey.
Because poxvirus ITRs are the complement and reverse of each other, the B7C-1 sequence in
































































Figure 4.42B Sequences derived from within the cloned fragment B5-2 (K) and the end of B7C-
1 (V), which are predicted to span the ITR junctions of SPPV (figure 4.43). The ITR sequence is
shaded in black and the unique Bam HI site situated at the right end of B7C-1 and the common
Not I sites are shaded in grey. The sequence diverges 22bp from the left terminal Bam HI site of
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4.6 COMPLETE RESTRICTION ENDONUCLEASE MAPS OF SPPV
In order to determine the complete restriction endonuclease maps of SPPV, the ten extensively
overlapping cosmid clones were aligned with each other via the Bam HI, Kpn I, Eco RI and Hind
III sites present within the overlapping regions (figure 4.44). The positions of restriction sites
correlated extensively between overlapping clones. Furthermore, the locations of the Bam HI
and Kpn I sites also correlate with previously mapped regions designated as clusters 1, 2, 3A and
3B (sections 4.2.4, 4.2.5 and 4.2.7), which indicates the accuracy of the restriction maps
constructed using the cosmid clones.
The complete restriction endonuclease maps for the Bam HI, Kpn I, Eco RI, and Hind III sites
and a partial map of the Not I sites are presented in figure 4.45. As previously established
(section 4.5.1), the terminal Kpn I fragments (designated as J and D in figure 4.45) are
approximately 5.3 and 9.0kb in size. Therefore the genome ends were predicted to be located
5.3kb left of the Kpn I fragment V and 9.0kb right of Kpn I fragment B'. This corresponds to the
genome ends being situated 0.41kb beyond the cloned and mapped Bam HI fragments of clusters
3A and 3B, hence the terminal Bam HI fragments, F' and G' were estimated to be approximately
0.4lkb in size.
The size of the Bam HI and Kpn I fragments were estimated from agarose gels of cosmid clone
DNA completely digested with Bam HI or Kpn I and where possible, compared with the size of
individually cloned Bam HI and Kpn I fragments. However, the majority of Eco RI and Hind III
fragments often spanned more than one cosmid clone and were too large to be estimated from
agarose gels. Therefore the sizes of the Eco RI and Hind III fragments were estimated by
calculating the distances between adjacent Eco RI and adjacent Hind III sites on a diagram
drawn to scale. Summation of the approximate sizes of the restriction fragments (table 4.6)
indicated that the SPPV genome is approximately 158kb in size.
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Fragments Not\ Kpn I Bam HI Eco Rl Hind III
A 10.1 17.5 15.8 48.9 76.8*
B 7.75 11.7 14.0 47.6 69.0
C 7.4 9.6 13.8 35.1 12.4*
D 7.25 9.0* 13.3 14.1
E 6.6 8.4 11.35 3.9*
F 5.75 7.1 9.9 3.9*
G 5.45 6.85 8.6 1.9
H 5.3 6.55 6.3 1.8
1 5.15 5.9 5.7 0.6
J 4.7 5.3* 4.75
K 4.3 5.25 4.65
L 4.15 5.05 4.6
M 4.1 4.9 4.5
N 3.75 4.85 4.1
0 3.3 4.8 3.9
P 3.1 4.65 3.15
Q 2.8 4.3 3.15
R 2.4 3.9 3.05
S 2.4 3.85 3.05
T 2.4 3.4 2.95
U 2.35 3.25 2.65
V 2.3 3.1 2.6
w 2.3 2.8 2.55
X 2.15 2.45 1.6
Y 1.55 2.25 1.15
z 1.5 2.05 1.15
A' 1.3 1.85 1.1
B' 1.25 1.8 0.9
C' 1.25 1.6 0.8
D' 1.25 1.45 0.8
E' 1.2 0.9 0.65
F' 1.05 0.7 0.41*
G' 0.9 0.55 0.41*








Totals 122.12 157.88 157.54 157.8 158.2
Table 4.6 The approximate sizes of the Kpn I, Bam HI, Eco Rl and Hind III restriction fragments
that comprise the complete genome of SPPV. The Not I restriction map is incomplete and
therefore only the size of the fragments that have been mapped are presented here. An asterisk
(*) indicates the end fragments, which are predicted to contain a terminal hairpin loop structure.
For the location of each fragment refer to figure 4.45.
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4.7 DISCUSSION
4.7.1 Restriction endonuclease mapping techniques
Hybridisation between overlapping cloned or isolated restriction fragments is a technique that
has been successfully used to determine the restriction endonuclease maps of many poxviruses,
albeit in conjunction with other techniques. For example; single restriction digests of genomic
DNA to determine the number and the size of restriction fragments that constitute the genome,
restriction profile analysis of singularly, doubly digested or partially digested genomic DNA,
identification of the rapidly reannealing covalently linked end fragments performed by
renaturing viral DNA singularly digested with a restriction enzyme and heat-denatured, and
Southern blotting in order to identify and estimate the size of overlapping fragments too large to
be cloned into plasmid vectors.
Extraction of SPPV DNA from scab material harvested from clinical cases consistently produced
low quantities of viral DNA that appeared heavily contaminated with squirrel DNA. Hence, a
clear restriction profile of SPPV could not be visualised. As a result, it was impossible to
determine the number and size of restriction fragments that constitute the SPPV genome, or to
map the genome using the restriction profile analysis of genomic DNA. However, Southern
blotting of digested genomic DNA allowed the three restriction endonucleases: Not I, Bam HI
and Kpn I to be selected on the basis that all the restriction fragments produced were estimated
to be small enough to theoretically clone into the pBluescipt plasmid vector. It was envisaged
that complete restriction endonuclease maps (with exception of the terminal fragments) could be
constructed by identifying overlapping cloned fragments by hybridisation and aligning them
accurately by restriction profile analysis of the cloned fragments.
This approach to mapping the genome was partially successful. In total, approximately I34kb of
the SPPV genome was mapped, although in four non-contiguous blocks (termed clusters 1, 2,
3A and 3B), separated by three unmapped regions of unknown size. Extensive screening of the
randomly cloned fragments by hybridisation failed to identify any restriction fragments situated
adjacent to the mapped regions. Therefore, the regions between the mapped clusters could not be
deduced. The reasons for the failure of hybridisation to identify adjacent to the mapped regions
are numerous.
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Firstly, it is likely that not all restriction fragments were cloned. The random cloning procedure
was inefficient at generating large numbers of clones. Despite repeated cloning attempts, the
total number of Not I, Bam HI and Kpn I clones generated was only 655. Physical damage such
as shearing and fragmentation arising from natural decay processes or mechanical damage
during the extraction procedure may have impaired the quality of the DNA, and impurities such
as residual salt or phenol present in the extracted DNA preparation may have also reduced
cloning efficiencies.
It is a reasonable assumption that a number of the clones generated using the random cloning
procedure are not viral in origin. As previously explained, a proportion of the extracted DNA
was squirrel genomic DNA, therefore cloning of the contaminating DNA would occur alongside
the cloning of viral DNA. Although the percentage of contaminating clones within the genomic
libraries was not determined, it is likely that the actual number of viral clones in the libraries is
far less than the total number of clones. These problems could have been overcome by
expanding the size of the genomic libraries and subsequently screening more clones, however
this was not possible as the supply of scab from isolate 1296/99 was limited. Increasing the
amount of DNA available by pooling material extracted from different scab isolates was not
considered appropriate, as isolates of the same parapoxvirus species often exhibit heterogeneous
restriction profiles (Wittek et al., 1980; Robinson et al., 1982; Rafii and Burger, 1985;
Gassmann et al., 1985; Robinson et al., 1987; Gilray et al., 1998; Mazur et al., 2000), which
must be the result of underlying genetic differences.
The possibility that some of the Bam HI and Kpn I fragments were too large to clone was ruled
out. It was predicted from the southern blot of digested genomic SPPV DNA (figures 4.1 and
4.2) and later confirmed from the complete restriction endonuclease maps that none of the Bam
HI and Kpn I restriction fragments were larger than could be theoretically cloned into the
pBluescript vector. In fact the two largest fragments: Kpn I fragment A and Bam HI fragment A,
were successfully cloned into pBluescript using the random cloning procedure (clones pK47-l
and pB3-l).
Secondly, it is possible that cloned fragments situated adjacent to the mapped regions were not
detected by hybridisation because of the close proximity of two or more restriction sites. For
example, at the left end of cluster 3A the Not I and Bam HI sites are located within lOObp of
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each other. Theoretically the colormetric DIG-system is able to detect fragments overlapping by
lOObp, however in practice, particularly when screening bacterial colonies sensitivity was much
reduced. Improving the sensitivity of hybridisation and detection by using a sensitive detection
system such as 32P or confining library screening to purified cloned DNA rather than screening
bacterial colonies would have been time-consuming, but may have overcome these problems.
Due to the limited success of restriction mapping the SPPV genome using restriction fragments
cloned into a plasmid vector, a second method was sought in order to complete the restriction
endonuclease maps. Contiguous stretches of DNA approximately 30kb to 42kb in length were
cloned into a cosmid vector. The commercially available SuperCos I cosmid vector (Stratagene)
was chosen due to the advantages that double cos site vectors offer over traditional single cos
site vectors. The extra cos site eliminated the need to dephosphorylate the vector to prevent
packaging of cosmid concatamers into the phage capsids. This allowed the insert DNA to be
dephosphorylated, preventing the multiple insertion of fragments into the cloning site, thus
removing the need to size fractionate the insert DNA. As size fractionation generally results in a
large loss of DNA, the SuperCos I vector was particularly useful in this study where DNA was
in short supply. Due to the limited quantity of SPPV, DNA extracted from the wild type scab
isolate 1296/99 was mixed with a carrier DNA in a ratio of 1:4 prior to cloning. The carrier
DNA source was rainbow trout (Oncorhynchus mykiss). This was selected due to the low G+C
content: approximately 40 to 50% G+C (R. Sharif personal communication) and the abundance
of fish tissue in the laboratory where this study was performed. It was predicted that the use of a
carrier DNA with a low G+C content would allow differentiation between the G+C rich SPPV
clones and the A+T-rich carrier DNA clones when the library was screened with DIG-labelled
probes.
The previously mapped and cloned restriction fragments were utilised in screening the cosmid
library. The selection of mapped restriction fragments from along the entire length of the SPPV
genome enabled SPPV cosmid clones to be identified by hybridisation and their approximate
location within the SPPV genome to be estimated. Furthermore, comparison of the previously
mapped regions with the restriction profiles of the cosmid clones enabled ten cosmid clones to
be selected that were predicted to overlap extensively with each other and span the entire length
of the genome (with the exception of the end fragments containing hair pin loop structure).
Detailed restriction endonuclease maps of the Bam HI, Kpn I and Eco RI were determined using
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the partial digest and end-labelling method developed by Rackwitz et al., (1984 and 1985).
However, the Not I sites occurred too frequently for the partial digest and end-labelling method
to be used successfully, therefore the Not I map was not completed. As only four cosmid clones
possessed a Hind III site, therefore the complete Hind III map was easily determined using only
restriction profile data.
The advantages of the cosmid mapping method were; it was rapid, and it was easily adapted for
a number of restriction endonucleases. However, the plasmid cloning method enabled many
locations along the SPPV genome to be easily sequenced without the need to perform time-
consuming subcloning of the cosmid clones.
4.7.2 General structure of the genome
SPPV was formally classified as a parapoxvirus (van Regenmortel et al., 2000) based upon the
morphological similarities to parapoxvirus particles (Scott et al., 1981), however, until now, no
molecular evidence to support or disprove the classification of SPPV as a parapoxvirus has been
provided. The average G+C content of the SPPV genome is estimated to be 66.4% (table 4.3),
which is comparable to the G+C content found in parapox and molluscipox virus genomes
(Wittek et al., 1979; Senkevich et al., 1997). The estimated size of the SPPV dsDNA genome is
approximately 158kb, making it the largest of the classified parapoxviruses. The size of
parapoxvirus genomes generally lie within a range of 130 to 150kb (van Regenmortel et al.,
2000). However this size range is misleading, as wild type parapoxviruses and low passaged
tissue-cultured viruses generally range from 139kb to 145kb (Menna et al., 1979; Robinson et
al., 1982; Robinson et al., 1987; Homer et al., 1987; Mercer et al., 1987; Mclnnes et al., 2001),
whilst parapoxviruses exceeding 145kb in size are all virus strains that have been extensively
passaged in tissue culture. The larger size of parapoxviruses serially passaged in tissue culture
have been shown to be the result of genomic rearrangement of the terminal sequences by
duplication, transposition and deletion events (Rafii and Burger, 1985; Fleming et al., 1995;
Cottone et al., 1998; Mclnnes et al., 2001). The SPPV used in this study was a wild type isolate
and therefore its larger size is not the result of adaptation to tissue culture. The size of MOCV
subtype 1 is approximately 190kb (Senkevich et al., 1997) and little variation in size exists
between different isolates and subtypes of MOCV (Burgert and Darai, 1991). SPPV is
approximately 13kb larger than wild-type parapoxviruses and 32kb smaller than MOCV; hence
the SPPV genome does not correspond in size to any of the G+C-rich poxviruses characterised
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so far. The only poxviruses that correspond in size to SPPV belong to the leporipoxvirus genus,
which are approximately 160kb in size (Delange AM, 1984; Russell and Robbins, 1989).
However, the G+C content of leporipoxvirus genomes is approximately 40% (Cameron et al.,
1999; Wilier et al., 1999). To date, closely related viruses assigned to the same genera always
have comparable G+C composition (van Regenmortel et al., 2000). Therefore, on the basis of
G+C content, SPPV is unlikely to belong in the leporipoxvirus genus.
The ITRs of SPPV were estimated to be approximately 4.96kb and they presumably terminate
with hairpin loop structures, which are common to all poxviruses. The size of ORFV ITRs vary
from 3.1kb to 3.4kb for the wild type viruses (Fraser et al., 1990; Mclnnes et al., 2001) and up to
18kb for the larger tissue-culture adapted viruses (Cottone et al., 1998). The ITRs of MOCV are
approximately 4.7kb (Senkevich et al., 1997), whilst the ITRs of leporipoxviruses are much
larger at approximately 11.5kb to 12.4kb (Upton et al., 1987; Cameron et al., 1999; Wilier et al.,
1999). Therefore in terms of size the ITRs are most like the molluscipoxviruses. Analysis of
nucleotide sequence derived from within the ITR of SPPV (figures 4.42A and B) suggested a
G+C content of approximately 65.3%. Hence, the G+C content of the central region of the
genome is maintained towards the termini as in molluscipoxviruses and parapoxviruses (Fraser
et al., 1990; Senkevich et al., 1997). Further analysis of the right-terminal sequence of SPPV
revealed that the DNA sequence that spans the ITR junction (extending 300bp left and right of
the right-ITR junction) is extremely G+C-rich at 72.67%. This situation is also evident in ORFV,
with the corresponding 600bp right-terminal region also extremely G+C-rich at 83.67% (EMBL
accession number M30023). In contrast the same region in MOCV (EMBL accession number
U60315) is less G+C-rich at 66.17%.
Fundamental differences in the frequency of restriction sites exist between SPPV and
parapoxvirus genomes. For example, one striking difference is the frequency of Bam HI sites, in
SPPV there are thirty-three sites whilst in ORFV isolates there are between ten and twelve sites
(Robinson et al., 1987; Mercer et al., 1987; Mclnnes et al., 2001). Consequently, the Bam HI,
Eco RI, Kpn I and Hind III restriction endonuclease maps of SPPV do not resemble restriction
maps or correspond to restriction profiles of wild-type isolates or low passaged strains of ORFV,
BPSV, PCPV and PNZV (Menna et al., 1979; Wittek et al., 1980; Robinson et al., 1982; Rafii
and Burger, 1985; Gassmann et al., 1985; Robinson et al., 1987; Horner et al., 1987; Mercer et
al., 1987; Gilray et al., 1998; Mclnnes et al., 2001). This was not unexpected, because unlike the
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orthopoxviruses, the different species of wild-type or low passaged parapoxviruses are highly
divergent in restriction profiles (Wittek et al., 1977; Esposito et al., 1978; Mackett and Archard,
1979; Wittek et al., 1980; Esposito and Knight, 1985; Gassmann et al., 1985; Robinson and
Mercer, 1995). Therefore, if SPPV is a separate species belonging to the parapoxvirus genus, the
restriction map is unlikely to resemble previously characterised parapoxvirus species. Likewise,
the restriction maps of SPPV did not correspond to any of the published profiles of MOCV
subtypes 1, 2 and 3 (Porter and Archard, 1992). Therefore the use of restriction profile analysis
to establish the relationship of SPPV to the parapoxviruses is unsuitable due to the lack
conservation between the different parapoxvirus species.
In this chapter the base pair composition of the SPPV genome and restriction endonuclease maps
are presented, however these alone are not sufficient to determine the genetic relationship of
SPPV to other poxviruses. Therefore in the next chapter the general relationship of SPPV with
parapoxviruses are investigated using cross-hybridisation between SPPV and ORFV. The
relationship of SPPV to other poxviruses is also discussed, with reference to the establishment of




GENETIC COMPOSITION OF THE SPPV GENOME




Restriction endonuclease profiles of viruses belonging to the orthopox, avipox and capripox
virus genera have shown that the genomes are highly conserved in a genus-specific manner
(Mackett and Archard, 1979; Esposito and Knight, 1985; Schnitzlein et al., 1988; Gershon and
Black, 1988). Whereas, restriction endonuclease maps are similar only in a species-specific or
subtype-specific manner for poxviruses belonging to the parapox, molluscipox and leporipox
virus genera (Wittek et al., 1980; Porter and Archard, 1992; Cabirac et al., 1985). As previously
established the restriction profile of SPPV does not resemble that of any characterised
parapoxvirus species to date (chapter 4.0). Therefore restriction mapping and profiling is a
useful technique, but has limitations in determining the genetic relationship of a newly classified
member of the parapoxvirus genus, like SPPV, with existing member species.
Cross-hybridisation of genomic DNA from different poxvirus species has been used to
characterise the relationship between species and determine organisation of poxvirus genomes
(Mackett and Archard, 1979; Esposito and Knight, 1985; Gershon and Black, 1988; Porter and
Archard, 1992). However due to the disparate G+C composition of poxvirus genomes,
comparison by hybridisation is only possible between viruses with similar G+C contents. For
this reason hybridisation of the SPPV genome is only possible with the other G+C rich genomes
found in the parapox and molluscipox viruses, and not with the orthopoxvirus genomes.
Cross-hybridisation of the genomes of different parapoxvirus species has demonstrated that the
central regions of parapoxvirus genomes are highly related, however the terminal regions only
cross-hybridise between isolates of the same species and are therefore species-specific
(Gassmann et al., 1985). Identification of the regions of the SPPV and ORFV genomes that
hybridised extensively with each other would be useful in determining the level of conservation
between the two genomes. Conversely, the identification of the regions of the SPPV genome
which did not hybridise with ORFV DNA would be equally valuable as it would indicate regions
which were relatively more divergent from ORFV or even unique to SPPV.
The complete DNA sequencing of several poxvirus genomes has increased our understanding of
the relationship between different poxvirus genera and species (Goebel et al., 1990; Massung et
al., 1994; Senkevich et al., 1997; Cameron et al., 1999; Wilier et al., 1999; Afonso et al., 2000;
Tulman et al., 2001; Lee et al., 2001; Afonso et al., 2002; Shchelkunov et al., 2002; Gubser and
Smith, 2002). Taken together, restriction endonuclease maps, hybridisation and sequencing have
revealed that poxvirus genomes consist of a conserved central core of genes that are generally
essential for the replication of the virus and the production of infectious progeny virus. Flanking
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the central core are the variable regions, which contain genes non-essential for replication and
are often genus or species-specific. Many of these genes are homologues of cellular genes, some
of which have been shown to confer a replication advantage to the virus in vivo (Bugert and
Darai, 2000).
Sequencing at defined points along the genome was employed in this study to produce a genetic
map of SPPV to allow a detailed comparison of the organisation of the SPPV genome with other
poxviruses. In addition, sequence was obtained from the regions that were predicted to be
divergent from ORFV by hybridisation (section 5.2) in order to investigate the presence of
species-specific genes.
5.2 GENERAL RELATIONSHIP BETWEEN SPPV AND ORFV
SPPV cosmid clones 3, 5, 9, 24, 28, 43, 51, 54, 81 and 86 were previously characterised and
shown to overlap extensively and span the entire genome of SPPV with the exception of the
terminal 0.4kb (section 4.5.1). The cosmid clones were digested with the restriction
endonuclease Kpn I and the resulting fragments separated by electrophoresis in a 0.5% agarose
gel. Southern blots were prepared and hybridised with digoxygenin (DIG) labelled probes
derived from eleven regions of the ORFV strain orf-11 genome and the ITR region of MRI scab
isolate (Mclnnes et al., 2001). The locations of the probes within the ORFV genomes are shown
in figure 5.1.
ORFV was the parapoxvirus chosen for the comparison as it is the most well characterised
species of the parapoxvirus genus, with preliminary genetic maps of ORFV strains NZ2 and
D1701 having been published (Mercer et al., 1995; Buttner and Rziha, 2002) and a preliminary
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5.2.1 Hybridisation of SPPV with ORFV
The SPPV Kpn I fragments which hybridised with the ORFV probes are summarised in table
5.1. Probes 1, 2, 3, 4, 5, 7, 8, 9, 10 and 11 all hybridised with SPPV, however probes 6 and 12
did not. A schematic representation of which ORFV probes hybridised with which SPPV Kpn I
restriction fragments is shown in figure 5.2, and is described in more detail in the text that
follows.
Probes 2, 3, 4, 5, 7, 8, 9, 10 and 11 all hybridised with SPPV Kpn I fragments in an order
identical to the order of the probes themselves, demonstrating a general genetic relationship and
a high degree of collinearity between the SPPV and ORFV genomes. There were few Kpn I
fragments within this region which did not hybridise with the ORFV probes. This collinear and
cross-hybridising region in SPPV extended from approximately 17kb to 133kb and as a result is
predicted to form the conserved central core of the genome. Flowever several differences were
noted between the viruses towards the ends of the genomes.
Probes 3, 7, 8 and 11, derived from the near terminal regions of the ORFV genome hybridised
with several SPPV Kpn I fragments located towards the ends of the SPPV genome. However, the
hybridisation signal between these ORFV probes and some of the SPPV Kpn I fragments was
weak when compared with that of the control ORFV DNA. For example, probe 11 hybridised
with SPPV Kpn I fragments extending from fragment O near the left end of the SPPV genome to
fragment Y located towards the centre (figure 5.3A). Fragments Y, L and H (respective sizes
2.25, 5.05 and 6.55kb) hybridised strongly with probe 11, however fragment O (4.8kb)
hybridised weakly. No hybridisation signal was detected with fragment H' (0.25kb), which is
situated between fragments O and H. Likewise probe 3 hybridised weakly with a Kpn I fragment
corresponding to Kpn I fragment M (figure 5.3B). A similar situation was also observed with
probe 8. Probe 8 hybridised strongly with the SPPV Kpn I fragments corresponding in size to U
and B. However, weak hybridisation was also detected with fragments corresponding in size to S
and W. Fragment I', which is situated between fragments S and W, did not hybridise.
Probe 7, which spans a 12.7kb region of the ORFV genome hybridised with Kpn I fragment C',
which is only 1.6kb in size. The fragments flanking C' did not hybridise with probe 7 (figure
5.3C).
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Kpn I Size Kpn I fragments spanned by the cosmid clones Hybridisation









L 5.05 4r 11
Y 2.25 11




m o co 9
Z 2.05 9
00LU 9
K 5.25 # 9 and 2









U 3.25 t» 8




G 6.85 4> NH
B' 1.8 NH
D 9.0 4i NH
Table 5.1 Summary of the SPPV Kpn I fragments (listed in the first column from the left end to
the right end of the genome with their sizes listed in column 2) which hybridised with the ORFV
DIG-labelled probes depicted in figure 5.1. Hybridisations were performed with Kpn I digested
cosmid clone DNAs, the region of the SPPV genome each cosmid clone overlaps is indicated in
columns 3 to 12 by the bars (• •). Column 13 summarises the ORFV probes that hybridised
with SPPV Kpn I fragments, a * suffix indicates that the hybridisation was very weak and NH
indicates that the Kpn I fragment did not hybridise with any of the ORFV probes. A schematic
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Seven consecutive Kpn I fragments (B\ D, F, J, G, V and X) located at the ends of the SPPV
genome did not hybridise with any of the ORFV probes. In addition, the ORFV probes 6 and
12, which are located at the ends of the ORFV genome also did not hybridise with SPPV.
The lack of or weak hybridisation observed between the end fragments of ORFV and SPPV
is probably due to divergence at the nucleotide level. In support of these observations, cloned
SPPV DNA was labelled with DIG and hybridised with ORFV (orf-11) Kpn I restriction
fragments using the same hybridisation conditions as hybridisation of SPPV with the ORFV
probes. The results correlated well with the hybridisation of SPPV with ORFV in that the
central region of the two genomes hybridised extensively, whilst the terminal regions
showed little or no hybridisation (results not shown).
The hybridisation conditions employed in this study were relatively stringent. Hybridisation
and the subsequent washes of the Southern blots were performed at high temperature (65°C)
with a wash solution of a low salt concentration (0.5X SSC). It was predicted that the
stringent conditions would enable the regions of the SPPV genome that are highly conserved
with ORFV and those regions that are less so to be distinguished. Therefore, the SPPV Kpn I
fragments that did not hybridise with ORFV DNA are not necessarily unique to SPPV.
Instead they may just lack sufficient homology to ORFV to enable hybridisation to be
detected at the stringency used. Hence, the regions that are unique to SPPV and regions
divergent from ORFV cannot be distinguished using this hybridisation technique alone.
Interestingly probe 1, which is derived from the right-end of the ORFV genome hybridised
with the Kpn I fragment I, which is situated at the left-end of SPPV (figure 5.4). Therefore it
appears that the left-end of the SPPV genome shares DNA homology with the right-hand end
of wild type ORFVs, suggesting a translocation of sequence in SPPV with respect to ORFV.
In summary the central region of SPPV extending from 17kb to 133kb generally hybridised
with ORFV in a collinear order, suggesting a high degree of relatedness between the two
viruses. However, the terminal regions of the SPPV genome consist of non-hybridising
fragments and a possible translocation of sequence with respect to ORFV. On the basis of
hybridisation, the terminal regions of the SPPV genome (extending from Okb to 17kb and
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Figure 5.4 Southern blot of SPPV DNA cloned into the SuperCos I cosmid vector and ORFV
(orf-11) genomic DNA digested with Kpn I and hybridised with ORFV probe 1. A strong
hybridisation signal can be seen with the ORFV control DNA and a weak hybridisation signal
with SPPV Kpn I fragment I.
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5.3 DNA SEQUENCING OF THE SPPV GENOME
The differences noted between the SPPV and ORFV genomes, when compared by
hybridisation (section 5.2) may be a result of differences in the complement of genes present,
their homology at a nucleotide level and the order/spatial distribution of genes.
To further characterise these differences short lengths of DNA sequence were obtained from
a number of defined locations in the SPPV genome. Particular attention was paid to the
terminal regions of the genome in the hope of identifying genus-specific genes, which would
aid in determining the taxonomic relationships of SPPV. In addition, the terminal regions
may also contain genes associated with immuno-modulation and virulence. Identification of
such genes may be of importance for future vaccine development. In total approximately
23kb of non-contiguous DNA of the SPPV genome was sequenced, which represent
approximately 15% of the total genome. Analysis of the resulting data allowed the
construction of a preliminary genetic map of SPPV.
5.3.1 Identification of homologous poxvirus genes in SPPV
Forty-seven sequences were obtained by sequencing the ends of cloned restriction
endonuclease fragments (section 2.4.7). FastA analysis of each DNA sequence (section
2.4.8.1) revealed that most were homologous with the G+C rich genomes of MOCV and
ORFV, however very few other poxviruses exhibited homology at the DNA level
presumably because of the disparity in G+C content. Despite underlying divergence in
nucleotide sequence, poxviruses encode proteins that are highly conserved in sequence
(Fleming et al., 1993; Mercer et al., 1995). Therefore predicted amino acid sequences rather
than nucleotide sequences were employed to search the databases for homologous sequence
as it was considered more likely that a homologous poxvirus protein would be identified
rather than a homologous DNA sequence (section 2.4.8.2).
A total of twenty-six poxvirus protein homologues were identified in this way. A further two
poxvirus protein homologues (homologues of VACV F13L and MOCV 157R) were
identified using targeted sequencing (sections 6.3.1 and 7.2) but are included in the genetic
map and comparison with other poxviruses for completeness. In the absence of any
previously described SPPV genes, the system of annotating ORFs used by Mercer et al.,
(1995) in describing a genetic map of ORFV was adopted. Each putative protein was
designated a co-ordinate code which corresponds to the location within the SPPV genome
(SP) and combined with either L or R to indicate the direction (left or right) of transcription
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(e.g. SP 29.9L). Whenever possible the location corresponded to the co-ordinate of the
initiating methionine (indicated by a m-suffix, e.g. SP 72.2Lm) or the termination codon
(indicated by a t-suffix, e.g. SP130.5L1), when not possible the co-ordinate corresponds to
the location of the restriction site at which the sequence was derived.
The nucleotide sequences that are predicted to encode poxvirus gene homologues are
presented in figure 5.5 along with the translated frames, except for the homologues of
VACV F13L and MOCV 157R, which are presented in sections 6.3.1 and 7.2. These data are
summarised in table 5.2, along with the predicted structure and/or function of each protein. A
further twenty-two DNA sequences did not contain any ORFs with recognisable identity to
other poxviruses (sequences not presented).
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Figure 5.5
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Not I N left SP 34.9R
MOCV 037R (63.3% over 49aa) Homologue: VACV E6R
fi£££££££GGAGCGGGAGTACACCTGCCAGATCTACCACGAGGACACGCTCTACCACATCCGCGAGTACAACACCTACCTCTTCCTCAAC
AAAEREYTCQ I YHEDTLYH I REYNT YLFLN
GAGGAGGACCCGCTCGTCCTCGACGCGGGCGTCCTGGTGCGGCTCTCCTACGTGCCCGCC 150
EEDPLVLDAGVLVRLSYVPA^_SP 34.9R
Not I N right SP38.7L
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CMPV C61L (68.9%over 196aa) Homologues: VACV E9L7MOCV 039L/ORFV 26.4L
TGAGTCCAGCTTGTACGAGTCCAGCTTCTCCGACTTCTGGATGT ACGCGTAGAGGTCGAAGAAGATGGTGCCGTTGTTGTTGTTNACGTG












E I DMFLYTROVDFRP 1 R <- SP 39.7
Kpn I A right SP 58.0L









Kpn I A left SP 59.4R
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YMTV I5R (40.0% over 60aa) Homologues: VACV L5R/MOCV 074R
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MOCV 077R (61.4% over 70aa) Homologues SP 65.93R*: VACV J4R/ORFV 53.1 Rm
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Not IX left SP113.2R
VACV A18R (62.3% over 146aa) Homologues: MOCV 123R
£££££££CCAAGCGCAAGGCGCGGGAGGGCCGGCCGCCGT ACGTGACCCTGCACCTGGCGTGCGGGTTCGGCAAGACGGTGACCGCCTGC
A A A K L H F G K
CACCTGATCGCCAAGCACCGCCTGCGCGCGGTGGTCTGCGTCCCCAACAAGATGATCATCCCCCAGTGGCGGGCGGCCGTGGAGGCGACG
K H N K M I I
GGGCGCGAGCACCTCGTCTCCGTCGACGGCGTGAGCAGCCTGCTGCGGGAGCTGCGCACCGTCACGCCCAGCGTGCTGGTGGTGGTCAGC
H L S V D G V S R E R T V PSVLVVVS
CGCCATTTCGGGAACGAGGAGTTCTGCCGCCTGGTCGACGAGCGGTACGACGTCCTGGTCGTGGACGAGTCGCACACGCACAACCTCATG
H N C R L D E R V V V D S H T H N L M
AACAACACCGCCATGGCGCGGTTCCTGGCCTTCCACCCTCCCCGCGTCTGCTACTTCCTCACGGCCACGCCGCGCGCGGTCAACCGG 447
N N M RFLAFHPPRVC R A V N R • SP 113.2R
Not I X right SP 115.3R
MOCV 126R (44.4% over 108aa) Homologues: VACV A20R
AAAGAGCTGGCTCGAGTGAGCCGGTGCCTGGCACGGGCCAACGACGCGACCGTCCAGAAGTACAACGCGCTCGTGGAGTGGGCCACCCGC
A R T V 0 K W A
ACGTACTGGACGGTGGGGGTGGCGCCCAGCGAGGGCGGCTCGGTCTCCGTGGCGCGGTACTACGCCGAGCCCGAGAGGCGCGAGTTCGAG
T Y W T S E
ATGGCGGCCGGCGAGTACGTCTTCTCGCTGGCCTTCTTCGGGACCGTCCTTCTCTTCACCAACGGGTCCCTGATGGAGGTCGGCGGGCGC
M A G T M E V G
GCGGCGGCGACGAACGAGCGGGTGGTCGCGGr.GTGCCGCGCGGTGGCGGCGGr. 323
AAATNERVVAA R A V A A A • SP 115.3R
Not I H left SP 118.1 R* and SP 118.1 Rn
MOCV 128R (58.6% over 116aa)
MYXV M114R (82.4% over 17aa)
Homologues SP 118.1 R*: VACV A23R
Homologues SP 118.1 Rm: VACV A24R/MOCV
129R/ORFV 103.3R
GmiLmiCGCCCGCGTGGCCGCGCCGGCGGAGCTTCGACGAGAAGATGGCGCTGATCGCCGACGGCCCGGGGACTACGGCGTGGGCAAC
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TTCCGCGTGGGCATGTTCAACCTGACACACACGCGGCAGATCGCCTCGACCGTCTTCCCCTCGCTGCTCGACGACGCCAGCAAGATCAAG
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TTCTTCAAGGGCAAGAAGCTCAACATCGTCGCCATCGGGTCCCTGGAGGAGTGCCGCCGCTACGTGGAGCAGGCGGACTGGCTCCTGGAC
K K N I S L D W L L D
GTCATGGCGCGGCGGTCCGCGACGCTGGACGCGCTGGACATCGCCCGCGCCCCCGTGGACGCGCTCAAAGACCTTTTAAAGTGAAAGAAA
V M A R R S D A L D I APVDALKD •SP 118.1 R'
ACAACGCCCACAAATGGAGCAGCGTCTCGGTTACAAGTTCCTGGGGGCCGACCCGAAGGCCGGCGT 426
SP 118.1 R"1 M 0 D
Not I J right SP 130.5Lm and SP 130.51'
MPV A29L (38.0% over 50aa)
MOCV 134L (42.6% over 47aa)
Homologues SP 130.5Lm: VACV A27L/MOCV
133L/ORFV 108.2Lm
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Not I D left SP 131.2L
VARV A32L (56.2% over 73aa) Homologues: VACV A29L/MOCV 135L/ORFV
109.5L
GCGGCCGCGCGGCGCGACGGCGATAAAGGGGACCTCGCCGCGGAAGCCGTCCCGCAGCACCGGGCGCACGTTGCCGTACTCGCGGTTGAA
R P V A i P V E G G 0 R V P R V N R N F
GACCTCGGCGTCGAGGAAGGTCAGCCGGGCCACGAGCGCGTCGTTGACGACCGTGCCGGAGCTGAAGGCGACCAGCTCCACGGCCTGCTC
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Not ID right SP138.3R'
LSDV 127R (26.3% over 99aa) Homologues: VACV 37R/MOCV 149R
ATCGCCTTCGCCATGCGCCTGCTGACGGACAAGATCACCGGCCGCGTCGTCTGCGAGCAGTCTGATGGTCGGCGGGGACTGGTTCACCGT











Figure 5.5 SPPV sequence derived from the ends of cloned restriction endonuclease
fragments. Sequencing was performed by the Functional Genomic Unit (Moredun Research
Institute) using PE Biosystems 377 DNA sequencer. The nucleotide sequences are
presented along with the translated ORFs that are predicted to encode homologues of
poxvirus proteins as determined by FastA analysis. The text immediately above each
sequence details the restriction fragment and the left or right end that each sequence
derived from, and the location co-ordinate of each putative SPPV protein [e.g. SP 19.05L
(see section 5.3.1 for an explanation)]. The closest homologue is also indicated with the
percentage identity between the two proteins, together with known homologues from VACV,
MOCV and ORFV (see appendix 2.0 for the protein alignments performed by the FastA
algorithm). The sequences that did not appear to encode known poxvirus genes are not
shown here.
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5.3.2 The comparison of putative SPPV proteins to those encoded by other
poxviruses
Twenty-six of the twenty-eight poxvirus protein homologues identified in SPPV are
conserved across the genera and have been identified in many individual species including;
VACV, VARV, MOCV, SFV, MYXV, FPV, LSDV, YLDV, MPV and SWPV (Johnson et
al., 1993; Massung et al., 1994; Senkevich et al., 1997; Cameron et al., 1999; Wilier et al.,
1999; Afonso et al., 2000; Tulman et al., 2001; Lee et al., 2001; Afonso et al., 2002;
Shchelkunov et al., 2002; Gubser and Smith, 2002); except for homologues of the VACV
genes A27L and A37R which are absent in the FPV genome. SPPV ORFs SP21.7L"1 and
SP155.0R1 have one poxvirus match each in the database to the putative MOCV proteins
026L and MOCV 157R, which were previously believed to be unique to MOCV (Senkevich
et al., 1996 and 1997).
As SPPV is classified as a parapoxvirus (van Regenmortel et al., 2000), it was therefore
expected that the putative SPPV proteins would exhibit the greatest identity to the ORFV
proteins. However the complete genome sequence of ORFV has yet to be determined, and
possibly as a result, only five of the SPPV sequences resulted in a direct match with ORFV
proteins during database searching. Four other SPPV sequences corresponded with genes
putatively identified in the ORFV genome by comparison of each with VACV rather than by
direct comparison with each other. Direct comparison with each other was not possible
because sequence obtained from SPPV and the sequence published for the four ORFV genes
do not overlap as they correspond to different regions of the same gene.
A broad view of the data revealed that the closest alignment of twelve of the twenty-eight
putative SPPV proteins were with MOCV proteins. Orthopoxviruses accounted for nine of
the closest alignments, whilst the remaining seven ORFs aligned with parapox, avipox,
leporipox, capripox and yatapox viruses. The availability of the complete DNA sequence of
MOCV and its high G+C content (Senkevich et al., 1997) may account for the high level of
protein alignment with SPPV. Codons in G+C rich genomes will naturally have a bias
towards a G or a C in the first or second position of a codon, which will invariably alter the
amino acid coded for when compared to A+T rich genomes. It then follows that proteins
from two different poxvirus species are more likely to show a high amino acid identity if
they have comparable G+C contents.
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Despite the differences in G+C content, the closest alignment of nine SPPV proteins were
with orthopoxvirus proteins. However, most of these proteins were also highly conserved in
MOCV and little difference in the percentage identity (as calculated by the FastA algorithm)
of SPPV with MOCV and orthopoxvirus proteins was observed. Likewise, six of the seven
SPPV proteins that appeared to be most closely related to parapox, avipox, leporipox,
capripox and yatapox viruses all had a similar percentage identity with MOCV, suggesting
that these proteins are also highly conserved within the poxvirus family. The exception was
ORF SP138.3R1. This protein aligned only with LSDV and SFV homologues of VACV
A37R. Further analysis revealed that homologues of the VACV A37R gene are poorly
conserved at the protein level between different poxviruses.
Of the five sequences derived from SPPV that overlap with published ORFV genes, only one
protein, SP19.05L (section 7.2) was the most closely related to ORFV. This ORF
corresponded to the major EEV protein (homologue of VACV F13L). However many
orthopox, molluscipox and capripox virus F13L homologues also gave similar percentage
identities, suggesting that this is a highly conserved gene. The remaining four SPPV ORFs,
SP29.9L, SP38.7L, SP118.1Rm and SP130.2L, which corresponding to the VACV proteins
E4L, E9L, A24R and A27L aligned with published ORFV sequence but not as the closest
homologue.
To refine the analysis, some of the SPPV sequences were trimmed such that they
corresponded to the region for the ORFV protein present in the databases. The FastA
analysis was then performed again with the shorter sequence. Despite this, VACV proteins
remained the closest homologues. For example, ORF SP38.7L most closely resembled the
VACV E9L DNA polymerase gene, despite trimming the sequence. However, comparison of
SP38.7L with all the vertebrate poxvirus E9L sequences suggests that the poxvirus DNA
polymerase genes are highly conserved.
ORF SP130.2L is predicted to encode the IMV fusion protein based on homology to other
poxvirus homologues of the VACV A27L. However, the percentage identity of SP130.2L
with other poxviruses A27L homologues is low suggesting this gene may be poorly
conserved in SPPV.
In summary the results discussed in this section indicate that putative SPPV proteins are
most homologous with proteins derived from G+C rich poxviruses such as MOCV. The
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restricted volume of sequence published for the parapoxviruses may have limited the number
of matches observed with putative SPPV proteins. Comparison of complete gene sequences
and/or phylogenetic analysis may be more accurate in determining the evolutionary
relationship of SPPV to the poxviruses (chapter 7.0).
5.4 GENETIC MAP OF SPPV
The locations of the predicted poxvirus homologues were plotted onto a schematic
representation of the genome (figure 5.6). The location of each homologue corresponds to
those summarised in table 5.2, and where possible the location corresponds to the initiating
methionine or the termination codon of putative SPPV genes; where this was not possible the
location of restriction site the sequence originates from is given.
5.4.1 Comparison of the genetic map of SPPV with the regions hybridised with
ORFV
All of the sequences derived from the region of the genome extending from approximately
30kb to 118kb, exhibited identity with at least one previously described poxvirus protein.
Hence the sequencing results correlate well with the hybridisation data described in section
5.2.1, in that the region of SPPV, which hybridised strongly with ORFV contains many
conserved poxvirus genes.
Twenty-two sequences derived from near the genome ends (Okb to 30kb and 124kb to
158kb) did not exhibit nucleotide or protein homology with any of the poxvirus sequences
deposited in the databases. Hence, the locations of these sequences correspond well with
regions of the SPPV genome that did not hybridise with ORFV, suggesting the presence of
sequence possibly unique to SPPV, absent from ORFV or too divergent from ORFV for
hybridisation to occur. However a number of differences were noted between the
hybridisation and sequence data and these are discussed in the text that follows.
We have identified homologues of the VACV genes A29L, A32L and A37R located within
SPPV Kpn I fragments G'and F. Comparison of the completely sequenced poxvirus genomes
has revealed that homologues of the VACV genes A30L, A32L, A37R are present in one or
more species belonging to each genus, except FPV which lacks A37R (Afonso et al., 2000).
It is therefore likely that these genes will be present in ORFV. However, no visible
hybridisation signal was observed between the restriction fragments of ORFV and SPPV
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too divergent in ORFV and SPPV for hybridisation to be visualised at the hybridisation
stringency used. Unfortunately direct comparison of the sequence of the corresponding
homologues in SPPV and ORFV was not possible because the ORFV sequences are not
available in the databases.
A number of SPPV Kpn I fragments (S, F, W and M) hybridised weakly with ORFV DNA.
Analysis of sequence obtained from within these fragments identified homologues of the
VACV genes F13L, F15L, A16L, A17L, A18R and A20R. Homologues of these genes have
been identified in all the completely sequenced vertebrate poxvirus genomes to date and are
therefore likely to be present in ORFV. The weak hybridisation signals visualised suggest
that these genes are divergent at the nucleotide level between ORFV and SPPV. However
due to the absence of ORFV sequence in the databases no direct comparison of these genes
could be performed between ORFV and SPPV, except for the F13L homologue. FastA
alignment of the SPPV and ORFV F13L homologues revealed that they are only 61.6%
homologous at the nucleotide level. Low levels of homology between SPPV and ORFV may
explain the weak hybridisation signals with Kpn I restriction fragments S, I', W and M when
using stringent hybridisation conditions.
As previously discussed probe 1, which is derived from the right end of the ORFV genome
hybridised with Kpn I fragment I, which is situated at the left end of SPPV, suggesting a
translocation of sequence (section 5.2.1). Sequencing of ORFV has revealed that the
homologue of mammalian vascular endothelial growth factor (VEGF), interleukin-10 (IL-
10), F9L, F10L and several ORFs without homologues in the databases are located within
the region spanned by ORFV probe 1 (Mercer et al., 1995; Fleming et al., 1997; Rziha et al.,
2003). Four short lengths of sequence were obtained from within SPPV Kpn I fragment I,
totalling approximately 2kb. Analysis of these sequences failed to identify homologues of
the characterised ORFV genes. However if one or more of these genes are present within
Kpn I fragment I they may be located between the regions sequenced and result in
hybridisation between ORFV and SPPV. Alternatively, the hybridisation between probe 1
and Kpn I fragment I may be the result of one or more the unpublished genes being
conserved in both viruses, but in different locations.
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5.5 COMPARISON OF THE GENOME ORGANISATION OF SPPV WITH
OTHER POXVIRUSES
To better understand the relationship of SPPV with other poxviruses, the genetic
organisation of the SPPV genome was compared to the poxvirus genomes: ORFV (NZ2),
VACV (Tian Tian) and MOCV (subtype 2).
A genome alignment of SPPV with ORFV (NZ2) was performed because SPPV is classified
as a parapoxvirus (van Regenmortel et al., 2000) and ORFV is the most characterised
member of this genus. However, in the absence of a complete sequence of ORFV, only a
preliminary alignment could be produced as only nine genes were identified as being
common to both viruses. Mercer et al., (1995) showed that ORFV is essentially collinear
with VACV in the order and spatial distribution of genes, although several differences do
exist in the terminal regions of the genomes. VACV has been completely sequenced;
consequently a detailed alignment of SPPV and VACV could be produced using twenty-six
genes predicted to be common to both viruses. Due to the collinearity of ORFV and VACV,
the alignment of SPPV with ORFV could be extrapolated from an alignment of SPPV with
VACV. Initially, SPPV was aligned with the Tian Tian strain of VACV, however since then,
mistakes in the annotation of the Tian Tian genome have been noted (communication C
Upton, XlVth International Poxvirus and Iridovirus Workshop, 2002). These mistakes
concern the incorrect annotation of methionine and termination codons of a small number of
ORFs. However, as no mistakes are apparent with the VACV ORFs that correspond with
those identified in SPPV and it is the location of homologous points within a gene that
concerns us here, the Tian Tian genome was deemed sufficiently accurate for the purpose of
genome alignment with SPPV.
Due to the extensive protein homology between SPPV and MOCV (section 5.3.2) and as
MOCV belongs to the only G+C rich genus other than the parapoxvirus genus; an alignment
with MOCV was performed to assess the relatedness of SPPV with the molluscipoxviruses.
MOCV has been completely sequenced, therefore a detailed alignment using twenty-seven
genes predicted to be common to both viruses could be produced.
SPPV was aligned with ORFV, VACV and MOCV using the locations of genes predicted to
be common to both genomes in the alignment as points of homology. As MOCV and VACV
have been completely sequenced and the coding segments (CDS) of each ORF identified, it
was possible to calculate the location in the MOCV or VACV genomes that corresponded
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with SPPV co-ordinate by examining the FastA protein alignments of SPPV with MOCV
and VACV.
The alignment of SPPV with the ORFV genome was more difficult because often the
sequence obtained from SPPV and the sequence published for the corresponding ORFV
genes did not overlap as the sequences are derived from different regions of the same genes.
In this situation the homologous location in ORFV corresponding to a SPPV co-ordinate had
to be estimated; this was achieved by extrapolating the alignment of the SPPV and ORFV
protein via alignment with protein from a third poxvirus.
Once all the homologous co-ordinates in the ORFV, VACV and MOCV genomes were
calculated or estimated, SPPV was manually aligned with each genome to allow visual
comparison of organisation and spacing of genes (figure 5.7). In addition, the distance
between a number of conserved poxvirus genes identified in SPPV, ORFV, MOCV and
VACV were calculated and compared (table 5.3).
The ORFs in SPPV predicted to encode poxvirus proteins are identical in order to the
homologues found in ORFV, VACV and MOCV. Therefore SPPV is highly collinear to
other poxviruses in the order of genes that have been identified so far. However, the spatial
distribution of genes is different in SPPV when compared with ORFV, MOCV and VACV.
By visual comparison of the genome alignments (figure 5.7), the intervals between the
corresponding genes in MOCV are greater than in SPPV. In contrast the distances between
the corresponding genes in VACV and ORFV are smaller than in SPPV. The intervals
between the nine genes homologues identified in SPPV, ORFV, MOCV and VACV
demonstrate this spacing difference (table 5.3).
The size of the intervals between genes in MOCV, VACV and ORFV that most closely
resemble those calculated in SPPV are highlighted in grey in table 5.3. The interval between
VACV genes A27L and A29L and the homologues in ORFV are identical to those found in
SPPV. However, the intervals between four pairs of genes in VACV are more like those
calculated for SPPV than ORFV or MOCV. In comparison the intervals between two pairs of
genes in ORFV and the interval between one pair of genes in MOCV are most like SPPV.
Therefore from this data it appears that the organisation of genes in SPPV is more consistent


















































































































































































Table5.3Summaryofthdistanc sbe we nhomologousgenitPPV,ORF(NZ2)VACTiaTi )dMO( u type2g nomes.hd ts ded greyindicat dthtervalsbetweengennORFV,VACaMOt trclos tin valSPP . 212
The notable difference in distribution of genes is the interval between homologues of the VACV
genes A24R and A27L. In SPPV the distance is 12. lkb, in ORFV, VACV and MOCV this
distance is much smaller at 6.0kb, 4.7kb and 7.5kb respectively. Sequence was obtained from the
SPPV genome from two locations situated between the homologues of A24R and A27L. FastA
analysis of the nucleotide sequence and putative translated ORFs failed to reveal homology with
previously described poxvirus genes.
5.6 DISCUSSION
Homologues of the VACV genes extending from F9L to A34R are generally found in all
poxviruses and represent the conserved central core and is likely contains to the minimal gene
complement required for viral replication (Gubser and Smith, 2002). The region of the SPPV
genome extending from 17kb to 133kb hybridised with the central region of ORFV,
demonstrating a genetic relationship between the central regions of the two poxviruses (figure
5.2). The establishment of a genetic map of SPPV revealed that the cross-hybridisation regions
of ORFV and SPPV contain homologues of the VACV genes extending from F13L to A32L.
Therefore cross-hybridisation data corresponds extremely well with the region representing the
conserved central core of genes. Many of the twenty-six genes located within the central region
of the SPPV genome are predicted to be essential for the replication of poxviruses as they
encode for proteins involved in viral transcription and DNA replication (table 5.2). The
sequences derived from within the central region of SPPV genome shares greater than 60%
homology at the DNA level with the G+C rich poxviruses MOCV or ORFV, which would
account for the hybridisation of this region with ORFV. The general organisation of the central
region of SPPV (17kb to 133kb) was predicted to be collinear with ORFV based upon the
identical order which the ORFV probes and SPPV Kpn I fragments hybridised. The order and
orientation of the twenty-six genes located in the central core of the genome were identical to the
homologues described in all characterised poxviruses except FPV, which has undergone
rearrangement of the central regions (Afonso et al., 2000). Therefore SPPV is collinear with
most other poxviruses.
The spacing of genes in SPPV is more similar to the spacing of genes in ORFV and VACV,
although considerable differences do exist. VACV and ORFV have previously been described as
being highly coliinear, although minor differences in the spacing of genes do exist (Mercer et al.,
1995). From the data (table 5.3), it appears that the spacing of genes in SPPV is more like that
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found in VACV than ORFV. However, due to the limited amount of ORFV sequence data only a
total of nine homologous points between ORFV and SPPV could be established and therefore it
is not possible to determine, with certainty, if SPPV is more consistent with VACV or ORFV in
genome organisation.
Towards the ends of the central core in SPPV the gene content and organisation is less conserved
than in the centre, when compared with other poxviruses. For example, at the left end of the
conserved central core of SPPV a homologue of the MOCV unique gene 026L was identified
(Senkevich et al., 1997). One major difference in the organisation of genes located towards the
right end of the SPPV central core is the distance between the homologues of the VACV genes
A24L and A27L. Here the distance is much larger in SPPV than in ORFV, VACV or MOCV.
Sequence derived from two locations situated between A24L and A27L did not match with any
known poxvirus DNA or protein sequence deposited in the databases. The closest DNA
homologies of this G+C rich region were with rodent sequence (EMBL accession numbers
AF292401 and AC013622). This indicates that approximately 7kb of DNA, possibly host in
origin, may have been incorporated into the SPPV genome during in the evolution of this virus.
Towards the termini several sequences also gave the closest FastA matches with rodent DNA.
Homologues of cellular genes are found in all poxviruses characterised to date and many of
these genes confer an advantage to the virus in vivo by interfering with the host immune
response (Bugert and Darai, 2000). The transfer mechanism of host genes to poxvirus genomes
is unclear. However, VACV DNA ligase has been shown to efficiently ligate the 3'-hydroxyl
group of RNA with the 5'-phosphate group of DNA, hence providing a possible route in which
cellular mRNA could be incorporated into poxvirus genomes (Sekiguchi and Shuman, 1997).
The direct incorporation of RNA based genetic information into poxvirus genomes may also
explain the absence of host derived introns within poxvirus genomes.
The terminal regions of parapoxvirus genomes only cross-hybridise in a species-specific manner
(Gassmann et al., 1985). Therefore it is not surprising that ORFV did not hybridise with lOkb at
the left end and 25kb at the right end of the SPPV genome, suggesting that the ends of the two
genomes diverge at the DNA level.
Analysis of sequences obtained from the terminal (non-hybridising) regions of SPPV failed to
match with known poxviruses sequences, except for sequence corresponding to the VACV gene
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A37R and MOCV 157R. MOCV 157R is not present in ORFV in a comparable location (Rziha
et al., 2003) and therefore will not result in cross-hybridisation between SPPV and ORFV.
Homologues of the A37R are not well conserved at the protein or nucleotide level across the
poxvirus genera. The lack of hybridisation of the SPPV restriction fragment containing A37R
(Kpn I fragment F) with ORFV suggests that the genes expected to be located within this
fragment (homologues of VACV A33R to A37R) are divergent from ORFV at the DNA level.
The rarity of identifiable homologues of poxvirus genes located at the ends of the SPPV genome
indicates that the terminal regions may be mostly unique to SPPV. Further analysis of the
terminal regions may result in the identification of genes associated with host range or immune
modulation, knowledge that is essential for future production of a vaccine.
DNA hybridisation suggests that the lOkb to 17kb region of the SPPV genome consists of DNA
sequence that is homologous to the right end of ORFV genome (spanned by probe 1) (section
5.4.1). Several genes have been identified in ORFV from the probe 1 region, including
homologues of the VACV F9L and F10L (Rziha et al., 2003). Sequence analysis of several
parapoxvirus species has revealed that F9L and F10L are translocated to the right-end of the
genome close to the ITR junction, with respect to other poxviruses (Mercer et al., 1995; Rziha et
al., 2003; Ueda et al., 2003). The hybridisation of ORFV DNA containing the F9L and F10L
homologues with the left end of the SPPV genome may suggest that the translocation event,
which is common to all parapoxviruses characterised to date, may not have occurred in SPPV.
Therefore it is probable that F9L and F10L homologues in SPPV may be found at the left end of
the genome within Kpn I fragment I. However mapping the location of these genes in SPPV
using DNA sequencing or hybridisation is required to confirm this.
In summary, the genome of SPPV consists of a central core region containing conserved genes
essential for virus replication, which is flanked by non-conserved terminal regions. These
terminal regions may encode for SPPV-specific genes that were acquired from the host during in
co-evolution. Hence, the organisation of SPPV is consistent with other poxvirus genomes
(Gubser and Smith, 2002). Hybridisation studies using DNA templates of specific ORFV genes
and phylogenetic analysis was performed in order to further characterise the relationship of
SPPV with ORFV and to possibly identify genes associated with immune modulation that are
common to both viruses. This is discussed in chapter 6.0.
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CHAPTER 6.0
GENES ASSOCIATED WITH IMMUNO-
MODULATION OR VIRUS VIRULENCE AND
TRANSCRIPTION CONTROL SIGNALS PRESENT
IN THE GENOME OF SPPV
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6.1 INTRODUCTION
Random sequencing of SPPV enabled a preliminary genetic map to be determined, however only
nine of the SPPV genes matched published ORFV genes (section 5.3.1). Therefore comparison
of the genomic organisation of the two genomes was limited. Characterisation of the ORFV
genome is ongoing in the laboratory where this study was performed. A preliminary map of the
early genes of ORFV (strain orf-11) has been produced and cDNAs encoding ORFV early genes
isolated (C Mclnnes personal communication). A series of DNA hybridisations, using several
cloned ORFV early genes as probes, were performed in order to investigate the presence of
homologous sequences in the SPPV genome and clarify the organisational relationship between
SPPV and ORFV. The presence of four genes in SPPV encoding for: a homologue of
interleukin-10 (IL-10), homologue of vascular endothelial growth factor (VEGF-E), the
interferon resistance protein (E3L) and the granulocyte macrophage colony stimulating
factor/interleukin-2 inhibitory factor (GIF), was investigated in the first instance using
hybridisation.
Three of these genes, IL-10, GIF and E3L are implicated in modulation of the host immune
response (Haig et al., 1998; Deane et al., 2000; Fleming et al., 2000; Haig et al., 2002). The
fourth gene (VEGF-E) is believed to enhance virulence by stimulating epidermal proliferation
and increasing cellular permeability, thereby increasing the number of target cells available for
ORFV infection and attributing to scab formation (Savory et al., 2000). To date, GIF and VEGF
genes have only been identified in parapoxviruses (Lyttle et al., 1994; Deane et al., 2000;
Mercer et al., 2002; Buttner and Rziha, 2002; Rziha et al., 2003; Ueda et al., 2003), whilst the
E3L gene is a highly conserved in most poxviruses sequenced to date, except for MOCV and
FPV (Senkevich et al., 1997; Afonso et al., 2000). Recently a homologue of the IL-10 gene was
also identified in the capripoxvirus LSDV (Tulman et al., 2001).
It was hypothesised that SPPV was likely to possess a homologue of the ORFV VEGF-E, due to
the superficial similarities between SPPV and ORFV dermal lesion pathology. Erythmatous
response and extensive scab production are a general feature of both diseases and the lesions are
often haemorrhagic in nature (Edwards, 1962; Keymer, 1983; Reid, 1991; Sainsbury and
Gurnell, 1995; Sainsbury and Ward, 1996; Buttner and Rziha, 2002). The haemorrhaging
associated with SPPV lesions would suggest an underlying vascularisation, however
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histopathological examination of SPPV-induced lesions have not been performed to confirm
this.
DNA sequencing was also employed to investigate whether homologues of the VACV E3L and
the ORFV VEGF-E genes are present in the SPPV genome. The characterisation of the SPPV
genome structure (chapter 4.0) and the construction of a genetic map (section 5.4) enabled
targeted sequencing of the regions of the SPPV genome that may contain homologues of these
genes. However, the probable locations of the homologues of the ORFV genes IL-10 and GIF in
the SPPV genome could not be sufficiently determined to enable targeted sequencing. This was
due to insufficient data concerning the regions flanking the ORFV genes IL-10 and GIF and the
corresponding regions in SPPV at the time this study was performed.
Sequence located upstream of putative translation initiation (ATG) and downstream of putative
termination (TAG, TAA, TGA) codons that were identified during random or targeted
sequencing was assessed for poxvirus-like promoter and termination signals. The identification
of transcription control elements is a positive indicator of the likelihood that the ORFs identified
encode genuine genes.
Phase-specific transcriptional control sequences have been extensively characterised in VACV.
Analysis of VACV promoters revealed that both early and intermediate gene promoters are
organised into three functional regions; a transcription initiator, the promoter core and a spacer
region (Davison and Moss, 1989a; Baldick et al., 1992) (figure 6.1). Although the two promoters
are similar in organisation and have comparable A+T contents, several differences do exist.
Mutational analysis of the core regions of early and intermediate promoters has revealed that
several conserved nucleotides are essential for strong promoter function. The sequence of the
VACV late promoter is quite different from early and intermediate promoters and consists of the
conserved initiator sequence TAAAT (figure 6.1), which is often preceded by an A+T-rich track
approximately 20nt in length (Davison and Moss, 1989b).
Early gene transcription ceases approximately 50nt downstream of a conserved TTTTTNT
signal (Yuen and Moss, 1987). No termination signals have been identified for intermediate and
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late transcription, which would explain the heterogeneous lengths of intermediate and late
transcripts (Weir and Moss, 1984; Baldick and Moss, 1993).
The A+T-rich transcription control sequences of VACV are remarkably well conserved in the
G+C rich genomes of parapox and molluscipox viruses (Mercer et al., 1989; Fraser et al., 1990;
Naase et al., 1991; Blake et al., 1991; Fleming et al., 1991; Sullivan et al., 1994; Sullivan et al.,
1995b; Sullivan et al., 1995a; Mercer et al., 1996b; Senkevich et al., 1997). Therefore it was
hypothesised that similar sequences would also be found in SPPV. Hence putative SPPV
promoter sequences located up stream of several putative ORFs were identified and compared
with those preceding comparable MOCV and VACV genes. The relevance of putative SPPV










































Figure 6.1 Schematic representation of the VACV early, intermediate and late promoters
adapted from Davison and Moss (1989a and 1989b) and Baldick et al., (1992).
Transcription occurs with a purine (G or A) located within the initiator element of the early
promoter and within the AAA initiator sequence for intermediate and late promoters. An
11 nt A+T rich spacer region separates the A-rich conserved cores of early and intermediate
promoters from the initiators. In late promoters the spacer is only 6nt and does not have any
sequence requirement. The nucleotides essential for strong promoter function are
highlighted in black.
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6.2 HYBRIDISATION OF SPPV WITH ORFV GENES
Cloned DNAs (cDNAs) encoding for ORFV homologues of the VACV genes: E3L, I3L, G2R,
L2R, J4R, H5R, A8R, A33R and the ORFV genes IL-10, VEGF-E and GIF (table 6.1 for a
summary of the gene functions) were excised from their plasmid vector and radio-labelled with
32
|a- P] dCTP using the random prime method outlined in section 2.4.5.2.1.
SPPV cosmid clones 5, 9, 28, 51 and 86, which span the SPPV genome (section 4.6) and ORFV
genomic DNA (strain orf-11) were digested with Kpn I. 1.5pg of each digested DNA sample
was electrophoresed on a 0.6% (w/v) agarose gel (figure 6.2). The gel was depurinated,
denatured, neutralised and the DNA transferred to nylon membrane using the Southern blotting
procedure (section 2.4.5.3.1).
Membranes were incubated at 60°C with the [a-32P] dCTP-labelled ORFV cDNAs for
approximately 16 hours. The hybridised membranes were sequentially washed with increasing
stringency until a positive hybridisation signal could be visualised with minimal background
hybridisation (section 2.4.5.5) and the resulting autoradiographs can be seen in figure 6.3.
A homologue of the VACV gene J4R, which encodes for the RNA polymerase subunit RP022,
was previously identified in SPPV by sequencing (section 5.3.1). Hence cDNA encoding for the
ORFV homologue of the VACV gene J4R was used as a control probe to verify that homologues
of the ORFV genes could be detected in SPPV with the hybridisation conditions used.
Hybridisation of SPPV Kpn I digested cloned DNA with labelled J4R ORFV cDNA and
subsequent washing at high stringency resulted in the detection of the SPPV J4R homologue
(figure 6.3). However, the hybridisation signal of ORFV J4R with SPPV is much weaker when
compared with the control ORFV DNA, suggesting underlying sequence divergence at the
nucleotide level. The hybridised SPPV fragment is situated within cosmid clone 5 and




Genes conserved in several poxviruses:
E3L1 dsRNA binding, PKR inhibitor, IFNy resistance Davies et at., 1993.
I3L1 ssDNA-binding protein, interacts with R2 subunit Rochester and Traktman,
of ribonucleotide reductase. 1998.
G2R1 Late transcription elongation factor Condit et a/., 1996.
L2R1 unknown
J4R1 RNA polymerase subunit RP022 Broyles and Moss, 1986.
H5R1 Late transcription factor VLTF-4 Kovacs and Moss, 1996.
A8R1 Intermediate transcription factor VTLF-3 Sanz and Moss, 1999.
A33R1 EEV glycoprotein, promotes cell to cell spread Roper et at., 1996 and 1998.
IL-102 Functional homologue of IL-10 Fleming et at., 1997; Tulman
etal., 2001.
Genes unique to oaraooxviruses:
VEGF-E2 Functional homologue of VEGF Lyttle et at., 1994.
GIF2 IL-2 and GM-CSF inhibitor Deane et at., 2000.
Table 6.1 Summary of the gene function and level of conservation within the poxvirus family of
the ORFV cDNA used to probe SPPV DNA.
1
The ORFV cDNAs are referred to by the VACV homologue nomenclature,
2















Figure 6.2 SSPV DNA cosmid clones 86, 51, 5, 9 and 28 and ORFV strain orf-11 DNA, digested
with Kpn I and electrophoresed on a 0.6% (w/v) agarose gel. The DNA bands were visualised by
Ethidium bromide staining and illumination under UV light.
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Figure 6.3
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Figure 6.3 Southern blots of Kpn I digested SPPV cosmid clones and Kpn I digested ORFV
DNA (strain orf-11) (depicted in figure 6.2) hybridised with several [a-32P] dCTP-labelled ORFV
cDNAs. All hybridisations were performed at 60°C for 16 hours and the hybridised membranes
sequentially washed twice for 30 minutes each using low stringency conditions
(2XSSC/0.1%SDS at room temperature), medium stringency conditions (2XSSC/0.1%SDS at
60°C) or high stringency conditions (0.2XSSC/0.1%SDS at 60°C). The membranes were then
exposed to medical X-ray film for 30 minutes and the developed using a compact X2 automated
film processor (X-Ograph imaging systems). Autoradiographs were scanned and digitised using
scanner and Image Master LabScan v3.01 software (Amersham Pharmacia Biotech).
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Homologues of the VACV genes H5R, I3L and A8R were also clearly detected in SPPV by
hybridisation with ORFV cDNAs (figure 6.3). The intensity of the hybridised Kpn I fragments
was sufficient to be able to clearly distinguish between hybridised fragments and background at
medium stringency. The ORFV cDNA H5R probe hybridised with SPPV Kpn I fragment E
(located within cosmid clone 5 and 8.4kb in size), probe I3L hybridised with Kpn I fragment A
(located within cosmid clone 51 and 17kb in size) and probe A8R hybridised with Kpn I
fragment Q (located within cosmid clone 51 and 5.05kb in size). The mapped locations of
homologues of H5R, I3L and A8R correspond well with their predicted locations extrapolated
from the genetic map of SPPV (section 5.4 and figure 5.2) and are comparable to the locations
found in other poxvirus genomes.
Hybridisation of SPPV DNA with the ORFV cDNA probes G2R and L2R resulted in non¬
specific hybridisation, which could not be eliminated with stringent washing. Though Kpn I
fragment L appeared to hybridise more intensely with ORFV L2R, it is likely to be non-specific
hybridisation as the putative location of L2R within Kpn I fragment L does not correspond with
the location in any of the characterised poxviruses. Hybridisation of SPPV DNA with the ORFV
cDNA probe A33R did not produce a visible signal. The absence of a clear hybridisation signal
with the ORFV probes G2R, L2R and A33R would indicate these genes are absent in SPPV,
however homologues of these three gene have been identified in all poxviruses sequenced to
date, except FPV, which lacks L2R and A33R (Afonso et al.t 2000). Therefore homologues of
L2R, G2R and A33R were thought likely to be present in the SPPV genome, but they may not be
sufficiently conserved with the corresponding ORFV genes at the nucleotide level to be detected
by DNA hybridisation.
Hybridisation of cloned SPPV DNA with ORFV cDNA probes E3L, GIF, VEGF-E and IL-10,
with washes performed at medium stringency, did not produce any intense hybridisation signals,
except with the control ORFV DNA. When the membranes were washed at low stringency,
heavy background hybridisation was visible on all four blots. However, four SPPV Kpn I
fragments, located within cosmid clones 51 and 86, hybridised more intensely with the GIF
probe at low stringency than other fragments. The four fragments correspond to the Kpn I
fragments, A, L, O and I. These Kpn I fragments are not adjacent and therefore the hybridisation
seen is unlikely to be the result of a GIF homologue overlapping one or more of the SPPV Kpn I
fragments. Furthermore, the GIF gene is located near the right end of the genome in ORFV
(Deane et al., 2000; Buttner and Rziha, 2002) and the cosmid clones 51 and 86 are derived from
the left end of the SPPV genome. These observations suggest that the SPPV DNA fragments that
seemingly hybridise with the GIF probe are likely to represent non-specific hybridisation.
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6.3 TARGETED SEQUENCING
In the absence of clear hybridisation signals between SPPV genomic DNA and ORFV cDNA
encoding VEGF-E and E3L, regions of the SPPV genome were sequenced in order to investigate
the presence or absence of these genes.
6.3.1 Sequencing the region predicted to contain a homologue of the ORFV
vascular endothelial growth factor (VEGF-E)
In parapoxviruses the VEGF-E genes are located close to the right ITR (Lyttle et al., 1994;
Rziha et al., 2003; Ueda et al., 2003). Therefore DNA sequence was obtained from the
comparable region in SPPV and analysed for the presence of a homologue of the ORFV VEGF-
E gene. Overlapping sequences were obtained from the cloned restriction fragments Bam HI W
and Not I L by sequencing the ends of the cloned fragments or with specifically designed
oligonucleotide primers. The contiguous sequence extends leftwards from the right-ITR junction
for 1050bp (figure 6.4) and spans the region comparable to ORFV that contains the VEGF-E
gene.
FastA analysis was performed with the nucleotide sequence, but no homologous poxvirus DNA
sequence was detected. Likewise, no VEGF protein was detected with any of the translated
putative ORFs. However, one ORF (designated SP 155.0R1) aligned with two related MOCV
proteins MOCV 003L and MOCV 157R (Senkevich et al., 1997). SP 155.0R' exhibited 29.9%
and 27.5% identity at the amino acid level with MOCV proteins 003L and 157R respectively.
Although the location of the termination codon for SP 155.OR1, MOCV 003L and MOCV 157R
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Figure 6.4 DNA sequence derived from the unique region situated immediately out-with ITR at
the right end of the SPPV genome presented in the same orientation as the SPPV genome (5'
to 3'). The right ITR junction is indicated in the figure and is located at nucleotide position 1050
on the sequence presented. The predicted amino acid sequence of the putative ORF SP
155.OR* is presented below the DNA sequence.
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6.3.2 Sequencing the region predicted to contain homologues of the ORFV
interferon (IFN) resistance and RNA polymerase subunit RPO 030 genes
The homologue of the VACV RNA polymerase subunit RPO 030 gene (E4L) was identified by
sequencing the left end of Not I fragment I (section 5.3.2), however the sequence did not contain
either the E4L initiation or termination codons. In most poxviruses a homologue of VACV gene
E3L is located immediately downstream of E4L. Therefore it was important to establish the
location of the E4L termination codon so that the region downstream of the E4L homologue
could be analysed to determine if a homologue of E3L is present within the SPPV genome in a
location comparable to other poxviruses.
The Not I fragment located left of fragment I was predicted to contain the termination codon of
E4L. In order to identify the termination codon and obtain DNA sequence from the region of the
genome to the left of the E4L homologue, the Not I fragment H' was completely sequenced
using vector-specific T3 and T7 primers. In addition, the left end sequencing of Not I fragment I
was repeated using the T7 primer and extended further by sequencing Not I fragment I using
oligonucleotide primer (E4L-1) in order to identify the initiation codon of E4L. Additional DNA
sequences were also obtained by sequencing the overlapping Bam HI fragment H using the
oligonucleotide primers, E4L-2 and E4L-3 (figure 6.5 for schematic representation of the
sequenced regions of Not I fragments I and H' and the Bam HI fragment H). Using the
overlapping sequences, a 1.6kb contiguous sequence was obtained and is presented in figure 6.6.
Putative ORFs were identified using the analysis software DNASTAR MapDraw v5.00
(DNASTAR Inc.). The translated putative ORFs were compared to protein sequences deposited
in the SWALL library using the FastA algorithm to identify homologous sequences (section
2.4.8.2). Two ORFs, designated SP 30.72Lm and SP 29.55Lm exhibited identity with previously
characterised poxvirus proteins. ORF SP 30.72Lm corresponded with homologues of the VACV
gene E4L and is discussed further in section 6.3.2.1. ORF SP 29.55Lm exhibited limited identity
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LEE 1 NYEVGKRLCK I GFLAYRL I DKEVGST 1170
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GACACGGCATTATTCTCGGACATAGCGCGCATATCCAATCCTACAATTTCGGAATTAGACGAGGCGCGCGCCCCCGAGCTCCGGTGCGCC




Figure 6.6 Contiguous nucleotide sequence of the region spanning Not I fragment H' and the left
end of Not I fragment I (see figure 6.5) presented in the same orientation as the SPPV genome (5'
to 3'). The predicted amino acid sequences, which are encoded by the reverse complement DNA
strand (not shown), of the homologue of the VACV gene E4L (SP 30.72Lm) and putative ORF SP
29.55Lm are present below the DNA sequence. The potential initiating methionines are indicated
with the # symbols for each ORF. Putative early transcription control sequences are indicated by
the symbol + for the promoter core and the symbol * for the initiator and a putative late promoter
initiator is double underlined.
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6.3.2.1 SPPV homologue of the VACV gene E4L
FastA analysis of the putative ORF SP 30.72Lm revealed the closest matches were with poxvirus
homologues of the VACV E4L gene. The precise length of the putative protein cannot be
accurately determined from sequence data alone, because there are three possible initiating
methionine codons located in the N-terminal region of ORF SP 30.72Lm, at amino acid positions
1, 21 and 24 (indicated by # symbols in figure 6.6). However, FastA analysis of the predicted
amino acid sequence, which included the three putative initiating methionines, revealed that the
initiating methionines of all poxvirus E4L homologues aligned with the SPPV sequence between
amino acid position 11 to 33. This suggests that the methionine at position 1 is unlikely to be the
initiating methionine and the actual protein will be shorter at the N-terminus. Only the initiating
methionine of the MYXV homologue aligned with SPPV sequence at a location corresponding
with one of the three methionines, at amino acid 21. Therefore it is hypothesised that the
methionine at position 21 is the most likely to be the initiating methionine of the SPPV
homologue of E4L.
A termination codon (TGA) is located at nucleotide position 581 (figure 6.6). When the ORF is
translated, beginning with the methionine at position 21, the putative homologue of the E4L
protein is predicted to be 297 amino acids in length. This does not correspond in length with any
of the poxvirus E4L homologues characterised to date. To ensure that the location of the
termination codon at position 581 and the resulting length of the ORF are not due to sequencing
errors; this region was re-sequenced three times. The location of a termination codon at
nucleotide position 581 was confirmed, and therefore, the predicted length of the SPPV
homologue is likely to be genuine.
The SPPV homologue of E4L is 38 amino acids longer than the orthopoxvirus E4L genes, which
have a uniform length of 259 amino acids. Likewise, the SPPV homologue is longer than the
E4L genes characterised in capripox, leporipox, suipox, avipox and yatapox virus genera by 96,
75, 75, 115 and 108 amino acids respectively. Only the terminal 89 amino acid sequence of the
parapoxvirus ORFV E4L homologue is available (Mclnnes et cil., 1998). The FastA alignment of
the SPPV homologue with partial sequence ORFV homologue demonstrated that the C-terminus
of ORFV E4L aligned with the amino acid at position 200 in the SPPV sequence (figure 6.7).
This suggests that the ORFV E4L is truncated by approximately 97 amino acids at the C-
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terminus with respect to SPPV. In contrast, the corresponding MOCV gene is much longer than
the SPPV gene by approximately 147 amino acids.
FastA alignment of the SPPV E4L protein with other poxviruses revealed considerable identity
between the central regions of all poxvirus E4L homologues. However identity was only
maintained to the "FRD" motif located at amino acid positions 191 to 193 (figure 6.7). The E4L
proteins of ORFV, FPV, YLDV and the capripoxviruses terminated within 1 to 7 amino acids
after the FRD motif. The leporipox and orthopoxvirus E4L genes were longer but significant
gapping was required to align them with SPPV and identity was much reduced. In contrast,
identity from the FRD motif onwards is maintained with MOCV until the end of the SPPV
protein but is much reduced.
E4L plays an important role throughout infection and is likely to be expressed at more than one
transcriptional phase. The homologues of the E4L ORF in SFV, SWPV, MYXV and LSDV are
preceded by early promoter like elements (Wilier et al., 1999; Cameron et al., 1999; Tulman et
al., 2001; Afonso et al., 2002). However, the MOCV and MPV E4L homologues are preceded
by both early and late promoters (Senkevich et al., 1997; Shchelkunov et al., 2002). A deviation
of late promoter initiator (TAAAAT) shown to be functional in VACV by mutational analysis of
the TAAAT sequence (Davison and Moss, 1989b) was identified in the SPPV sequence
upstream of the putative methionine codons (indicated on figure 6.6). Furthermore,
approximately 6nt upstream of the TAAAAT sequence an A+T-rich region extends for 20nt.
However, no early or intermediate promoter elements corresponding with the VACV promoter
consensi could be identified. In addition, no termination signal was apparent downstream of the
SPPV E4L homologue. The absence of a termination signal is consistent with VACV and ORFV
(Broyles and Pennington, 1990; Mclnnes et al., 1998).
Therefore, in summary the E4L gene in SPPV is unique in terms of length. Minor sequence
heterogeneity at the N-terminus is apparent when compared with other poxviruses. The C-
terminus is however considerably different to other poxviruses with respect the length and
predicted amino acid sequence. In addition, the transcription promoter sequences preceding
other poxviruses E4L genes are not conserved in SPPV.
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SPPV with ORFV
150 160 170 180 190 200
SPPV: ILDEKYNPRCPSCRSKNTIPMMVQMRAADEPPTVRYTCRDCQKHFAPPRFRDRLDRRDED
ORFV: VLDEKFNLPCPSCQSKNTMPMMIQTRSADEPPLIKYACKNCQKSFNPPKFCEKKGKPKg
40 50 60 70 80
SPPV with SPV





180 190 200 210 220 230
SPPV: PPTVRYTCRDCQKHFAPPRFRDRLDRRDEDEDRAPRRKKKGAGDAEAAAAAVAPQDQYES
VACV: PPLVRHACRDCKQHFKPPKFRAF RNLNVTTQSIHENK EITEILP
180 190 200 210 220





180 190 200 210 220 230
SPPV: VRYTCRDCQKHFAPPRFRDRLDRRDEDEDRAPRRKKKGAGDAEAAAAAVAPQD-QYESED
MOCV: VRYVCKDCNKHFSPPKFRS—PRGGHAEPGPPEGVSRGTQGSHAPAGEGEPEHVARRPRT
190 200 210 220 230
240 250 260 270 280 290
SPPV: GASPEELPEDASPEPIDPDNLLEPEPWDPASPGSEPCDECPNCAEDENHAAENGLEDGF
MOCV: RAKERACKCEVESEKAETKAVAEAKEET-PVSEEAAQCLENAASAENVAHSDDEEFADDP
240 250 260 270 280 290
SPPV: EVD@
MOCV: GPVPVPEVLSADDAAAAAAVADALDNANDVTTGNADDEDASEKDADEDAEKDTDGDAEDN
300 310 320 330 340 350
Figure 6.7 FastA alignment of the terminal region of the SPPV E4L homologue with the E4L
homologues of ORFV, SPV, VACV and MOCV. Considerable homology between SPPV and
other poxvirus E4L homologues is apparent prior to the FRD motif (highlighted in grey). The
alignments degenerate after the FRD motif, which can be seen as the truncation of the aligned
sequence, extensive gapping or reduced homology. The C-terminal amino acids, when shown,
are highlighted in black.
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6.3.2.2 Putative ORF SP 29.55L"1
The putative ORF SP 29.55L'" was compared to amino acid sequences deposited in the SWALL
library databases. The only matches detected were with parapox and capripoxvirus homologues
of the VACV E3L. However identity was limited to the region of the SPPV sequence extending
from 29 to 75 amino acids (figure 6.8). Beyond amino acid 75, identity was not detected with
any poxvirus E3L sequence. The relevance of the homology or lack of with the different
domains of the E3L protein with respect to function is discussed further in section 6.5.
The sequence preceding the putative ORF SP 29.55Lm contains sequence corresponding to
VACV early promoters (indicated on figure 6.6). The sequence of the putative early promoter
compares favourably with the consensus sequence of the VACV early promoter (Davison and
Moss, 1989a). The putative coding region of ORF SP29.55L"1 cannot be precisely determined
because three possible methionine sites (indicated on figure 6.6) are located downstream of the
putative early promoter.
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10 20 30 40 50 60
SPPV: MSNRMPFQRPIMSGHGLHHKIIALMTSVPNDLGLTAAYIARCLGVTKRDINRQLYSMWEC
GPPV: MACECASLILELLRKSDDKLPAKQIAKELGISKHEANRQLYRMLEL
10 20 30 40
70 80 90 100 110 120
SPPV: GYVDCVRSTNPPKWFWTPALGTAIRNSGYRAGGAVHDWIATGEAAAADDAARGARAEAAA
GPPV: DDV-CCEDGNPPRWFVECAPSAPTEEDENSDTEPMETEAGCDTLFGGDIDIMTQSAVMRL
50 60 70 80 90 100
Figure 6.8 FastA alignment of the predicted amino acid sequence of SPPV ORF SP 29.55Lm
with the most significant match, the interferon resistance protein (homologue of VACV E3L) of
the parapoxvirus (GPPV), which causes proliferative dermatitis in goats. The percentage identity
of the two putative proteins is 47.8% over a 46 amino acid overlap.
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6.4 TRANSCRIPTION CONTROL SEQUENCES
When putative translation initiation (ATG) and termination (TAG, TAA, TGA) codons were
identified during DNA sequencing, the DNA sequence up or downstream of the putative genes
were examined for poxvirus-like promoter and termination signals. Examples of poxvirus-like
transcription promoters identified in SPPV and termination signals are presented in figures 6.9 to
6.13 and are discussed in the text that follows.
6.4.1 Early gene transcription control sequences
6.4.1.1 Early promoters
An example of a putative early promoter preceding the homologue of the MOCV 026L gene in
SPPV is presented in figure 6.9. The putative promoter core region of SPPV corresponds
extremely well with early promoter consensus sequences of VACV and MOCV (Davison and
Moss, 1989a; Senkevich et al., 1997). No specific transcriptional analysis has been performed on
the MOCV 026L gene. However, transcriptional analysis of several putative early genes of
parapox and molluscipox viruses has shown that VACV-like early promoters are functional in
G+C rich genomes (Fleming et al., 1991; Fleming et al., 1992; Fleming et al., 1993; Sullivan et
al., 1995b; Sullivan et al., 1995a; Mercer et al., 1996b; Bugert et al., 1999). This suggests that
the VACV-like early promoter sequences identified in SPPV may also be function in a manner
similar to other poxviruses.
6.4.1.2 Early termination signals
The sequence downstream of several putative SPPV genes were analysed in order to identify
putative early genes termination signals (TTTTTNT), which terminate transcription 20 to 118nt
downstream of the signal in VACV and G+C rich poxviruses (Yuen and Moss, 1987; Fleming et
al., 1991; Fleming et al., 1992; Mclnnes et al., 1998; Bugert et al., 1998; Bugert et al., 1999).
Only one T5NT signal was identified in SPPV, 22nt downstream of the putative stop codon of
the SPPV homologue of the VACV early gene A37R (figure 6.10).
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Figure 6.9 Example of an early putative gene promoter identified in SPPV preceding the
homologue of the putative MOCV gene 026L. The sequences of SPPV and MOCV immediately
preceding the gene are presented in a pileup format with gapping to allow alignment. Note the
sequences are presented as the complement and reverse of their actual situation within the
genomes. The putative initiating methionine codons (ATG) are underlined. The region predicted
to form the core region of the early promoter (-28 to -13) is highlighted in black. The spacer
element (-12 to -2) is highlighted in light grey with black text and the region predicted to contain
the transcription initiation element (-1 to +6) is highlighted in dark grey with white text.
A37R putative early termination signal








Figure 6.10 Example of a putative early gene transcription termination sequence found in SPPV.
120bp of DNA sequence located after the termination codon of the homologues of the VACV
A37R found in SPPV, MOCV and VACV are presented in a pileup format without alignment.
Putative early termination sequences are highlighted in black.
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6.4.2 Intermediate promoters
An example of a putative intermediate promoter identified in SPPV is presented in figure 6.11.
The promoter precedes the homologue of the A18R VACV gene, which encodes a transcription
cofactor (Simpson and Condit, 1995; Xiang et al., 1998; Lackner and Condit, 2000). The
sequence is highly conserved with MOCV, VACV and MYXV in all three regions of the
putative promoter. Although no transcriptional analysis of the intermediate genes have been
performed for any the G+C-rich poxviruses, the level of conservation of putative MOCV, SPPV
and ORFV putative promoters with VACV (Baldick et al., 1992; Senkevich et al., 1997; Deane
et al., 2000) would suggest that transcription occurs by the same mechanism as in VACV.
6.4.3 Late promoters
DNA sequence was obtained from the regions preceding several putative late genes in SPPV
(figure 6.12). In the case of the homologues of VACV A17L and A32L genes, late promoter
initiator sequences are present either in combination or upstream of the putative initiating
methionine codon. The VACV late gene initiator sequence (TAAAT) is also conserved in the
G+C-rich genomes of MOCV and ORFV (Naase et al., 1991; Klemperer et al., 1995; Senkevich
et al., 1997). No transcriptional analysis has been performed to determine the location of the 5'
end of mRNAs in MOCV; however transcription is initiated with an A-residue within the
TAAAT sequence in ORFV and VACV (Davison and Moss, 1989b; Fleming et al., 1993;
Sullivan et al., 1994). The long A+T-rich track preceding the TAAAT sequence are associated
with strong promoter activity in VACV (Davison and Moss, 1989b), these also appear to be
conserved in SPPV despite the overall high G+C composition of the SPPV genome.
6.4.4 Dual function promoters
Often, more than one promoter type is identified in the sequence preceding multiphase genes
that are therefore expressed throughout infection. An example of a multiphase gene is presented
in figure 6.13. Putative early, intermediate and late promoters have been identified preceding
homologues of the A18R genes in many poxviruses (Johnson et al., 1993; Massung et al., 1994;
Senkevich et al., 1997; Cameron et al., 1999; Wilier et al., 1999; Afonso et al., 2000; Tulman et
al., 2001; Lee et al., 2001; Afonso et al., 2002). In addition, A18R is reportedly transcribed and
functions throughout the replication cycle in VACV (Simpson and Condit, 1995; Xiang et al.,
1998; Lackner and Condit, 2000; Condit and Niles, 2002). A putative intermediate (section
6.4.2) and late promoter precede the SPPV homologue of the VACV gene A18R.
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Figure 6.11 Example of a putative intermediate promoter found in SPPV. The highly conserved
DNA sequence immediately preceding the ATG codons (underlined) of the homologues of the
VACV A18R in SPPV, MOCV and VACV are aligned using ClustalW. The region predicted to
form the core region of the promoter is highlighted in black. The spacer element is highlighted in
light grey with black text, and the initiator is highlighted in dark grey with white text.





A32L putative late promoter




Figure 6.12 Examples of homologues found in SPPV of the VACV genes A17L and A32L that
possess VACV-like late promoters. The sequences of SPPV MOCV and VACV immediately
preceding the genes are presented in a pileup format without alignment with the initiating codon
(ATG) on the right. Putative late promoters are highlighted in black and the A+T rich tracks
preceding the promoter are shaded in grey.
A18R putative intermediate/late promoter





Figure 6.13 Example of the homologue of VACV gene A18R identified in SPPV that possess a
VACV-like intermediate/late promoter. The DNA sequences of SPPV MOCV and VACV
immediately preceding the A18R gene are aligned using ClustalW with the initiating codon
(ATG) on the right. Putative late promoters are highlighted in black and the A+T rich tracks
preceding the promoter are shaded in grey. The core region of the putative intermediate
promoter is indicated with the symbol + and the initiator is indicated with the symbol *.
241
6.5 DISCUSSION
Hybridisation of SPPV DNA with several ORFV cDNAs resulted in the identification of
homologues of the VACV genes I3L, J4R, H5R and A8R. SPPV DNA did not hybridise with
ORFV cDNA encoding for VEGF-E, IL-10, GIF and the homologue of the VACV E3L gene,
suggesting that these genes are absent in SPPV. In addition, ORFV cDNAs encoding for G2R,
L2R and A33R also did not hybridise with SPPV DNA, even at low hybridisation stringency.
The three genes, G2R, L2R and A33R are conserved in all poxviruses sequenced to date, except
for FPV which lacks L2R and A33R (Afonso et al., 2000). Consequently it was predicted that
these genes would also be conserved in SPPV. This indicates that some SPPV and ORFV genes
may not be sufficiently conserved at the nucleotide level for hybridisation to occur, and therefore
cross-hybridisation, or lack of, cannot determine with certainty the presence or absence of
specific genes in the SPPV genome. Therefore a second approach was used involving DNA
sequencing to investigate the existence of homologues of defined ORFV genes in the SPPV
genome. The construction of a genetic map of SPPV (see section 5.4) and establishing the
locations of the ITR junctions (see section 4.5.2.1) enabled the regions of the SPPV genome
comparable to the regions of ORFV that contain the VEGF-E and E3L genes to be identified and
extensively sequenced.
Little is known about the immuno-modulator/virulence genes and their locations in parapoxvirus
genomes other than ORFV. As a consequence, it is unknown if a homologue of the VACV E3L
gene is conserved in all parapoxviruses. However, recent studies have confirmed that the VEGF
gene is present in PCPV in a location comparable to ORFV, but absent in BPSV (Rziha et al.,
2003; Ueda et al., 2003). A homologue of the ORFV IL-10 gene is situated in the BPSV genome
in a location conserved with ORFV (Fleming et al., 1997; Rziha et al., 2003). It is unknown if a
homologue of IL-10 is present in the PCPV genome, although a homologue of the GIF gene has
been identified in PCPV and BPSV (C. Mclnnes personal communication). These data suggest
that VEGF, GIF and EL-10 genes may be semi-conserved in parapoxvirus genomes. However the
hybridisation data suggests that all four ORFV genes are absent in SPPV.
DNA sequencing identified the termination codon of the E4L homologue in SPPV and the
region of the genome further downstream was sequenced in order to investigate if a homologue
of E3L was present. In all poxviruses sequence to date the initiation codons of the E3L
homologues are generally located within 66nt of the E4L termination codons (Johnson et al.,
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1993; Massung et al., 1994; Mclnnes et al., 1998; Senkevich et al., 1997; Cameron et al., 1999;
Wilier et al., 1999; Afonso et al., 2000; Tulman et al., 2001; Lee et al., 2001; Afonso et al.,
2002; Shchelkunov et al., 2002; Gubser and Smith, 2002). No comparable ORF was identified in
SPPV within 66nt of the termination codon of E4L. However a putative ORF (SP 29.55Lm) that
is preceded by early promoter-like sequence was identified 216nt downstream of the E4L
termination codon. FastA analysis of SP 29.55L"1 revealed amino acid homology with parapox
and capripox virus E3L homologues over the first 75 amino acids, but not beyond. The abrupt
cessation of identity at amino acid 75 strongly suggests that VACV E3L gene homologue is
disrupted in SPPV.
Characterisation of the VACV E3L protein has revealed that the N-terminal region is associated
with nuclear localisation of the protein (Chang et al., 1995a) and the C-terminal is essential for
dsRNA binding and the inhibition of the IFN-induced, dsRNA-dependent protein kinase
pathway (PKR) (Chang and Jacobs, 1993). Both the C and N-terminal regions of the VACV E3L
protein are required for full virus pathogenesis in the mouse model (Brandt and Jacobs, 2001).
The apparent lack of homology of the SP 29.55L"1 ORF with the C-terminal regions of poxvirus
homologues of the E3L gene strongly suggests that SP 29.55L"1 is not involved in PKR
inhibition (reviewed in section 1.6.1). ORF SP 29.55Lm may represent a disrupted and therefore
non-functional homologue of E3L or alternatively a gene unique to SPPV that may localise in
the nucleus of infected cells, but without the capability of binding dsRNA. The presence of early
promoter elements that are highly conserved with strong VACV early promoters suggests that
this putative gene is transcribed.
Characterisation of poxvirus genomes from all genera suggests that VEGF homologues are
unique to the parapoxvirus genus. Two distinct forms of the VEGF-E protein have been
identified, one in ORFV isolate NZ2 and one in ORFV isolate NZ7. The two forms exhibit only
41.1% amino acid identity to each other (Lyttle et al., 1994). In addition, extensive phylogenetic
analysis of VEGF-E genes sequenced from twenty-two ORFV strains and isolates supported the
existence of two distinct forms of VEGF-E but also revealed considerable heterogeneity in
sequence within VEGF-Es that group together phylogenetically (Mercer et al., 2002). The
genetic heterogeneity of VEGF-Es may explain the inability to identify a homologue of VEGF-E
in SPPV using hybridisation. However, sequence analysis of the SPPV genome near to the right
ITR junction also failed to identify a homologue of ORFV VEGF-E. Taken together these data
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indicate that SPPV does not possess a homologue of ORFV VEGF-E, which is surprising
considering the haemorrhagic pathology exhibited by SPPV lesions.
In the right terminal region of SPPV, instead of a VEGF-E gene, a homologue of the putative
MOCV proteins 003L and 157R was identified in the ORF designated SP155.0R". These two
MOCV are related to each other at the amino acid level. Each MOCV protein contains a putative
signal peptide, a transmembrane helix, and an immunoglobulin domain and may function as a
plasma membrane receptor with as yet unknown specificity (Senkevich et al., 1997). The
putative MOCV 157R and MOCV 003L proteins have not been identified in any other poxvirus.
Therefore the data published to date suggests this ORF is unique to SPPV and MOCV.
Transcriptional control sequences have been extensively characterised in the A+T-rich genome
of VACV and the promoter and termination signals are invariably A+T-rich (Yuen and Moss,
1987; Davison and Moss, 1989a; Davison and Moss, 1989b; Baldick et al., 1992). Despite the
disparity in G+C content, the VACV A+T-rich transcriptional control sequences are also
extremely well conserved SPPV. This is consistent with the conservation of VACV
transcriptional control sequences in the other G+C rich genomes of parapox and mollusci
poxviruses (Mercer et al., 1989; Fraser et al., 1990; Naase et al., 1991; Fleming et al., 1991;
Fleming et al., 1992; Fleming et al., 1993; Sullivan et al., 1994; Sullivan et al., 1995b; Sullivan
et al., 1995a; Mercer et al., 1996b; Senkevich et al., 1997; Deane et al., 2000). Remarkably, the
conserved nature of the transcriptional control sequences is reflected in the ability of poxviruses,
which are divergent in overall G+C content, to transcribe genes in a cross-species manner. For
example, VACV extracts are able transcribe an ORFV early gene in vitro (Vos et al., 1992).
Likewise, Fleming et al., (1992) reported that a recombinant VACV containing three ORFV
early genes produced transcripts of a length comparable to ORFV; and the sites of transcription
initiation were highly conserved in the recombinant VACV and the native ORFV. However
quantitative differences in transcripts were noted and Fleming et al., (1992) postulated that
generically different transcription factors have specific promoter sequence requirement for
optimal transcription. Therefore it is a reasonable assumption considering the high degree of
homology shown between SPPV, MOCV and VACV transcription control signals that the
mechanism of transcription in SPPV and the associated factors will be relatively well conserved
with other poxviruses, despite differences in overall G+C content.
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The data presented in chapters 4.0 to 6.0 has described several differences between SPPV and
other parapoxviruses, including genome size, restriction profiles, genetic organisation and the
apparent absence of all parapoxvirus-specific immuno-modulating/virulence genes in the SPPV
genome. The lack of a homologue of VACV E3L gene is also surprising considering that all
poxviruses completely sequenced to date possess this gene, except for MOCV and FPV
(Senkevich et al., 1997; Afonso et al., 2000). The existence of two putative MOCV specific-
genes in SPPV, one of which is located within the species-specific terminal regions, suggests
that SPPV may not be so closely related to the parapoxviruses as initial morphological
observation suggest. Therefore in chapter 7.0 the investigations undertaken pertaining to the
phylogenetic relationships of SPPV are discussed.
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CHAPTER 7.0
PHYLOGENETIC ANALYSIS OF SPPV
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7.1 INTRODUCTION
Several differences exist between SPPV and the other parapoxviruses (discussed in section 6.5).
Taken together they suggest that the classification of SPPV as a parapoxvirus may be incorrect.
Therefore to clarify this issue, phylogenetic analysis was performed on two genes, homologues
of VACV genes F13L and E4L, which are conserved across all members of the poxvirus family.
The VACV F13L gene encodes the 37KDa major membrane protein, which is absent in
intracellular mature virus (IMV), but is abundant in the additional membranes of intracellular
and extracellular enveloped virus (LEV and EEV) (Payne, 1978; Hirt et al., 1986; Goebel et al.,
1990). F13L localises in the membranes of the trans-golgi network and is believed to facilitate
the wrapping of IMV in the additional membranes possibly by the direct interaction with an
unidentified protein(s) on the surface of IMV (Blasco and Moss, 1991; Grosenbach and Hruby,
1998; Sanderson et al., 2000).
Most published parapoxvirus sequences are derived from ORFV, however the homologue of
VACV F13L has been partially sequence in several accepted and tentative parapoxvirus species.
The F13L gene was initially sequenced in ORFV (Sullivan et al., 1994). Inoshima et al., (2000)
developed a diagnostic polymerase chain reaction (PCR) assay for the detection of parapoxvirus
using oligonucleotide primers designed from the sequence of the ORFV F13L gene. The pan-
parapoxvirus primers (PPP-1 and PPP-4) were shown to be capable of amplifying a 600bp
region of the F13L genes in ORFV, BPSV, PCPV, PVNZ and several parapoxvirus isolates from
cattle, sheep, Japanese serows, reindeer (reindeerPPV) and seals (sealPPV), but not from VACV
or FPV (Inoshima et al., 2000; Tryland et al., 2001; Inoshima et al., 2001; Becher et al., 2002).
Phylogenetic analysis with the F13L gene has recently been performed to infer speciation within
the parapoxvirus genus (Inoshima et al., 2001), and to provide evidence supporting the inclusion
of sealPPV and reindeerPPV as separate species belonging within the parapoxvirus genus
(Becher et al., 2002; M. Tikkenan personal communication). Due to the availability of F13L
sequences derived from several parapoxvirus species, the F13L gene was specifically chosen for
phylogenetic analysis. As the pan-parapoxvirus primers have successfully been used to amplify
the F13L homologues of all parapoxviruses tested so far, it was predicted that the PCR approach
would also be successful in amplifying the SPPV homologue (section 7.2).
247
The evolutionary relationships of eucaryotic viruses have been previously investigated using
phylogenetic analysis of DNA-dependent RNA polymerase subunits (Sonntag and Darai, 1996).
Several RNA polymerase subunit genes have been partially sequenced in SPPV (section 5.3.1,
table 5.2), and the SPPV homologue of the RNA polymerase subunit RPO 030 (homologue of
the VACV E4L gene) was completely sequenced (section 6.3.2.1). Complete E4L gene
sequences have been published for at least one representative member from each genus, except
the parapoxvirus genus. Only a partial E4L sequence has been published for ORFV (Mercer et
al., 1995). However the complete E4L gene sequence of the ORFV isolate MRI has recently
been determined in the laboratory where this study was performed (C. Mclnnes personal
communication); enabling phylogenetic analysis to be performed using complete E4L gene
sequences of at least one species from each genus.
The VACV E4L gene encodes the DNA-dependent RNA polymerase subunit predicted to have a
molecular mass of 30KDa and exhibits structural similarity with the eucaryotic transcription
elongation factor TFIIS (Ahn et al., 1990). The homology with TFIIS suggests that E4L may
play a role in transcription elongation. E4L also has an additional role as an intermediate
transcription factor (VACV intermediate transcription factor, VITF-1) (Rosales et al., 1994a),
however the precise function of E4L in intermediate transcription has yet to be determined.
7.2 IDENTIFICATION AND SEQUENCING OF THE GENE ENCODING THE
MAJOR EEV MEMBRANE PROTEIN (F13L)
7.2.1 Amplification of F13L by polymerase chain reaction
A homologue of the VACV F15L gene was identified during DNA sequencing of the right end
of the SPPV Not I fragment K (section 5.3). Because of the size of the Not I K fragment, it was
hypothesised that it would also contain a homologue of the VACV F13L gene. Amplification of
the SPPV F13L by PCR was attempted using the oligonucleotide primers PPP-1 and PPP-4
[PPP-1 (5'-GTC GTC CAC GAT GAG CAG CT-3') and PPP-4 (5'-TAC GTG GGA AGC GCC
TCG CT-3') (Inoshima et al., 2000)] using the cloned SPPV restriction fragment Not I K as
template DNA and ORFV NZ2 DNA as the positive control. Reaction volumes of 50|Lll
contained the DNA template ranging in concentration from lOOng to lpg, 50pmol of each
oligonucleotide primer, 200pM of each dNTP and 2 units of DNA Taq polymerase. DNA was
amplified using the cycle parameters: denaturation at 95°C for 10 minutes followed by 25 cycles
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of denaturation at 95°C for 1 minute, annealing at 50°C for 1 minute and extension at 72°C for 1
minute (section 2.4.6.1).
In all of the ORFV NZ2 positive control reactions, a PCR product of approximately 600bp was
amplified, which indicates that the PCR reaction conditions were suitable for the amplification
of the F13L gene (results not shown). However no PCR product was obtained with the SPPV,
thus suggesting that the DNA sequence of the F13L in SPPV is different from the
parapoxviruses in the regions corresponding to the PCR primers, or that the F13L gene was not
present in the Not I K fragment.
7.2.2 Mapping of the F13L gene
Despite no PCR product being amplified, it was still expected that the homologue of the F13L
gene would be situated at the left end of the SPPV genome within Not I fragment K and so the
location was mapped using DNA hybridisation. Plasmid DNA containing the Not I fragment K
was digested with the restriction enzyme Pst I, which cleaved the DNA once within the vector
and three times within the insert (figure 7.1). The digested DNA products were electrophoresed
on a agarose gel along with the Kpn I-digested SPPV cosmid clones 5, 9, 28, 51 and 86 (section
4.6) and ORFV NZ2 genomic DNA also digested with Kpn I. A Southern blot was prepared
(section 2.4.5.3.1) from the agarose gel depicted in figure 7.1. The 0.6kb PCR product that was
amplified from the positive control ORFV NZ2 DNA (section 7.2.1) was labelled with
digoxygenin (DIG) and used to hybridised with the Southern blot (sections 2.4.5.1.2 and
2.4.5.4).
The DIG-labelled ORFV PCR product hybridised with a Kpn I fragment located within SPPV
cosmid clone 86 and the 5kb Pst I digest product of the plasmid clone containing SPPV Not I
fragment K (figure 7.2), confirming that F13L is located at the left end of the SPPV genome
within the Not I fragment K as predicted. The 5kb Pst I fragment was predicted to consist of 3kb
plasmid DNA attached to the right-terminal 2kb of SPPV Not I K fragment. The 5kb fragment
was purified from an agarose gel (section 2.4.4.1) and the plasmid clone re-circularised by
Iigating the ends together using DNA ligase.
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Figure7.1Agaroseelelectrophoresisofth KpnIdigestedco midslon(5,928,51 and86),KpnIdigestedORFVg omicDNA (isolateNZ2)andtheoIfragm ntKcl ned intopBluescriptSK" lasm dvectorand digestedwi hP tI.
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Figure7.2Southernblotfthagarosel depictedinfigur7.1probwi hthDIG- labelledF13LPCRproductthatw samp ified fromORFVNZ2DNAwithPPP-1and4 oligonucleotideprim rs(In shimaetat.,2000). TheF13LprobehybridisedwithORFVandt SPPVclonesN tIKa dosmid86(<—).
7.2.3 Sequence analysis of F13L
DNA sequence was obtained from both ends of the SPPV DNA sequence contained within this
new clone. Sequence derived with the T3 primer corresponded with the sequence previously
obtained from the right end of Not I fragment K (encoding a homologue of the VACV gene
F15L). Hence, confirming that the 2kb Pst I fragment corresponds with the right end of Not I
fragment K. Sequence derived with the T7 primer was translated into all six ORF and the
sequence databases searched for homologous proteins. The most significant match with the
predicted amino acid sequence of the SPPV ORF designated SP 19.05L (figure 7.3) was with the
ORFV NZ2 homologue of VACV F13L. The partial sequence of the SPPV F13L homologue
corresponded with the published sequence of several parapoxvirus (Inoshima et al., 2000;
Becher et al., 2002). The regions in ORFV and SPPV, which corresponded to the PCR primers
PPP-1 and PPP-4 exhibited considerable differences in nucleotide sequence. Suggesting that the
pan-parapoxvirus primers were unlikely to anneal with the SPPV DNA templates under the
conditions used. Hence explaining the inability to amplify a product from the SPPV DNA by the
PCR.
7.3 MULTIPLE SEQUENCE ALIGNMENT OF THE E4L AND F13L GENES
The majority of the DNA sequences that are published for the parapoxvirus F13L homologues
are derived from the pan-parapoxvirus PCR products (Inoshima et al., 2000; Becher et al., 2002)
and correspond to the central region of the ORFV F13L homologue, extending from amino acids
137 to 320 (Sullivan et al., 1994). The F13L sequence derived from SPPV DNA (section 7.2.3)
also spans this region (ORFV amino acids 129 to 344). Therefore it was aligned with all the
known parapoxvirus F13L homologues and a further 15 sequences, with at least one member
from each of the remaining chordopoxvirus genera being represented. The multiple alignment
programme ClustalW (section 2.4.8.4.1) was used with the window of alignment corresponding
to the ORFV amino acids 137 to 320 (figure 7.4).
The multiple sequence alignment generated by ClustalW was validated by shading the amino
acids according to their physiochemica! propeilies. Despite the obvious differences between the
SPPV sequence and that of the other poxviruses at the amino acid level, the F13L homologues
were conserved at the physiochemical level. The percentage identity values (section 2.4.8.4.1) of
SPPV sequence with those derived from viruses belonging to all eight defined poxvirus genera
are summarised in table 7.1. Surprisingly, the percentage identities of the SPPV sequence with















SFTEFRRRLDRALPAYESYLGLTK I TS I SG
CCCCGTGAGCGAGGCGCTGCCGCGTACCAG 660
GTLSASGRVL * SP !9-05L
Figure 7.3 DNA sequence corresponding to the SPPV F13L homologue. The sequence is
presented in the same direction as the SPPV genome (5' to 3'). The predicted amino acid
sequence of the putative ORF SP 19.05L, which is encoded by the reverse complement DNA
strand (not shown) is presented below the DNA sequence.
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Table 7.1 The percentage identities of the putative SPPV major membrane protein (F13L) and
the RNA polymerase subunit RPO030 (E4L) with homologues derived from virus species
belonging to the eight defined poxvirus genera. The percentage identities were obtained from
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—jure 7.4 Multiple sequence alignment of the predicted amino acid sequences of poxvirus F13L genes,
luding several accepted and tentative species of the parapoxvirus genus. The multiple sequence
jnment was performed using the Clustal W alignment algorithm (Thompson et at., 1994) and aligned
lino acids shaded according to their physio-chemical properties (Taylor, 1986). The identity of each virus
ndicated by its standard abbreviation (van Regenmortel et at., 2000) or as defined in the summary of
deviations (located at the beginning of this thesis).
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The precise length of the SPPV homologue of the VACV E4L gene could not be determined,
however estimates suggest that it does not correspond in length with any of the characterised
poxvirus E4L genes (section 6.3.2.1). A preliminary multiple sequence alignment was performed
with the complete amino acid sequence of the SPPV and several other poxvirus E4L genes
representing all eight defined genera (results not shown). As expected there was considerable
variability at both ends of the E4L alignment, however a conserved "core" of approximately 180
amino acids was identified. Thus a second multiple sequence alignment was performed with
amino acids 34 to 211 of the SPPV sequence and the comparable regions of 16 other E4L
homologues representing all of the defined poxvirus genera (figure 7.5).
As with the F13L alignment, the E4L alignment was also validated by shading the aligned amino
acids according to their physio-chemical properties. At the physio-chemical level all sequences
were completely conserved, although gaps were inserted into some sequences at enable
alignment. The percentage identities of the SPPV E4L sequence with the 16 aligned poxvirus
sequences were calculated (table 7.1). Identity ranged from 58% to 64% for most genera,
however SPPV exhibited the lowest identity with the parapox and avipox viruses (ORFV and
FPV) at 55%.
7.4 PHYLOGENETIC TREE CONSTRUCTION
Phylogenetic trees were constructed from the multiple sequence alignments depicted in figures
7.4 and 7.5 using the maximum likelihood algorithm PROML (section 2.4.8.1.3). The trees are
presented in radial form in figures 7.6 and 7.7. Bootstrap resampling, based on 100 data sets
(section 2.4.8.1.4) was used to examine the statistical significance of the observed clades.
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-gure 7.5 Multiple sequence alignment of the central region of the SPPV RNA polymerase subunit
30030 (homologue of VACV E4L gene) with sixteen other poxvirus E4L homologues, representing at
rst one member of each defined poxvirus genera. The alignment was performed using the ClustalW
jorithm (Thompson et ai, 1994) and the aligned sequences shaded according to their physio-chemical
iperties (Taylor, 1986). The identity of each virus is indicated by its standard abbreviation (van





















Figure 7.6 Phylogenetic tree of the Chordopoxviridae based upon analysis of the predicted
amino acid sequence of the major membrane protein (homologues of the VACV F13L gene).
The tree was constructed from multiple sequence alignment data (figure 7.4) using the
maximum likelihood algorithm PROML and evaluated by bootstrap analysis of a hundred
resampled data sets. Defined genera where two or more member species were included in
the analysis are circled. Genera where only one representative member species was included
are not circled and are referred to by their standard abbreviation. Relevant bootstrap
percentages supporting diverging branches are shown where appropriate.
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ORFV
Figure 7.7 Phylogenetic tree of the Chordopoxviridae based upon analysis of the predicted
amino acid sequence of the RNA polymerase subunit RPO030 (homologues of the VACV
E4L gene). The tree was constructed from multiple sequence alignment data (figure 7.5)
using the maximum likelihood algorithm PROML and evaluated by bootstrap analysis of a
hundred resampled data sets. Defined genera where two or more member species were
included in the analysis are circled. Genera where only one representative member species
was included are not circled and are referred to by their standard abbreviation. Relevant
bootstrap percentages supporting diverging branches are shown where appropriate.
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7.5 DISSCUSSION
The pan-parapoxvirus primers (Inoshima et al., 2000) were successfully used to amplify a region
of the F13L homologue in all parapoxvirus species tested to date except for SPPV, which casts
further doubt on the validity of including SPPV in the parapoxvirus genus. Furthermore, the
percentage identity between the SPPV F13L homologue and other poxviruses was generally
greater with species belonging to genera other than the parapoxviruses. This was also true for the
percentage identities between the SPPV E4L homologue and those derived from species
belonging to genera other than the parapoxviruses. Indeed the percentage identity between SPPV
E4L and ORFV E4L was only 55%, whereas all other poxvirus species, except for FPV, shared
at least 58% identity. These differences between SPPV and the parapoxviruses are also reflected
in the phylogenetic trees.
Phylogenetic analysis of the F13L protein grouped the five recognised species of parapoxvirus
(ORFV, BPSV, PCPV and PVNZ) and the tentative species of sealPPV and reindeerPPV
together, with 82% support from the bootstrap resampling (figure 7.6). The SPPV sequence
branched off from the parapoxvirus clade along with five other genera and was placed on a
separate branch of the tree with 68% support from the bootstrap resampling. Indeed, the
placement of SPPV on a branch separate from all other defined poxvirus genera suggests that
SPPV may represent a separate genus of the poxvirus family.
Phylogenetic analysis of the E4L sequences also supports the inferred phylogeny of SPPV as a
virus that is distinct from all defined poxvirus genera (figure 7.7). Once again ORFV was placed
on a distinct branch, with 95% support from bootstrap resampling, whilst SPPV appeared on a
branch of its own, supported by 64% from bootstrap analysis. This again supports the





8.1 COMPARISON OF SPPV TO OTHER POXVIRUSES
This thesis describes the morphology and the characterisation of the genome of the SPPV isolate
1296/99, which has subsequently been shown to be highly virulent and cause severe disease in
all red squirrels challenged with this isolate (Thomas et al., 2003, accepted for publication). The
general surface morphology of the SPPV isolate 1296/99 (section 3.2) was similar to that of the
parapoxviruses and consistent with observations previously reported for SPPV (Scott et al.,
1981). The dsDNA genome was estimated to be 158kb in length and consists of approximately
66.4% G+C. The central core region of SPPV hybridised strongly with the central core region of
the ORFV genome, suggesting that the central regions of the two genomes are highly conserved
at the nucleotide level. Furthermore, DNA sequencing putatively identified twenty-six genes,
which are highly conserved within the poxvirus family and are generally essential for viral
replication, located towards the centre of the SPPV genome. The order of these genes in SPPV is
also identical to the order found in other poxviruses, which indicates that SPPV is consistent
with other poxviruses in terms of genome organisation. However, the terminal regions of the
SPPV genome did not hybridise with ORFV suggesting that the two genomes are divergent
towards the termini. This was not unexpected as the terminal regions of the different
parapoxvirus species do not cross-hybridise (Gassmann et al., 1985).
Despite exhibiting a similar surface morphology and a comparable genomic G+C content, SPPV
differs from the parapoxviruses in several important areas. 1) The size of the SPPV genome is
approximately 18kb larger than all known wild type parapoxviruses (Menna et al., 1979;
Robinson et al., 1982; Robinson et al., 1987; Horner et al., 1987; Mercer et al., 1987; Mclnnes
et al., 2001). 2) No parapoxvirus genus-specific genes were identified in the SPPV genome
despite extensive DNA sequencing of the regions predicted to contain such genes. 3) The
distances between the putative genes in SPPV are considerably different from the distances
observed in ORFV (Mercer et al., 1995), particularly towards the ends of the genome. Moreover,
there appeared to be a greater similarity between the ORFV and VACV genomes than between
SPPV and ORFV. 4) The translocation (with respect to other poxviruses) of the F9L and F10L
homologues from the left to the right end of the ORFV genome (Mercer et al., 1995) may not
have occurred in SPPV, although the identification and mapping of these genes in SPPV is
required to confirm this assumption. The translocation of these two genes is also apparent in the
genomes of PCPV and BPSV (Ueda et al., 2003; Rziha et al., 2003) and therefore may prove to
be a defining feature of parapoxviruses. 5) The VACV E3L and the three ORFV genes, IL-10,
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GIF and VEGF that are associated with immuno-modulation and virulence appear to be absent in
SPPV. This was most surprising for the E3L gene, which is conserved in nearly all poxviruses
characterised to date except for MOCV and FPV (Senkevich et al., 1997; Afonso et al., 2000).
6) Two genes believed to be unique to MOCV (026L and 157R) were identified in the SPPV
genome in comparable locations to MOCV. Taken together this data indicates that genomic
divergence between SPPV and ORFV is greater than the level of divergence observed between
the other parapoxvirus species. This may suggest that SPPV does not belong in the parapoxvirus
genus.
The comparable genomic G+C content between SPPV and MOCV and the presence of two
MOCV specific genes in the SPPV genome raises the possibility that SPPV may belong in the
molluscipoxvirus genus. However this is unlikely as the clinical pathology of the two diseases is
quite different. MOCV causes small self-limiting epithelial tumours in the dermis of humans
(Diven, 2001). In the red squirrel, SPPV produces large necrotic dermal lesions, which are often
haemorrhagic (figure 8.1). In addition to the different pathologies, the MOCV genome is
approximately 32kb larger than SPPV and when the two genomes are compared, the spatial
distribution of genes is markedly different.
In an attempt to clarify the taxonomic relationships of SPPV, phylogenetic analysis of two
putative SPPV proteins that are conserved across all eight genera was employed (chapter 7.0).
Contrary to the formal classification of SPPV as a parapoxvirus (van Regenmortel et al., 2000),
the analysis provided no evidence to support its classification as such. Indeed the SPPV
sequences did not group with any of the clades representing defined poxvirus genera, suggesting
that SPPV may represent a separate genus of the poxvirus family. In view of data presented in
this thesis it may be appropriate to remove SPPV from the parapoxvirus genus and place it into a
new genus on its own. In addition, the misleading name of squirrel parapoxvirus (SPPV) should
be changed to squirrel poxvirus (SQPV).
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Figure 8.1 Red squirrel 1296/99 found dead during in an outbreak of SQPV in Gateshead,
Northumbria. The animal has severe necrotic and haemorrhagic lesions on the face, hands, feet
and thorax attributed to SQPV. Negative contrast electron microscopy revealed parapoxvirus-
like particles in the lesions and sera collected from this animal tested positive for antibodies
against SQPV by ELISA (Sainsbury et a!., 2000).
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8.2 FURTHER CONSIDERATIONS
The red squirrel is now all but extinct from England and Wales with just a few isolated
populations remaining. The remaining stronghold in Scotland is now under threat from
interloping grey squirrels and SQPV (Pepper and Paterson, 1998; P. Nettleton personal
communication). This situation is mirrored in Italy where the red squirrel is being rapidly
displaced by the greys in deciduous woodland (Lurz et al., 2001). Conservation strategies
encompass several areas including; habitat management, translocation and reintroduction of red
squirrels, supplemental feeding programmes and grey squirrel control (reviewed in section
1.8.4). However, in the UK, many conservation programmes have encountered problems due to
SQPV (Venning et al., 1997; Jackson, 1999). Whether SQPV is present in the red and grey
squirrel populations of continental Europe is at present not clear. A vaccine may prove to be
essential for the continuation and success of many red squirrel conservation programmes and
ultimately the survival of the red squirrel species.
On the basis of the inclusion of SQPV into the parapoxvirus genus, many assumptions were
made regarding viral transmission, host range and genes associated with immuno-modulation
that SQPV might possess. All of these are critically important for the development of effective
vaccine and conservation strategies, and in view of the findings reported in this thesis, many of
these assumptions may prove to be incorrect.
Circumstantial evidence suggests that the grey squirrel is the source of SQPV which was
introduced to the UK with the grey squirrel (Middleton, 1930). Serological evidence and
computer modelling also implicates the grey squirrel as a reservoir for SQPV, capable of
transmitting the disease to the susceptible red squirrel (Sainsbury et al., 2000; Rushton et al.,
2000; Tompkins et al., 2003). In addition, the rapid clinical progression of the disease
(Tompkins et al., 2002) and the high mortality rate seen in the red squirrel suggests that it is not
the natural host species for SQPV. The grey squirrel's resistance to SQPV may be due to the co-
evolution of host and virus resulting in genetic resistance. Conversely, the lack of previous
exposure to SQPV would suggest that the red squirrel lacks genetic resistance and is therefore
susceptible to SQPV. In this, SQPV may have many parallels with MYXV. MYXV is primarily
a disease of North and South American brush and jungle rabbits and infection of the host species
causes a non-lethal localised cutaneous fibroma. MYXV was recently introduced to Europe and
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Australia where, in the naive European rabbit, it causes a fatal systemic infection (Robinson and
Kerr, 2001).
Further research is required to confirm that infected grey squirrels are capable of transmitting the
virus to susceptible red squirrels and the route(s) of transmission needs to be identified. In
addition alternative reservoir species cannot be ruled out. A preliminary study assessing different
rodent species for their potential as reservoir hosts has been carried out (section 3.3). The data
suggests that the wood mice and bank voles are not involved in the epidemiology of SQPV.
However this work is not conclusive for rodents as a whole as only two species were assessed. In
future, several species of rodent should be assessed and these should preferably be sampled from
an area during in an outbreak of SQPV.
Previously it was assumed that the mode of transmission of SQPV was similar to that of the
parapoxviruses; via direct contact with infectious scab material either between individuals and/or
environmental contamination (Sainsbury and Gurnell, 1997). These routes are feasible between
red squirrels where infection results in extensive cutaneous lesions, although the rarity of clinical
symptoms in the grey squirrel would suggest that transmission from the grey to the red squirrel
via the scab route is unlikely. However, in parapoxvirus infections, transmission from
asymptomatic animals has not been ruled out (Nettleton et al., 1996b). An alternative route of
transmission is passive transmission via biting insects, which is known to occur in
leporipoxviruses. A report of an unusual epizootic of squirrel fibroma virus (SQFV) in America
described large numbers of grey squirrels with proliferative lesions around the eyes and ears
(Terrell et al., 2002). The facial lesions were attributed to biting insects favouring hairless region
of the body and the eyelids were proposed to be the site of inoculation. In SQPV the onset of
clinical symptom also occurs around the hairless eyes, nose and mouth (Edwards, 1962;
Sainsbury and Gurnell, 1995). Clearly the potential involvement of insect vectors in the
epidemiology of SQPV warrants further investigation. In addition, grey squirrels need to be
assessed to see if virus is present despite the absence of pathology. Now that DNA sequence of
SQPV is available, a diagnostic PCR could be developed and utilised in these studies. A greater
understanding of the transmission of SQPV may provide insight into control measures that could
be implemented during epidemics to reduce infection rates.
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Numerous examples exist of successful vaccination strategies involving the use of one poxvirus
to provide protection against another. However vaccination within a genus is more successful
than between genera. For example, VACV cross-protects against other orthopoxviruses such as
VARV and the emerging MPV (section 1.1), however it does not cross-protect sheep against
ORFV (Robinson and Mercer, 1988). Therefore, in terms of vaccination strategy, it is important
to establish the relationship between SQPV with the other poxviruses. As SQPV is formally
included in the parapoxvirus genus, it was a possibility that SQPV vaccination strategies would
encounter the same problems as ORFV vaccination. ORFV vaccines routinely comprise of live
attenuated ORFV strains such as D1701 and scabby mouth or live unattenuated virus such as
Scabivax™. However, vaccination only provides partial protection and the vaccinees are
susceptible to reinfection with a virulent ORFV although the severity of the disease is reduced
(Nettleton et al., 1996a). The lack of complete protection may be due to the array of immuno-
modulating factors that parapoxviruses possess. However, as SQPV appears to be only distantly
related to the parapoxviruses, the application of a live attenuated strain of SQPV may provide
complete protection.
Attenuation of poxviruses is most often achieved through prolonged passage in tissue culture.
Evidence suggests that an attenuated strain of SQPV may arise from the extensive passage of the
tissue culture isolate of SQPV. This is one option that could be pursued in the development of a
vaccine against SQPV. Alternatively manually disrupting known virulence or immuno-
modulating genes has also been demonstrated as a method to attenuate a poxviruses (Rziha et
al., 2000). Obviously such genes will need to be identified in SQPV, however the ongoing DNA
sequencing of the terminal 30kb of the SQPV genome should help to resolve this matter.
An undesirable effect of vaccination with live attenuated VACV and ORFV is that secondary
contacts are susceptible to infection with the vaccine strain. In the case of VACV this has
promoted safety concerns (Moss, 1996a). With ORFV secondary contacts often develop lesions
around the mouth comparable to those seen in natural infections (Haig and Mercer, 1998).
Infection of secondary contacts, which is considered undesirable in VACV and ORFV
vaccination, may actually be beneficial in terms of a wildlife vaccination strategy. A
transmissible vaccine will readily disseminate amongst the unvaccinated individuals within a
vaccinated population, thereby avoiding the need to individually trap and vaccinate each animal.
In addition, the virus may continuously circulate within a population thereby maintaining a high
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degree of protection. An attenuated and transmissible isolate of MYXV was shown to confer
protection against challenge with virulent MYXV in vaccinated European rabbits and in
secondary contacts (Barcena et al., 2000). This transmissible MYXV strain was exploited as a
vaccine vector expressing the capsid protein of the calicivirus rabbit haemorrhagic disease virus
(RHDV). Field trial vaccination demonstrated that all inoculated rabbits and 50% of
uninoculated rabbits seroconverted to both MYXV and RHDV (Torres et al., 2001).
The use of an attenuated and transmissible SQPV strain may warrant further investigation as a
vaccine strategy for the immunisation of red squirrels against SQPV. Obviously the release of
any virus into the wild should be undertaken only after rigorous safety testing to ensure that
there are no adverse effects of the vaccine and that the live vaccine has a limited host range.
Experimental release should take place in contained environment, as the effects of the virus in
wild animals may differ from the effects in laboratory animals due to stresses such as other
diseases, predators, nutritional stress and competitors (Torres et al., 2001).
In summary the data presented in this thesis strongly suggests that SQPV is not a parapoxvirus.
Therefore previous assumptions regarding transmission of SQPV in the wild, the possession of
parapoxvirus virulence and immuno-modulation factors and the efficacy of potential attenuated
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Table A1.1 Summary of hybridisation results produced by dot-blot, Southern blot and colony
screening of the Bam HI clones and fragments with Not I DIG-labelled fragments. Positive and
negative signals are depicted with the symbols: + and - respectively. Blank cells indicate that
the Not I DIG-labelled fragments were not used to screen the Bam HI clones.
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Table A1.2 Summary of hybridisation results produced by dot-blot, Southern blot and colony
screening of the Kpn I clones and fragments and fragments with Not I DIG-labelled fragments.
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Kpn I Clones and Fragment
BamHIDIG-LabelledPro s
K1-1 K1-TC K4-1 K11-1 K11-2 K13-1
;




* K45-1 K46-1 K47-1
B1A-1 +
B2-1
B3-1 - - - - + - - - - - - - - - - +
B5-2 -
B6A-1 - - - + - + - - + - - - - - -





B13-1 - - - - - - - - - - - - + - -
B16C-1
B19-1 - - - - - + + - - + - - - - -










Table A1.3 Summary of hybridisation results produced by dot-blot, Southern blot and colony


































































































































































































































































































































































































































TableA1.5Summaryofhybridisatione ultsprod cedyd t-blot,S utherlotandc l nyscr ingfthNIl n sfrag nt withKpnIDIG-labelledc ones. 302
Bam HI Clones and Fragments




CD B7D-1 B7C-1 iCOCD B11-1 B12-1 iooCD B16C-1 B19-1 B20B-1 B20A-1 B24-1 B25-1 iCOC\JCD B30-2 B51-2 B70-2 B98-1 B164-2

















K18-1 - - - + - - - - - - - + - -
K19-1 - - - - - - - - - - - - + - - - - -






K45-1 - - - - - - - - - + - - + +
K46-1 - - - - + - - + - - - - - -
K47-1 + - +
Table A1.6 Summary of hybridisation results produced by dot-blot, Southern blot and colony
screening of the Bam HI clones and fragments with Kpn I DIG-labelled fragments.
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Kpn I Clones Bam HI Fragment Sizes (kb) Not I Fragments Sizes (kb)
pK45-1 11.5, 5.3*, 2.45, 0.65, 0.55 10.1, 3.6*, 2.7, 2.3, 1.55, 0.3
pK46-1 4.9*, 4.6 5.2*, 3.5, 0.8
pK18-1 6.4, 3.5* 8.0*, 1.3, 0.7
pK31-1 9.85* 6.1*, 2.85, 0.85
pK21-1 6.7*, 2.1 8.8*
pK47-1 6.2*, 2.05 4.6*, 2.5, 1.05
pK1-TC 3.95*, 3.65 6.6*, 0.75, 0.45
pK13-1 7.8* 4.4, 3.1*, 0.4
pK43-1 7.75* 4.9*, 2.95
pK32-1 6.85* 3.2*, 1.45, 1.1, 0.65, 0.45
pK1 -1 3.8*, 2.4 4.75*, 1.5
pK4-1 2.97*, 2.7, 0.17 3.5*, 2.15, 0.25
pK11-2 3.2*, 1.85 5.0*
pK19-1 3.6*,1.3 3.9*, 0.9
pK11-1 4.6* 4.6*
pK24-1 3.5* 2.9*, 0.6
Table A1.7 Summary of the fragment sizes produced when Kpn I clones were digested
singularly with Bam HI or Not I restriction endonucleases. Fragments with the * suffix denote
those that include the 2.96kb pBluescript SK" vector.
304
Bam HI Clones Kpn I Fragment Sizes (kb) Not I Fragments Sizes (kb)
pB7D-1 6.7*, 4.9, 4.8, 2.0, 0.25 8.0*, 4.4, 4.05, 2.35
pB19-1 9.3*, 6.8, 0.65 6.6*, 4.6, 3.3, 1.3, 0.9
pB3-1 8.4, 4.7*, 3.1 7.4, 3.4*, 3.2, 1.24, 1.05
pB25-1 14.3* 11.5*, 2.3, 0.65
pB8-1 7.6, 5.3* 5.3, 4.0*, 1.35, 1.05, 0.85, 0.25, 0.14
pB11-1 7.6*, 1.75 8.0*. 0.8, 0.4
pB5-2 4.7*, 3.0 3.5*, 2.45, 1.2, 0.45
pB98-1 6.6*, 0.9 4.5*, 2.65, 0.45
pB51 -2 4.15*, 2.45, 2.1 5.5, 3.25
pB16C-1 6.3*, 1.4 3.75, 3.8*, 0.17, <0.075
pB164-2 2.95, 3.15*, 0.9 4.2*, 2.65, 0.32
pB6A-1 4.1*, 1.6, 0.6, 0.55 5.6*, 0.65, 0.65
pB26-1 6.0* 6.0*
pB13-1 5.3*, 0.85 4.4*, 1.65
pB1 A-1 3.25*, 2.05, 0.7 5.55*, 0.5
pB20A-1 5.5* 3.25*, 2.05, 0.3
pB20B-1 3.5*, 1.45, 1.0 5.85*
pB7C-1 5.55* 3.4*, 1.2, 0.55, 0.45
pB30-2 5.5* 5.5*
pB12-1 4.1* 4.1*
pB70-2 4.15* 3.1*, 1.1
pB2-1 3.76* 3.75*
pB24-1 3.55* 3.55*
Table A1.8 Summary of the fragment sizes produced when Bam HI clones were digested
singularly with Kpn I or Not I restriction endonucleases. Fragments with the * suffix denote those
that include the 2.96kb pBluescript SK" vector.
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Not I Clones Kpn I Fragment Sizes (kb) Bam HI Fragments Sizes (kb)
N9B-1 12.8* 11.5*, 1.65
N7-1 8.0*, 1.6, 0.55 7.6*, 2.65
N5-1 5.9, 3.1*, 0.5 7.0*, 2.55
N42-2 6.5*, 2.65, 1.45 5.6*, 2.95, 2.05
N22A-1 4.3*, 2.05, 1.4, 0.9 5.5*, 3.2
N13-1 3.5, 4.7* 5.1, 3.0*
N26A-1 7.8* 4.0*, 3.0, 0.65
N10B-1 5.7*, 2.45, 0.25 8.0*, 0.4
N4-1 6.8*, 1.5 8.25*
N65-2 7.1* 3.4*, 2.6, 1.1, 0.1
N16-1 7.3* 7.3*
N12-1 3.55*, 3.25 6.7*,
N14D-1 5.6*, 0.7 5.9*
N15D-1 3.5*, 2.6 5.5*, 0.47
N3-1 5.0*, 0.75 4.2*, 1.5
N24-1 3.25*, 2.1 5.25*
N55-2 5.4* 3.5*, 1.05, 0.8
N9A-1 4.4*, 0.8 3.75*, 1.5
N5-2 3.6*, 1.8 3.35*, 0.95, 0.85, 0.17
N30-1 5.3* 5.3*
N1-1 5.1* 5.1*
N6-1 3.1*, 1.45, <0.075 4.45*
N11A-1 4.5* 3.25*, 0.65, 0.65
N15H-1 4.3* 4.3*
N14A-1 4.2* 4.3*









Table A1.9 Summary of the fragment sizes produced when Not I clones were digested
singularly with Kpn I or Bam HI restriction endonucleases. Fragments with the * suffix denote
those that incorporate the 2.96kb pBluescript SK" vector.
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A parapoxvirus has been implicated in the decline of the red squirrel in the United Kingdom.
Virus was isolated from an outbreak of lethal disease in red squirrels in the north-east of England.
Experimental infection of captive-bred red squirrels confirmed that this virus was the cause of
the severe skin lesions observed. Electron microscopic examination of the virus showed that it
had a morphology typical of parapoxviruses whilst preliminary sequence data suggested a genomic
G + C composition of approximately 66%, again similar to that found in other parapoxviruses.
However Southern hybridization analysis failed to detect three known parapoxvirus genes, two of
which have been found so far only in the genus Parapoxvirus. Comparative sequence analysis
of two other genes, conserved across the eight recognized chordopoxvirus genera, suggests
that the squirrel virus represents a previously unrecognized genus of the Chordoxviridae.
prognosis for the survival of the red squirrel (Sciurus
aris) in the United Kingdom is poor. Numbers have
i in decline for the last 150 years (Lloyd, 1983; Gurnell
epper, 1993), with extinction in mainland England
ible within the next 20 years (Kenward & Holm, 1989;
rell & Pepper, 1993). Competition between red and
squirrels for habitat and food undoubtedly plays a
in replacement of the red species by the grey squirrel
Icher, 1997). However several authors have attributed
extinction of local populations of red squirrels to the
:nce of an epidemic disease that causes high mortality
lsbury etal, 1997, 2000; Rushton et al., 2000; Tompkins
,, 2003). The disease is characterized by ulcerated and
lorrhagic scabs affecting the skin around the eyes, nose
—lips which later spread to the ventral thorax, inguinal
and feet (Edwards, 1962; Sainsbury & Gurnell, 1995).
causative agent was identified tentatively by electron
oscopy as a parapoxvirus (SPPV) (Scott et al, 1981).
origin of the virus is not clear, but no clinical disease
•ecorded until the introduction of grey squirrels to the
■Sainsbury & Gurnell, 1995). A serological survey of
md grey squirrels from across the UK revealed that
of 223 apparently healthy grey squirrels had antibodies
>PV, whereas only 3-2% of 140 red squirrels were
■ositive (Sainsbury et al., 2000). All the seropositive red
rels were found dead or dying with symptoms typical
: poxvirus disease. There has only been one confirmed
:nt address: University of Otago, Dunedin, New Zealand.
report of SPPV-induced disease in a wild grey squirrel
(Duff et al., 1996), and generally grey squirrels are thought
to be unaffected clinically. However, the high seroprevalence
of antibodies to the virus and low incidence of disease
in grey squirrels suggest that they may be a reservoir for
SPPV, which is then transmitted to red squirrels causing
lethal disease.
Experimental infection with a mixture of isolates from
various outbreaks of scab disease confirmed that SPPV
is the agent responsible for the disease observed in red
squirrels. In contrast, infection of grey squirrels failed to
induce disease although all developed antibodies to the
virus (Tompkins et al., 2002). We have taken a single iso¬
late of the virus from an outbreak of disease in northern
England and shown that it alone causes a deleterious disease
in red squirrels. Sequencing and subsequent phylogenetic
analysis of genes from this virus casts doubt over its
relationship to the parapoxviruses.
Virus was isolated from a red squirrel (see supplementary
data at JGV Online: http://vir.sgmjournals.org) with typical
SPPV-induced haemorrhagic erythematous dermatitis about
the face and on the feet and was visualized by negative-
staining transmission electron microscopy. The SPPV parti¬
cles were generally ovoid with approximate dimensions
of 275 x 175 nm, similar to the parapoxviruses. The regular
basket-weave surface morphology characteristic of the para¬
poxviruses was also observed (Fig. 1A). However, the angle
at which the SPPV basket-weave ridges cross each other
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Days post-infection
(A) Virus from the scabs on a squirrel (1 296/99) found
Northumberland, England, exhibiting typical poxvirus-like
on the head, hands and feet (see supplementary data at
line: http://vir.sgmjournals.org), was visualized by negative-
transmission electron microscopy. (B) Two captive-bred
irrels were infected with virus isolated directly from scab
taken from squirrel 1 296/99. Scabs were homogenized in
d after clarification at 2000 g for 30 min at 4 °C, the virus
rified by centrifugation at 71 000 g for 30 min at 4 °C
a sucrose cushion (36%, w/w, in PBS). The virus pellet
suspended in PBS, the concentration estimated by electron
opy and adjusted to approximately 1 05 virus particles ml-1,
lirrels were infected with the virus suspension and their
ras monitored every 12 h according to the clinical scoring
of Tompkins et al. (2002). Animals exhibiting a clinical
8 or more on three consecutive occasions were removed
experiment.
to differ from that of other parapoxviruses, support-
previous observations made by Scott et al. (1981).
nation that this virus could induce scab disease was
d by experimental infection of two captive-bred red
squirrels. Virus was isolated directly from scab material and
its concentration was estimated by electron microscopy and
adjusted to approximately 10s virus particles ml-1 in PBS.
Squirrels were challenged by topical application of 0-2 ml
virus suspension to a scarification site on the right thigh
and also by subcutaneous injection of 0-2 ml into the right
thigh. The progression of disease in each animal was assessed
every 12 h using the clinical scoring system described by
Tompkins et al. (2002). Individuals scoring eight or more
on three consecutive occasions were removed from the
experiment, as it was predetermined that this severity of
disease would cause mortality in the wild. Both squirrels
succumbed to disease within 10 days. Severe secondary
lesions appeared within 2 weeks and the animals exhibited
lethargy and poor condition, appetite loss by up to 100 %
and reduction in body weight by up to 12 %. The prog¬
ression of disease in both individuals (Fig. IB) was not
significantly different from that reported previously
(ANOVA ^3 = 0-06, P= 0-83), with animals being
removed from the experiment at days 17-5 and 18-0,
compared to days 15-0, 17-0 and 18-5 in the previous
study with the mixture of viruses. The overall pathological
symptoms were consistent with those reported previously
in wild red squirrels (Edwards, 1962; Sainsbury 8c Gurnell,
1995), and confirmed that the isolated virus was virulent.
SPPV has been formally classified as a Parapoxvirus
(van Regenmortel et al., 2000), although Sands et al.
(1984) concluded that SPPV and Orf virus (ORFV) were
antigenically distinct. Furthermore, in a study of 27
monoclonal antibodies (mAbs) raised against ORFV, only
two were found to cross-react with SPPV (Housawi et al.,
1998). This contrasts with 17 mAbs that cross-reacted
with both Pseudocowpox virus (PCPV) and Bovine papular
stomatitis virus (BPSV) and six that cross-reacted with
Sealpox virus, suggesting that SPPV is more divergent from
ORFV than from these other parapoxviruses. To study the
relationship between SPPV and the other parapoxviruses
we attempted to identify genes within the SPPV genome
that were related to known ORFV genes and in particular
to those associated with modulation of the host immune
response and/or virulence. Five cosmid clones that span
the SPPV genome were screened for the presence of
sequence related to the ORFV GIF gene (encoding a
protein capable of binding interleukin-2 and granulocyte-
macrophage colony-stimulating factor; Deane et al., 2000),
the VEGF-E gene (encoding a protein related to mam¬
malian vascular endothelial growth factor; Lyttle ct al., 1994),
the IL-10 gene (encoding a protein closely related to
mammalian interleukin-10; Fleming et al., 1997) and the
orthologue of the H5R gene of Vaccinia virus (VACV)
(encoding a late transcription factor, VLTF-4; Kovacs 8c
Moss, 1996). Two of these genes, VEGF-E and GIF, have
been found so far only in parapoxviruses whilst the IL-10
gene has also been found in the capripoxvirus Lumpy skin
disease virus (LSDV) (Tulman et al., 2001). Orthologues
of H5R are found in each of the chordopoxvirus genera.
No specific hybridization between the ORFV probes and
Journal of General Virology 84
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'V DNA was detected with the exception of that corres-
lding to the H5R gene (results not shown). On the basis
this it was hypothesized that SPPV does not encode
lologues of any of the ORFV GIF, VEGF or IL-10 genes
that the corresponding SPPV sequences have diverged
iciently so as to prevent cross-hybridization. Com-
ative sequence analysis of 22 ORFV strains and isolates
lonstrated that the VEGF-E gene varies considerably
a within a single species of virus (Mercer et al, 2002).
s heterogeneity could explain our inability to identify
jrthologue of VEGF-E in SPPV by hybridization. VEGF-
:nes are present close to the right ITR junctions in two
he three parapoxviruses for which there is sequence
i available, that is in ORFV and PCPV, but not in BPSV
.tie et al., 1994; Rziha et al., 2003; Ueda et al., 2003).
sequenced approximately 1 kb of the corresponding
on of the SPPV genome, but were unable to identify an
iologue of VEGF-E. Instead an ORF with similarity to
003L and I57R genes of Molluscum contagiosum virus
)CV) was found (results not shown). These genes appear
epresent paralogues of each other although they do
:r at their 3' ends (Senkevich et al., 1997). The SPPV
: (GenBank accession no. AY312570) is approximately
o identical to the MOCV sequences, with the predicted
no acid sequences sharing approximately 28 % identity.
hybridization and sequence data taken together sug-
that SPPV probably does not possess an orthologue
3RFV VEGF-E. This was unexpected because the
:arance ofSPPV-induced lesions suggests an underlying
ularization similar to that of ORFV-induced lesions,
vascularization appears to be a function of VEGF-E
: knockout viruses lacking this protein produced lesions
had lower blood vessel formation in the dermis than
ns induced with wild-type virus and as a consequence
: considerably less erythematous and florid (Savory
., 2000).
e we were unable to identify known parapoxvirus
s associated with immunomodulation or virulence
in the SPPV genome we sought alternative genes with
h to explore the relationship between SPPV and other
poxviruses. Phylogenetic analysis with the partial
ence of the major outer envelope protein (orthologue
ACV F13L) has been used to infer speciation within
genus Parapoxvirus (Becher et al., 2002). Previous
/sis was based on the alignment of amino acids 137 to
(numbering with respect to the ORFV protein) because
lata produced for the majority of parapoxviruses are
red from PCR products using primers considered to
pecific for all parapoxviruses (Inoshima et al., 2000).
npts to obtain a PCR product from SPPV DNA using
: primers failed. Nevertheless we identified, by DNA
idization with the ORFV gene, a plasmid containing the
:sponding SPPV sequence. Sequence analysis revealed
>resence of an ORF (GenBank accession no. AY312569)
:sponding to amino acids 129 to 344 of the ORFV
fin. Pairwise alignment of the predicted SPPV amino
A novel poxvirus lethal to red squirrels
acid sequence with that of the four recognized species of
Parapoxvirus, ORFV, PCPV, BPSV and Parapoxvirus of red
deer in New Zealand (PVNZ), and the tentative member of
the genus, Sealpox virus, indicated that the SPPV protein
shared approximately 49 % identity to each. This was less
than with VACV F13L (57% identity). We aligned our
sequence with all known chordopoxvirus orthologues of
the F13L protein, representing all eight chordopoxvirus
genera, and constructed a phylogenetic tree based on a
maximum-likelihood algorithm (Fig. 2A). The analysis
grouped ORFV, BPSV, PCPV and PVNZ together with
Sealpox virus, but the SPPV sequence was placed on a
separate branch of the tree with 82 % support from the
bootstrap resampling. Indeed, the SPPV sequence was
placed on a branch of its own and did not partition with
any of the other poxvirus genera, suggesting that SPPV
represents a separate genus of the Poxviridae.
To gather support for this theory we performed a similar
phylogenetic analysis on a second SPPV gene. The ortho¬
logue of the VACV E4L gene (encoding the 30 kDa RNA
polymerase subunit; Ahn et al., 1990) was identified by
random sequencing of plasmid clones derived from the
SPPV genome. It was predicted to encode a protein of
297 amino acids, 38 amino acids longer than the VACV
protein. Likewise, it is predicted to be 96, 75, 75, 115, 108
and 104 amino acids longer than the corresponding pro¬
teins in the Capripox, Leporipox, Suipox, Avipox, Yatapox
and Parapox genera, respectively. In contrast, the MOCV
orthologue is predicted to be 147 amino acids longer
than the SPPV sequence. Due to the variation in length
between the different orthologues an initial alignment of
the 17 available sequences, representing the eight different
chordopoxvirus genera (and including the SPPV sequence),
was performed. This indicated that there was a core of
approximately 180 amino acids that were well conserved
across all the genera. A phylogenetic tree based on an
alignment of these 'core' amino acids was constructed.
Bootstrap resampling, based on 100 data sets, was used to
examine the statistical significance of the observed clades.
Once again the SPPV sequence appeared on a branch of its
own in the phylogenetic tree (Fig. 2B), separated from the
ORFV sequence (the only parapoxvirus sequence available)
with 95 % support from the bootstrapping exercise, and
64 % from the other poxvirus genera. This particular anal¬
ysis, however, failed to separate the orthopoxviruses from
the Leporipox, Suipox, Capripox and Yatapox virus genera
with any strong bootstrapping support. Therefore, although
this phylogenetic tree supports the general observation
that SPPV does not readily partition with the parapox¬
virus ORFV, the exact relationship between it and the other
chordopoxvirus genera is less well defined.
Despite similarities in the base composition, virion
morphology and in the pathological symptoms of the
disease caused by SPPV when compared to the other
parapoxviruses, the phylogenetic analysis presented here
provides no support to classify SPPV in the genus
Air.sgmjournals.org 3
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FWPV B ORFV
—Fig. 2. Phylogenetic analysis was performed on orthologous amino acid sequences aligned using the ClustalW algorithm.
Maximum-likelihood trees were generated using the PHYLIP PROML program. The model of amino acid substitution used was
hat of Jones/Taylor/Thornton (Jones et al., 1992), and a mixed model of rate heterogeneity, with four gamma rates and one
nvariant rate, was used. The input order of the aligned sequences was jumbled 10 times and the global rearrangement option
was selected. The gamma distribution parameter alpha and the fraction of invariable sites were calculated using the TREE-
'UZZLE program (Schmidt et al., 2002). The trees were evaluated using 100 bootstrap replicates (Felsenstein, 1985) and a
:onsensus tree produced using the CONSENSE program. Trees were visualized using the graphical software TREEVIEW version
1.6.6 (Page, 1996). Branch lengths are proportionate to genetic distances and numbers indicate the percentage of bootstrap
eplioates that support each of the internal branches. Where several members of a genus were analysed and grouped
ogether the name of the genus is indicated. When only one member of a genus was used in the analysis the species is
ndicated. (A) Phylogenetic analysis of 20 orthologues of the VACV major outer envelope protein (encoded by VACV F13L).
he tree is based on an alignment of amino acids 137 to 313 (numbering with respect to the VACV-COP protein). The
tccession numbers for each of the sequences used in this analysis are; SPPV (AY312569), ORFV (Q84145), BPSV
Q91UK2), PCPV (Q91UK3), PVNZ (Q91UK1), Sealpox virus (Q8JTI4), VACV (P20638), Variola virus (VARV; Q85369),
Jowpox virus (CPXV; Q8QN05), Camelpox virus (CMLV; Q8V2W9), Ectromelia virus (ECTV; Q8JLG8), Swinepox virus
SWPV; Q9IW61), LSDV (Q9QCQ1), Sheeppox virus (Q9QCQ2), Yaba monkey tumour virus (YMTV; Q9DHT5), MOCV
Q98189), Fowlpox virus (FWPV; P36316), Rabbit fibroma virus [SFV ('Shope fibroma virus'); Q9Q949], Myxoma virus
MYXV; Q83604) and Monkeypox virus (MPXV; Q8V535). (B) Phylogenetic analysis of 1 7 orthologues of the VACV RNA
lolymerase 30 kDa subunit (encoded by VACV E4L). The tree is based on the alignment of amino acids 23 to 199
numbering with respect to the VACV-COP sequence). The accession numbers for each of the sequences used in this
nalysis are; SPPV (AY310357), ORFV (AY299390), Sheeppox virus (C84152), SWPV (08V3R1), MYXV (C908R6),
ACV (P21082), YMTV (Q9DHS7), LSDV (08JU11), Goatpox virus (GTPV; d 1319), CMLV (08V2W1), MPXV (C8V527),
CTV (AAM92348), CPXV (Q8CMZ7), VARV (085373), SFV (Q9C941), FWPV (O9J5C0) and MOCV (098202).
xvirus. However, a much more extensive study of
PV genome and the genes it contains will be
d before the virus can be classified with certainty.
—lassification will be important when considering
:pidemiological and ecological studies.
preparing this manuscript we noted that the
d abbreviation given to the Squirrelpox virus
is the same as has been given to Sheeppox virus
tgenmortel et al., 2000). We would like to suggest
that the alternative abbreviation SQPV be adopted for
Squirrelpox virus.
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